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SUMMARY 
 
Stigma is broadly considered as an important obstacle in HIV prevention and 
treatment. In Mozambique, more PLWHIV have access to treatment than ever. 
ART increased their QoL and created a new context for stigma production.  
 
This cross-sectional study conducted in Northern Mozambique explored a 
possible association between stigma and QoL. The Berger Stigma Scale and 
WHOQOL-BREF were used to measure levels of HIV-related stigma and 
perceived QoL in two groups of PLWHIV receiving ARV, with participation in a 
HBC programme as the independent variable.  
 
The study uncovered a weak to moderate negative correlation between stigma 
and QoL scores. Statistically significant differences were discovered between the 
groups’ scores on the Berger Stigma Scale and a higher perceived QoL for 
PLWHIV in the HBC group on three WHOQOL-BREF subscales and on the 
overall score. The scores on the social relationships subscale indicated lower 
perceived QoL for PLWHIV in the HBC group. 
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« … stigma is less a barrier to providing AIDS care as it is the reflection of a 
complete lack of decent health care for the poor. Stigma is a symptom of this 
grotesque failure but it is often used as an excuse for further inaction ». 
 
Paul Farmer (2006), American anthropologist and physician 
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CHAPTER 1 : SITUATING THE RESEARCH PROBLEM 
 
1.1 INTRODUCTION 
 
With over 16.1% of its 15- to 49- year old population currently living with HIV, 
Mozambique is ranked 8th in Africa in terms of highest HIV prevalence rates 
(Joint United Nations Programme on HIV/AIDS 2008a; Population Reference 
Bureau 2006: 7). Overall, more than 1.8 million people are living with HIV in 
Mozambique (United Nations Joint Programme on HIV/AIDS 2006: 412). The 
number of people living with HIV (PLWHIV) in need of antiretroviral therapy 
(ART) exceeds the actual response by the Ministry of Health. In fact, as of 
December 1st 2007, 78,236 PLWHIV were receiving ART in Mozambique out of 
233,954 in need of treatment as estimated in October of 2005 (Global Fund 
2007:2; Government of Mozambique 2006: 21). 
 
Most Mozambicans, especially in rural areas, have to face many difficulties such 
as low levels of educational attainment, a weak public health care system, 
widespread poverty, unequal gender relations and food production which is 
dependant on rain-fed crops (African Union 2004: 1; Hardon, Davey, Gerrits, 
Hodgkin, Irunde, Kgatlwane, Kinsman, Nakiyemba, & Laing 2006: 1; Kessides 
2005: 1; Kim & Watts 2005: 769; Marston & de Cock 2004: 80; Organisation for 
Economic Co-operation and Development 2002: 226; Smit & Pilifosova 2001: 
903; United Nations Educational, Scientific and Cultural Organisation 2005). 
 
PLWHIV in rural areas not only face these problems, but have to deal with 
aggravating circumstances that further lower their life expectancy and quality of 
life (QoL). In the context of the study, rurality is an issue, as people living in rural 
areas have limited access to ART, low access to prevention of mother-to-child 
transmission (PMTCT), increased expenses in order to adhere to treatment and 
high levels of HIV and AIDS-related stigma (Hardon et al. 2006: 7; McCoy 2003: 
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31; Rosen, Sanne, Collier & Simon 2005: 1098; World Health Organisation 2007: 
5). These conditions form some of the barriers preventing PLWHIV in rural areas 
from enjoying a good quality of life.  
 
1.2 THE RESEARCH PROBLEM 
 
The targeted communities of the study, that is, residents in the Malema and 
Ribáuè Districts, are located in the Province of Nampula in Northern 
Mozambique (see Figure 3.1). Salama, a local non-government organisation 
(NGO), has been implementing a home-based care (HBC) programme for 
PLWHIV since 2006, first in Ribáuè and then in the Malema District in 2007. 
Before the completion of the current study, it had been impossible to measure 
QoL and HIV and AIDS-related stigma levels in Salama’s HBC programme.  By 
analysing the relationship between these variables, this study filled a knowledge 
gap relevant to the work conducted by the NGO as the reduction of HIV and 
AIDS-related stigma and the improvement of the quality of life of PLWHIV in the 
above mentioned communities is an objective of Salama’s HBC programme 
(Salama 2006:5).  
 
Research by Major and O´Brien (2005) has established that stigma affects 
people’s mental and physical health, and can be associated to a reduction in 
access to health care services. Also, a study by Remor (2002) has shown that 
there is a link between social support and ART adherence. Even though it is not 
a stated objective of home-based care by the Ministry of Health (Mozambique, 
Ministry of Health 2003: 4), anecdotal evidence gathered from programme staff 
and volunteers suggests that there is a relationship between the presence of a 
home-based care programme and reduced levels of HIV and AIDS-related 
stigma as well as an increase in the perceived quality of life for the PLWHIV 
benefiting from the programme.  Based on this, the central research focus of this 
study was to compare perceived quality of life and experiences of HIV and AIDS-
related stigma for PLWHIV in two groups: one consisting of PLWHIV on ART 
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receiving HBC services, and another of PLWHIV on ART not receiving HBC 
services.  
 
Thus, this study is an attempt to comprehensively describe the conditions for 
PLWHIV in the Malema and Ribáuè Districts, to ascertain their quality of life and 
experiences of HIV and AIDS-related stigma and to examine the relationship 
between these two concepts. 
 
1.3 THE METHODOLOGICAL ORIENTATION 
 
The study measured quality of life and HIV and AIDS-related stigma levels in two 
groups: one group composed of PLWHIV on ART receiving HBC services and 
another composed of PLWHIV on ART not receiving HBC services.  
 
A variety of separate quantitative instruments were employed within the same 
interview session to measure the perceived quality of life and HIV and AIDS-
related stigma levels experienced by the research participants. The Berger 
stigma scale (Berger, Ferrans & Lashley 2001), a tool designed to measure the 
levels of HIV and AIDS-related stigma experienced by PLWHIV, was used to 
review the levels of stigma experienced by each group and then compare levels 
between groups. In addition, an instrument based on the Portuguese, 
abbreviated version of the World Health Organisation Quality of Life Assessment 
(WHOQOL-BREF) was used to measure the quality of life in both groups 
(Canavarro, Simões, Vaz Serra, Pereira, Rijo, & Quartilho 2008; World Health 
Organisation 2004). 
 
1.4 THE PURPOSE OF THE STUDY 
 
The purpose of the study is to explore whether or not receiving HBC services is 
linked to quality of life and level of HIV and AIDS-related stigma experienced by 
PLWHIV on ART. Should a link be discovered, the nature of the interaction is to 
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be discussed. As it would be premature to look for a causal effect of HBC 
programmes on HIV and AIDS-related stigma scores and QoL measurements in 
PLWHIV before examining if a difference between PLWHIV in a HBC programme 
versus PLWHIV not in a HBC programme exist, the current study looked at 
correlation between those variables instead.  
 
The reason for choosing HBC as a research focus is that HIV and AIDS-related 
stigma reduction is considered to be an objective of HBC programmes 
(Waterman, Griffiths, Gellard, O’Keefe, Olang, Ayuyo, Obwanda, Ogwethe & 
Ondiege 2007:1037). However, the scientific literature available does not provide 
clear evidence that HBC services actually play a role in decreasing stigma in 
communities where they are implemented (Young & Busgeeth 2010). 
  
From the start, it was decided to focus on people accessing ART. This orientation 
was taken by the researcher because PLWHIV on ART have a confirmed HIV 
status and have disclosed at least to one health provider when they were tested 
for HIV. Also, because PLWHIV on ART have to fetch their medicines regularly at 
the local VCT (voluntary counselling and testing) facilities, they could be 
contacted to take part in the study without the researcher having to identify 
PLWHIV on ART in the general population, a process that would have entailed all 
kinds of ethical and methodological problems.  
 
1.5 THE RESEARCH OBJECTIVES 
 
The objectives of the study were to find answers to the following questions:  
 
1. Is there a difference in the level of HIV and AIDS-related stigma 
experienced by PLWHIV on ART receiving HBC services and the level 
experienced by PLWHIV on ART not receiving HBC services? 
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2. Is there a difference in the self-reported quality of life scores for PLWHIV 
on ART receiving HBC services and the scores for PLWHIV on ART not 
receiving HBC services? 
3. Is there a correlation between HIV and AIDS-related stigma and self-
reported quality of life? 
 
1.6 DEFINITIONS OF KEY TERMS 
 
1.6.1 HIV and AIDS 
 
HIV means “human immunodeficiency virus” and consists of two different 
subtypes: HIV-1 and HIV-2. It was discovered in 1983 by two teams of scientists, 
one led by Luc Montagnier in France and the other conducted by Robert Gallo 
(Van Dyk 2005: 4). 
 
AIDS stands for “Acquired immune-deficiency syndrome”. AIDS was identified in 
1981 after a cluster of men in the United States became ill with a rare form of 
pneumonia. HIV was found to be the causal agent for AIDS. (Evian 2003: 3). 
 
1.6.2 HIV and AIDS-related stigma 
 
To the ancient Greeks, the word stigma referred to a mark, such as a tattoo, that 
could serve a decorative or religious function. Also, burning, scarring and 
otherwise permanently marking a slave could indicate ownership. It is important 
to note that the notion of stigma did not necessarily carry a pejorative meaning to 
the Greeks, as some marks were related to military wounds and were hence 
considered to be proof of hardships endured (Simon 1992: 30). 
 
The sociologist Erving Goffman (1963: preface) explained that “Stigma is the 
situation of the individual who is disqualified from full social acceptance”. More 
specifically, HIV and AIDS-related stigma means “prejudice, discounting, 
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discrediting and discrimination that are directed at people perceived as having 
HIV or AIDS, and at individuals, groups and communities with which they are 
associated” (Herek, Mitnick, Burris, Chesney, Devine, Fullilove, Fullilove, 
Gunther, Levi, Michaels, Novick, Pryor, Snyder & Sweeney 1998:36). 
 
According to Berger et al. (2001: 519) who designed the instrument used to 
measure perceived stigma in PLWHIV in this study, stigma evolves from what a 
person perceives to be the attitudes of society in relation to people living with HIV 
and one’s actual knowledge of living with HIV. Furthermore, “The central concept 
- perceived stigma- is conceptualized as the person with HIV's awareness of HIV-
related actual or potential social disqualification (less than full social acceptance, 
social rejection), denial or limitation of opportunity (for example, in housing, jobs, 
or dental services), and negative change in social identity (how others see 
him/her)” (Berger et al. 2001: 519).  
 
1.6.3 Quality of life (QoL) 
 
The concept of quality of life is constructed by different perspectives in 
sociological literature. One perspective focuses on the relation between quality of 
life and health; definitions emerging from that vantage point “… range from those 
with a holistic emphasis on the social, emotional, and physical well-being of 
patients after treatment to those that describe the impact of a person's health on 
his or her ability to lead a fulfilling life” (Carr, Gibson & Robinson 2001: 1240). On 
the other hand, quality of life can be defined by so-called “objective” measures 
such as life expectancy, literacy rates and economic growth indices (Costanza, 
Fisher, Ali, Beer, Bond, Boumans, Danigelis, Dickinson, Elliott, Farley, Gayer, 
Glenn, Hudspeth, Mahoney, McCahill, McIntosh, Reed, Rizvi, Rizzo, Simpatico & 
Snapp 2008: 12).  
 
One of the features of quality of life research is that it is a multidimensional, 
complex and culture-bound concept that has different meanings depending on 
 7 
 
the individual, the society, the period in time and many other factors. In that 
context, Skevington (2002: 135) has come to the conclusion that each study has 
its own definition of quality of life. 
 
The World Health Organisation suggested a general definition as a guideline for 
the development of the WHOQOL-BREF, the instrument used to measure quality 
of life in the current study. The organisation: “… defines Quality of Life as 
individuals’ perception of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, 
standards and concerns. [It is] affected in a complex way by the person's 
physical health, psychological state, level of independence, social relationships, 
personal beliefs and their relationship to salient features of their environment” 
(World Health Organisation 1997: 1). 
 
Similarly, the definition proposed by Costanza et al. (2008: 12) establishes the 
level of attainment of human needs as the essence of the concept of quality of 
life. This definition converges with the one proposed by the World Health 
Organisation in the sense that social interactions, mental and physical health and 
autonomy reflect basic needs that could be perceived as being fulfilled or not for 
an individual. The level of satisfaction conveyed by the perception of fulfilment is, 
in fact, perceived quality of life. This perception can be measured objectively with 
an instrument such as WHOQOL-BREF, or can be appraised with qualitative 
indicators. In this study, quantitative data have been used to provide quality of life 
measurements.  
 
1.6.4 Home-based care (HBC) 
 
The World Health Organisation (2002: 6) defines community home-based care 
as “…as any form of care given to ill people in their homes. Such care includes 
physical, psychosocial, palliative and spiritual activities. [Its goal] is to provide 
hope through high-quality and appropriate care that helps ill people and families 
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to maintain their independence and achieve the best possible quality of life”. This 
definition matches the reality of the HBC programme investigated in this study, 
as it included all the components of care mentioned above. 
 
1.6.5 Antiretroviral treatment (ART) 
 
ART is a combination of antiretroviral drugs that suppresses HIV and puts a halt 
to the progression of AIDS. ART has a number of side-effects, as well as 
toxicities and interactions with other drugs. (Habib 2006: 287; World Health 
Organisation 2009) 
 
1.7 CONCLUSION 
 
This chapter introduced the context in which the study was conducted. 
Background information about Mozambique and the barriers to health for 
PLWHIV were discussed. Next, the research problem was circumscribed and the 
methodological orientation outlined the quantitative methods used in the study. 
The purpose of the research followed, in which the focus on people living with 
HIV on ART was explained. The next section covered the three research 
objectives of the study. Finally, definitions for HIV and AIDS, HIV and AIDS-
related stigma, quality of life, home-based care and antiretroviral treatment were 
provided. 
 
In the next chapter, the relevant available literature for the study will be explored, 
including a description of the social context of HIV and AIDS in Mozambique, the 
nature of HIV and AIDS-related stigma and the concept of home-based care. A 
short presentation of Salama, the organisation through which the study was 
conducted, is also provided. 
 
 9 
 
In the third chapter, the methodology of the study is analysed, with specific 
sections on research design, sampling methods, measurement of variables, data 
collection procedures, data analyses and ethical considerations. 
 
The fourth chapter exposes the findings of the study and the characteristics of 
the sample. This will precede the discussion in which the results will be analysed 
and interpreted.  
 
The fifth chapter proposes a conclusion composed of the limitations of the study, 
suggestions for further research and recommendations for policy and practice.  
 
The list of references and the annexes are provided at the end of the study. 
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CHAPTER 2 : LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
In this chapter, the researcher examines the interrelatedness of HIV and AIDS-
related stigma and quality of life for PLWHIV in the Mozambican context based 
on a review of existing data and theories. These ideas are expanded to consider 
HBC, ART and the relevance of this in addressing HIV and AIDS-related stigma. 
Also, the work of Salama, a national NGO involved in providing HBC services to 
PLWHIV in Malema and Ribáuè, is described. Finally, the theoretical point of 
departure of the study is outlined and a model integrating HIV and AIDS-related 
stigma and quality of life is proposed. 
 
2.2 THE SOCIAL CONTEXT OF HIV AND AIDS IN MOZAMBIQUE 
 
When news of AIDS became known around the world, well into the 1980s, 
Mozambique was less than ten years removed from its political independence 
(Cliff, Kanji & Muller 1986: 7). At that time, many experts did not believe that HIV-
infection would spread heterosexually on a large scale. When evidence to the 
contrary started to mount, researchers from developed countries thought that the 
heterosexual transmission of HIV represented a new subtype and branded it 
“African AIDS” (Kallings 2008: 228). That labelling probably contributed to the 
social construction of the concept of HIV and AIDS in both developed and 
developing countries, as societies assumed they had correctly identified the so-
called vectors for the spread of the disease, such as homosexuals or Haitians in 
North America, then started to blame them (Farmer 1992: 234).  
 
According to the official institution in charge of the national response to HIV and 
AIDS in Mozambique, the National Council, the first diagnosis of AIDS was made 
in the Northern Province of Cabo Delgado, in 1986. Interestingly, this first patient 
was defined as a foreigner of Haitian origin working as a medical doctor. In his 
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thesis about the HIV and AIDS response in Mozambique, Matsinhe (2006: 37) 
argues that by insisting that this first case was already infected with HIV before 
entering Mozambique, the National Council against HIV and AIDS showed a 
glimpse of the “…mixture of references and representations, often contradictory, 
stereotyped, that subtly nurture a system of negation, accusation and 
discrimination, with the sponsorship of the official discourse…” that would 
contribute to the social representation of HIV and AIDS in the country. 
 
In Mozambique, the social meaning of HIV and AIDS was influenced by political 
and historical aspects. Conspiracy theories considering AIDS to be a weapon 
developed by the Western world were often mentioned by the Soviets during the 
first years of the epidemic (Goodwin, Kozlova, Kwiatkowska, Nguyen-Luu, 
Nizharadzee, Realo, Külvet & Rämmer 2003: 1379). The fact that the pre-1985 
Soviet Union Government deemed AIDS to be a decadent Western disease, 
borne out of the capitalist lifestyle, paved the way to an association of HIV and 
AIDS with immorality (Kallings 2008: 232; Williams 1994: 92). As Mozambique 
maintained close social and cultural ties to the Soviet Union at that time, it can be 
argued that this interpretation of HIV and AIDS was, at least initially and in part, 
integrated into the local social construct of the disease. 
 
The process of acknowledgement that HIV and AIDS was a health problem in 
Mozambique has been, according to Matsinhe (2006), largely dependent on the 
support of the World Health Organisation (WHO). This, along with mostly foreign 
technical support and educational materials, contributed to the creation of the 
first Mozambican response to HIV and AIDS. As was the case in other African 
countries most affected by the HIV pandemic at the time, Mozambique’s health 
system was not prepared to deal with such a challenging threat (Fredland 1998: 
551). Matsinhe (2006: 38) argues that the most important aspect of this phase is 
the “…humble and clear acknowledgement of the incompetence and ignorance 
of the country in the face of a new and emergent problem”. 
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In 2000, the Mozambican government established a multi-sector HIV and AIDS 
Council and published its first national strategic plan to combat HIV and AIDS. 
Shortly after, in 2001, the health ministry introduced voluntary testing and 
counselling services in the public sector. During the same year, the parliament 
passed a law against the discrimination of PLWHIV in the workplace (World 
Health Organisation 2005: 1). Despite an apparent interest in defending the 
rights of PLWHIV, no study has been found in which HIV and AIDS-related 
stigma levels, or QoL of PLWHIV, have been measured in Mozambique. The 
extent and prevalence of HIV and AIDS-related stigma perceptions and 
experiences of Mozambicans living with HIV is thus unknown. 
 
Until 2001, the Mozambican government was, in congruence with the World 
Bank, the United States Agency for International Development (USAID), the 
European Union and other major donors, against the introduction of ART in the 
country. It justified its decision by referencing high costs, lack of laboratory 
facilities and human resources. Government authorities also believed that 
Mozambicans would not be able to maintain the necessary adherence to 
treatment required to make it effective (Matsinhe 2006: 132).  
 
After the idea of the introduction of ART in Mozambique finally made it to 
mainstream politics, the approach was still a very cautious one. Matsinhe (2006: 
135) believes it was due to two different factors, one behavioural and the other 
historical. Some health decision-makers thought that introducing ART could 
signal the end of the lethal threat posed by HIV infection, and as a consequence 
people would adhere less to prevention measures against HIV infection. The 
other factor is that because at first antiretrovirals (ARVs) were made available 
only to civil servants (considered the ‘elite’), it would be seen as an act 
reminiscent of post-independence socialism when the same ‘elite’ could 
purchase goods in relatively well-stocked shops while the remainder of the 
population had to form long queues in shops where nothing worthwhile could be 
bought (Matsinhe 2006: 135). The lack of initial commitment towards access to 
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treatment could be seen as a way for the Mozambican government to avoid 
taking policy routes that could have been interpreted as a promotion of unequal 
access to treatment in favour of the “elite”.  
 
Nevertheless, ARV roll-out was implemented at a very rapid pace after 2001. 
Data show that in March 2004, only 7,000 people in the country were accessing 
ART. By the end of 2007, 90,000 people were receiving the treatment (Joint 
United Nations Programme on HIV/AIDS 2008b: 12).   
 
The marked increase in the number of people accessing ART in that period could 
be interpreted as being the result of a new era of strong leadership and 
commitment on the part of the government in ensuring universal access to ART 
to all its citizens.  This interpretation however is debated. For example Nattrass 
(2008) compared antiretroviral coverage to predicted antiretroviral coverage as 
an indicator of AIDS leadership in countries all over the world. Out of 38 African 
countries studied, Mozambique came out as the fourth worst in terms of 
antiretroviral coverage in 2006 compared with what would be expected 
considering its gross domestic product per capita, external support, the scale of 
the epidemic, health-related demands and politico-institutional capacity. The 
variables chosen for the analysis could be argued with, but the study indicates 
that despite the rapid pace of the introduction of ART in Mozambique, the 
Ministry of Health was slower than its African counterparts in providing ART to its 
population. The situation, however, could have changed since 2006, as 
Mozambique has further accelerated its antiretroviral roll-out after that year (Joint 
United Nations Programme on HIV/AIDS 2008b: 12), and in September of 2009, 
161,381 Mozambicans were treated with ARV. Among them, 8,409 were living in 
the Nampula Province (Republic of Mozambique, Ministry of Health 2009). 
 
In Mozambique, access to ART continues to be a challenge, especially in rural 
areas. The lack of sufficient human resources has, in particular, been a problem. 
Van Damme, Kober & Kegels (2008) calculated that in order to reach the 2008 
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target of 132,000 people on ART, the delivery system would have required 264 of 
the current 360 medical doctors in Mozambique to work solely on implementing 
the ART programme. The authors of the study conclude that Mozambique, just 
like Malawi, Zambia, Rwanda and Tanzania, lacks the human resources needed 
to further expand their ART programme (Van Damme et al. 2008: 2110). 
However, research continues to suggest that ART in Africa is effective for those 
who have access to treatment (Boulle & Ford 2007: 503). 
 
In the next section, we will look at how stigma related to HIV and AIDS is 
produced and what are its consequences. 
 
2.3 HIV AND AIDS-RELATED STIGMA 
 
For many researchers, HIV and AIDS-related stigma is considered one of the 
most important obstacles in HIV prevention and treatment interventions, 
preventing PLWHIV from enjoying an acceptable health level (Campbell, Foulis, 
Maimane & Sibiya 2005: 808; Kalichman, Simbayi, Jooste, Toefy, Cain, Cherry & 
Kagee 2005: 135; Valdiserri 2002: 341). HIV infection carries a high level of 
social consequences. Thus, it is crucial to pay attention to the social aspects 
related to it, such as HIV and AIDS-related stigma (Green & Platt 1997: 90). 
 
The search for a unified conceptual framework to explain stigma is rendered 
complex by the fact that sociologists, psychologists, philosophers, health 
specialists and others have probed their disciplines to define it. As Deacon 
(2006: 419) puts it, the quest is “suffering from conceptual inflation”, and the 
typology used and the variety of competing theories can be overwhelming. In this 
study, some models for HIV and AIDS-related stigma are introduced. However, 
the following discussion is not an exhaustive review of the scientific literature on 
the topic. In fact, the models presented here have been selected for their ability 
to provide a framework grounded in a socio-cognitive approach, pioneered by 
work from Goffman (1963), and later explored by social psychologists (Mahajan, 
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Sayles, Patel, Remien, Sawires, Ortiz, Szekeres & Coates 2008: S70). This 
approach focuses mostly on perceptions of PLWHIV and the impact of these 
perceptions. 
 
Although stigma is considered to be universal (Burris 2008: 473; Keusch, Wilentz 
& Kleinman 2006: 527; Murthy 2002: 28), other researchers specify that what is 
stigmatised in a particular context at a particular time might not be considered as 
such in another context (Heatherton, Kleck, Hebl & Hull 2003: 65). Furthermore, 
not every disease has a potential for stigmatisation. According to Herek (1999: 
1109), HIV and AIDS possess four characteristics that contribute to the high level 
of stigmatisation related to it, namely: 
 
1) In HIV infection, the bearer is perceived to be responsible for the 
condition, as the behaviours leading to infection are understood to be 
avoidable and voluntary. As HIV is mostly transmitted through sexual 
contact in Africa, HIV and AIDS-related stigma is often related to the lethal 
potential of the infection intertwined with connotations of sexual deviancy 
(Carr & Gramling 2004: 31). 
2) There is still no cure to AIDS, and the disease is still thought of as a fatal, 
even if ART can prolong life. 
3) Infectious diseases have a higher potential for stigmatisation as they are 
perceived as a risk that can cause harm to others. 
4) Diseases such as AIDS cause the bearer to have visible signs and 
symptoms. These create more stigmatisation because they can disrupt 
social interactions. 
 
Merely understanding how general characteristics create a favourable context for 
stigmatisation is not enough, as stigma can exist outside of these conditions. 
Culturally-bound representations of disease, like witchcraft or a spiritual system 
involving fate, for example, can add layers of significance for local populations, 
and play an important part in shaping stigmatisation. This can lead to a very 
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complex web of behaviours and attitudes interacting with and responding to the 
situation of PLWHIV within the community (Liddell, Barrett & Bydawell 2005: 
693). Relations of power, gender inequality, political and economic conditions 
can also influence how stigma is created, maintained or avoided in the socio-
cultural context (Abadía-Barrero & Castro 2006: 1221; Link & Phelan 2001: 367; 
Ogden & Nyblade 2005: 38; Parker, Aggleton, Attawell, Pulerwitz & Brown 2002: 
9; Reidpath & Chan 2005: 425). In the next section, the context in which these 
conditions interact with each other in the process of stigma production will be 
outlined. 
 
2.3.1 The stigma production process 
 
As major contributors to research in the field of stigma, Link and Phelan (2001) 
have designed a theoretical framework exposing the various steps in the 
elaboration of stigma. The researchers’ model contains five components: 
 
1. Labelling and distinguishing a difference 
2. Linking people who bear the difference with negative connotations 
3. Creating a distinction between “us” and “them” 
4. Causing a loss of status for the bearers of the difference by discriminating 
against them 
5. Allowing the social, economic and political powers to maintain the four 
other components  
 
In the first step, PLWHIV are differentiated from people not living with HIV. As 
only HIV testing can permit a definite differentiation between the two groups, 
there are a number of strategies employed to discover HIV status by means of 
proxy markers, such as physical appearance, behaviour or discourse. (Suarez & 
Miller 2001: 292).  This strategy is called “faulty heuristics” by the researchers 
because it is based on unscientific or illogical beliefs. Guessing someone’s HIV 
status using proxy markers is more easily achieved when the person has 
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reached the full-blown AIDS stage, as signs of disease progression are then 
more obvious. For example, visible signs of later stage AIDS, such as facial 
lipoatrophy can cause people to involuntarily disclose their condition (Kavouni, 
Catalan, Brown, Mandalia & Barton 2008: 485). The differentiation can also occur 
when the person living with HIV displays specific behaviour linked to an HIV 
positive status, as shown in a study about an HIV treatment project in the Kibera 
slum in Kenya (Unge, Johansson, Zachariah, Some, Van Engelgem & Ekstrom 
2008:148). In that study, researchers noted that access to ARV was conditional 
to disclosure of one’s status to a treatment buddy. This amounted to compulsory 
disclosure, as patients were forced to tell a friend or their partner of their HIV 
status to get enrolled in the ART scheme. This condition was abandoned after 
the study showed that it led to stigma and threats from family members when 
they became aware that the patient had HIV. 
 
In the second step, a link is established between an HIV positive status and 
negative behaviour or attitudes, while preconceived ideas and stereotypes are 
constructed to create meaning (Skinner & Mfecane 2004: 158). As HIV can be 
sexually transmitted, some people might erroneously conclude that PLWHIV are 
unfaithful, sexual deviants, homosexuals or prostitutes (Bond, Chase & Aggleton 
2002: 348; Schatz 2005: 489; Ulasi, Preko, Baidoo, Bayard, Ehiri, Jolly, & Jolly 
2009: 256). This process can also be indirect, as when the media, without 
realising it, cause unnecessary stigma. For example, Lean and Lee (2008: 181) 
report a television broadcast in the United Kingdom that portrayed haemophiliacs 
living with HIV “through no fault of their own”.  This presentation inadvertently 
presented them as “innocent victims”, implying that there were other “not so 
innocent victims” undeserving of the same sympathy.  
 
The third step consists in making clear there is a difference between the 
stigmatiser and the stigmatised. In essence, the stigmatiser makes an attempt at 
providing evidence confirming the existence of a gap between his/her 
behaviours, attitudes or conditions and those believed to be the ones possessed 
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by PLWHIV. This can be achieved by increasing the existing body of 
preconceived ideas and generalisations toward PLWHIV, thus substantiating the 
perceived differences between the two groups. In this regard, Wang (1992) in her 
study on the production of stigma in injury prevention campaigns, points out that 
the slogans and images that portray disabled people as victims and that instil 
fear in others, involuntarily produce stigma.  
 
In the fourth step, the stigmatisers take on an active role in denying social status 
to the stigmatised. This removal of privileges is based on the belief that PLWHIV 
do not deserve to be treated equally. 
 
The stigma produced in the four initial steps could be of local significance only, 
with a few individuals affected. For it to transform into an “epidemic of stigma” 
(Herek & Glunt 1988), a facilitating social, economical and political environment 
has to be in place, which is the fifth and final step in the framework proposed by 
Link and Phelan.  
 
2.3.2 Types of stigma 
 
Stigma encompasses multiple dimensions (Green & Platt 1997: 90) that can be 
categorised in two subtypes: external and internal. 
 
External and internal stigma result in PLWHIV becoming distressed and living in 
fear of being stigmatised. HBC service providers may also suffer from stigma and 
discrimination because of their daily contact with PLWHIV (Lindsey, Hirschfeld & 
Tlou 2003; Orner 2006).  
 
2.3.2.1 External/enacted stigma 
 
External stigma (also named enacted stigma) refers to “… 
experiences of PLHA [people living with AIDS, see PLWHIV] being 
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treated unfairly and differently to everyone else”. (Futures Group 2006: 
6). An example of enacted stigma can be found in the testimony of 
Ana Maria Muhai, a woman living with HIV in Maputo, Mozambique: 
“Sabem, quando fiquei doente e sem força, já ninguém comprava na 
banquinha de verduras e bebidas que tinha montado perto de casa. 
Todos me apontavam com o dedo e não compravam os meus 
produtos por medo de se infectarem. Os meus filhos, e isto me doía 
mesmo muito, não podiam assistir televisão em casa de ninguém, 
porque tinham uma mãe seropositiva. A discriminação que os meus 
filhos sofreram foi a minha dor maior” (“You know, when I got ill and 
without strength, no one was buying at my vegetable and drinks stall I 
had installed near my house. Everybody was pointing a finger at me 
and they wouldn’t buy my products in fear of getting infected. My 
children, and that was really painful, couldn’t watch TV in anyone’s 
house, because they had an HIV-positive mother. The discrimination 
my children suffered was my greatest pain”) (Muhai 2006, translation 
made by the researcher from the original version in Portuguese). 
 
According to her verbatim, Ana Maria was treated badly by her 
community because she was ill and people thought that she was 
HIV-positive. The stigma extended to her children as they were also 
ostracised by family and friends. It can be hypothesised that 
neighbours and friends lacked knowledge about HIV and AIDS in 
general, and HIV transmission vectors in particular. This was a major 
factor in the maintenance of stigmatising attitudes, a situation 
consistent with research by Hamra, Ross, Karuri, Orrs & D’Agostino 
(2005: 912) which associated HIV and AIDS knowledge with less 
expressed stigma. 
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2.3.2.2 Internal/felt/imagined stigma 
 
Internal stigma (also known as felt or imagined stigma) refers to 
“…the way a person feels about themselves” (Futures Group 2006: 
6) and is expressed as feelings of shame or fear, especially in 
reaction to, or anticipation of, enacted stigma (Baskind & Birbeck 
2005: 69; Mawar, Sahay, Pandit & Mahajan 2005: 474). In their study 
of women living with HIV, Carr and Gramling (2004) found that some 
PLWHIV change the way they see themselves because of their 
infection. Whatever their personal identity was before being 
diagnosed, they could not see themselves as anything else but as 
women living with HIV after they received the diagnosis. One of the 
interviewees in the study described the lingering self-stigma process 
she dealt with thus: “When I look in the mirror, I no longer see Sonya. 
I see a woman with HIV disease. It is the first thing I think about when 
I wake up in the morning and the last when I go to sleep at night” 
(Carr & Gramling 2004:32).  
 
In a study about stigma in the United States, Lee, Kochman & 
Sikkema (2002: 315) found that most PLWHIV experience 
internalised HIV and AIDS-related stigma. The authors, however, 
advise not to generalise this conclusion to every person living with 
HIV as some do not feel stigmatised at all, as discussed in the next 
section 
 
2.3.3 The consequences of stigma 
 
Stigma can trigger a myriad of consequences for the person living with HIV, their 
family, the community and the nation as a whole. One of them is the negative 
effect on emotional health of PLWHIV (Fife & Wright 2000: 51).  
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Not every stigmatised person, however, places the same importance on the 
stigmatising condition. This is what Crocker and Major (1989: 620) call the 
“centrality of the stigmatising condition in the self-concept of the individual”. 
Although the focus can shift over time, for some people, HIV status can become 
a central aspect of their identity, while for others, it is considered as a peripheral 
attribute (Baumgartner 2007: 922).  
 
Even before knowing one’s HIV status, the fear or being stigmatised if the result 
is positive can lead to delays in HIV testing (Chesney & Smith 1999: 1162). 
When a person does get tested for HIV and the result is positive, the reaction can 
be to stop working or to try to find a new place to live (Wig, Lekshmi, Pal, Ahuja, 
Mittal & Agarwal 2006: 4), either out of fear of being stigmatised or because of 
actual stigma. 
 
Among the individual consequences of stigma, fear of being stigmatised which 
leads to non-disclosure of HIV status is considered to be a barrier to health (Carr 
& Gramling 2004: 37). Disclosing one’s HIV status is an important step for a 
person living with HIV, but some studies have shown that many opt not to 
disclose their status, even to medical providers at ART sites, until they become 
symptomatic or cannot care for themselves anymore (Jeffe, Khan, Meredith, 
Schlesinger, Fraser & Mundy 2000: 39). The fact that PLWHIV not on ART do 
not always disclose their HIV status to a health service provider is the reason 
why PLWHIV on ART have been chosen for the current study. PLWHIV on ART 
have disclosed their HIV status to the local counsellor at the VCT and are readily 
available as participants in a study as they have to maintain regular contact with 
the counsellor in order to access their medicine. 
 
In a rural context such as that in Malema and Ribáuè Districts, ART is usually 
initiated when the signs and symptoms, together with a positive HIV test result, 
indicate that such treatment is necessary in order to address opportunistic 
infections or to stave off the onset of full-blown AIDS. These signs and symptoms 
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have often been noticed by family members for some time before the person 
seeks help and treatment. In Salama’s HBC programme, the onset of AIDS-
related symptoms is often the initial step leading to HIV testing and, later, to the 
inclusion in the HBC programme. 
 
Serovich (2001:356) sheds some light on the different theories related to HIV 
disclosure: on one hand, there is the popular belief that more noticeable 
symptoms lead to increasing difficulty in keeping the condition secret and that 
this is the reason why PLWHIV eventually disclose their status. This is called the 
““progression of HIV infection theory”. The author has found, however, that the 
“consequence theory of disclosure”, according to which “...the relationship 
between disease progression and disclosure is moderated by the consequences 
one anticipates resulting from the disclosure”, could better explain why people 
disclose their HIV status. Based on her study, it seems as if people fear fewer 
consequences to disclose when there are measures taken in the health, legal 
and social systems, as well as steps taken to reduce stigma, discrimination and 
violence against PLWHIV. By understanding better how stigma and quality of life 
interact with the HBC services based on the conclusions of this study, it is 
possible that HBC service providers will be able to provide PLWHIV with 
scientific evidence of what to expect from disclosure of HIV status, in terms of 
social consequences and QoL. 
 
Related to non-disclosure, in some cases PLWHIV refuse to go for treatment or 
to use HIV services because they are afraid that the visits and the pill-taking 
rituals will expose their HIV status (Schuster, Collins, Cunningham, Morton, 
Zierler, Wong, Tu & Kanouse 2005: 807). This attitude can delay the onset of 
care and further complicate treatment as the person waits until symptoms are 
apparent and CD4 levels are very low (Chesney & Smith (1999: 1167). Also, 
failure to disclose can also mean fewer adherences to treatment, as PLWHIV 
who don’t tell anyone of their HIV status cut themselves off from potential 
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“treatment buddies” or family members who could remind them to take their 
medicine and support them with the secondary effects they experience.  
 
Other consequences of stigma might include higher unemployment, avoidance of 
social contact leading to a weakened financial situation, deteriorating health, lack 
of productivity, more time spent in medical consultation and gradual isolation, all 
of which further erode quality of life (Fife & Wright 2000: 51; Wig et al. 2006: 4). 
 
Finally, not all individuals react the same way to stigma. Wang (1992: 1093) for 
example, citing a study of former mental patients and people with disabilities 
conducted by Anspach, found out that some patients get involved in advocacy 
work as a response to being stigmatised. This would be one of the very few 
indirect, positive consequences of stigma, which demonstrates the potential for 
resilience amongst PLWHIV. In fact, Salama’s HBC programme includes 
volunteers who are living with HIV. These volunteers use their personal 
experience to increase acceptance of PLWHIV, and to help people recently 
diagnosed with HIV to cope with their new situation (Salama 2008: 9). 
 
As discussed above, the consequences of HIV and AIDS-related stigma are 
serious and can mean the difference between life and death for many PLWHIV. 
Because of this, the links between HIV and AIDS-related stigma and QoL of 
PLWHIV warrant a closer analysis. This study’s research questions have been 
chosen based on the importance of the impacts of stigma on the lives of 
PLWHIV, in the hope that a better understanding of the relation between HIV and 
AIDS-related stigma and QoL could help HBC programme developers to design 
interventions that could significantly reduce the impacts of stigma on PLWHIV.  
 
2.3.4 Interventions in the field of stigma and evidence-based approaches 
 
For years, reduction of stigma has been considered as an essential element to 
the HIV/AIDS response in many sub-Saharan Africa’s countries (Republic of 
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Uganda. 2000: xxxvi; Republic of Zambia 2006:13; Tanzania Commission for 
HIV/AIDS 2003: 30). In Mozambique, public interventions in the area of HIV and 
AIDS-related stigma are outlined in the Plano Estratégico Nacional de Combate 
ao HIV/SIDA (National Strategic Plan for the Fight Against HIV/AIDS). The 
Mozambican government has identified six main objectives in its HIV and AIDS-
related stigma reduction strategy (Republic of Mozambique 2004: 23).  
 
The first objective is to promote a greater visibility of PLWHIV. Promoting the 
active presence of PLWHIV in public debate, such as participating in 
conferences, giving speeches and, in general, shifting AIDS from an abstract 
concept to a personal encounter, are activities known to achieve stigma 
reduction (Klein, Karchner & O’Connell 2002: 51; Nyblade, Stangl, Weiss & 
Ashburn 2009: 15). The idea that empowering people is a condition for any 
successful policy-making which aims to reduce stigma is central to the work of 
Morrison (2006: 9) (See Figure 2.1). Participation in a group of PLWHIV is also 
an activity that is known to provide social support and stimulate empowerment 
(Brown, Macintyre & Trujillo 2003: 53; Ribble 1989: 54). 
 
Using a human rights approach to ensure that the rights of PLWHIV are 
respected is the second objective of the National Strategic Plan. For Chopra & 
Ford (2005:386), the human rights approach in the field of HIV and AIDS aims at 
enhancing “… the relationship between claims holders (community members) 
and duty bearers (people in authority, either from government or development 
agencies) so that ordinary people can realize their right to survival, health and 
development, and those in authority can fulfil their responsibility to govern 
effectively”. According to Castro & Farmer (2005:53), most practitioners in the 
field of HIV and AIDS consider stigma to be, in fact, a violation of human rights. 
Maluwa, Aggleton & Parker (2002: 13) also insist on the necessity of the human 
rights approach as a HIV and AIDS-related stigma reduction strategy. 
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The third objective of the Strategic Plan is ensuring access to health care and 
treatment for all.  Limited accessibility to a decent level of health care and 
provision of sub-par health services are inadequate responses to the problem, 
and the symptom of these failures is stigma, according to Farmer (2006: xiii).  
 
The fourth objective concerns the health workers. According to the Plan, they are 
the first agents of change when it comes to stigma reduction. In that aspect, the 
Mozambican strategic plan is parting ways with strategies which are considered 
to be evidence-based by Nyblade et al. (2005: 15). In the opinion of these 
authors, the involvement of the entire staff in a health care setting is necessary, 
especially in the area of training and policy-making. The authors suggest that 
putting the onus of stigma reduction on health professionals could be detrimental, 
as it reduces the feeling of ownership in the response to stigma for other workers 
at the health care facility, such as administrative and security staff. 
 
The Strategic Plan also considers the involvement of religious communities in the 
fight against HIV and AIDS-related stigma. Finally, it states that the debate on 
HIV and AIDS-related stigma has to be public and that every chance to discuss 
the matter should be seized. 
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stigma was available when the Berger Stigma Scale was developed, the authors 
conducted a large literature review and proposed a two-factor model: “… the 
individual’s perceptions of societal attitudes toward people living with HIV and his 
or her personal knowledge of being infected with HIV” (Berger et al. 2001: 519-
520). This explanation of the genesis of HIV and AIDS-related stigma is in line 
with Goffman’s views, according to which stigmatised people expect adverse 
reactions and are acutely aware that they possess a characteristic that 
contravene to social norms (Goffman 1963: 14).  The instrument was first tested 
in the United States and consists of 40 items, encompassing four subscales: 
personalised stigma, disclosure, negative self-image and public attitudes. Since 
its design, it has been used in many studies, such as Wright, Naar-King, Lam, 
Templin & Frey (2008), Buseh, Kelber, Stevens & Park (2008) and Mahendra, 
Mudoi, Oinam, Pakkela, Sarna, Panda, Rau, Singh & Rutenberg  (2007). 
Translations have been shown to be valid in different cultural contexts (Franke, 
Muñoz, Finnegan, Zeladita, Sebastian, Bayona & Shin 2008). A study by Bunn, 
Solomon, Miller & Forehand (2007: 205) has concluded that the HIV Stigma 
Scale is valid and reliable. 
 
Another scale available is the Sowell Stigma Scale. It consists of 13 items with 
a 4 point Likert scale. The scale was designed in the late nineties from research 
conducted with HIV-positive women in South-eastern United States (Emlet 2005: 
293).  
 
The AIDS-Related Stigma Scale designed by Kalichman et al. (2005) is an 
instrument designed in South Africa. It consists of 9 items, measures a wide 
scope of stigmatising beliefs and is based mostly on Goffman’s theory. The scale 
shows strong reliability and validity and has been tested on a diverse range of 
African men and women. 
 
While some researchers have hypothesised that stigma measurement tools must 
be tailor-made for every specific and local context, this would mean that no 
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stigma scale could be used outside the area where it was designed (Weiss, 
Ramakrishna & Somma 2006: 284) which is not helpful for the progression of 
worldwide sociological studies. However other researchers believe that stigma 
experienced in varied contexts can be measured by a comparable scale, even in 
countries both developed and developing (Van Brakel 2006: 329).  
 
A valid and reliable instrument that could be used across different cultural 
contexts is very useful, and this is the view taken by this study and by the choice 
of the Berger Stigma Scale as its main instrument for measuring HIV and AIDS-
related stigma. In the context of this study, the precursors of HIV and AIDS-
related stigma proposed by Berger et al. (2001: 519-520), that is individual 
perceptions of prevalent attitudes toward PLWHIV in the community and 
personal experience of being infected with HIV, are a component of the 
theoretical framework presented in Figure 2.3.  
 
2.4 QUALITY OF LIFE AND HIV 
 
Quality of life is now considered as a significant outcome in the continuum of 
health care provision (Hickey, Bury, O’Boyle, Bradley, O’Kelly & Shannon 1996: 
29).  According to Hays, Cunningham, Sherbourne, Wilson, Wu, Cleary, 
McCaffrey, Fleishman, Crystal, Collins, Eggan, Shapiro & Bozzette (2000: 714), 
“Health-related quality of life refers to how well a person functions and to his or 
her perceptions of well-being in the physical, mental, and social domains of life”. 
The concept of health-related QoL has been explored widely in scientific 
literature since 1980 and made necessary as a result of an increase in the 
number of chronic diseases that accompany longer life expectancy in many 
countries (Murdaugh 1997: NS41).  
 
A review of the available literature reveals a scarcity of research about HIV and 
AIDS-related quality of life in sub-Saharan Africa. Such a situation is problematic 
since an accurate assessment of QoL of PLWHIV could be used to examine the 
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impacts of ARV treatment both in terms of health improvement and effectiveness 
of invested resources (Hays et al. 2000: 714). One of the earliest studies in an 
African setting, published by O’Keefe and Wood (1996: 275), examined if HIV 
and AIDS impacted QoL in South Africans. The study concluded that QoL was 
impacted by HIV for people of every racial origin, without any significant 
difference between ethnic groups. Another more recent research studied the 
military in Nigeria and showed that PLWHIV had lower QoL scores and reported 
more post-traumatic stress disorder than seronegative colleagues (Olley & 
Bolajoko 2008: 94). In South Africa again, Jelsma, MacLean, Hughes, Tinise & 
Darder. (2005: 579) found that ART has a positive impact on QoL levels but that 
the secondary effects of the medicine have no significant influence on QoL 
scores. Furthermore, Greeff, Uys, Wantland, Makoae, Chirwa, Dlamini, Kohi, 
Mullan, Naidoo, Cuca & Holzemer (2009) concluded from a study covering five 
African countries that over time, ARV treatment seems to have a positive effect 
on perceived QoL. 
 
Quality of life can be influenced by the source of health care. This is especially 
relevant in the African context where health care is available (or not) from 
sources across the spectrum such as home-based care, traditional medicine and 
western medicine.  In a study in Zimbabwe, Taylor, Dolezal, Tross & Holmes 
(2008) have found that people who have been treated at a traditional African site 
show a greater improvement in their perceived QoL after one month than people 
who have been treated at a western medicine site. This is an important discovery 
that could further underline the potential effects of HBC on Qol in a programme 
such as the one developed by Salama, as traditional doctors are actively 
involved in the referral and treatment phase of PLWHIV in tandem with ART 
provision. 
  
 30 
 
 
2.4.1 Quality of life and HIV and AIDS-related stigma 
 
Until recently, very few studies had established a link between HIV and AIDS-
related stigma and QoL. A study by Dos Santos, Franca & Lopes (2007), based 
on a sample of 365 PLWHIV in Brazil, noted that the QoL levels for signifiers 
based on physical and psychological health were higher than those of people 
with another diagnosis, but that the signifiers referring to relationships were 
lower. They hypothesised that the difference was due to the impact of stigma, 
although no evidence was provided on this account.  
 
The latest studies on the subject revealed that QoL is negatively affected by 
stigma, so that for every increase in perceived stigma levels, there is a drop in 
life satisfaction levels (Greeff et al. 2009; Suit 2005:82). A study by Holzemer 
based on a sample of 726 PLWHIV in 14 sites in Africa, Porto-Rico and the 
United States demonstrated that 5.3% of the explained variance in the QoL 
scores was due to stigma. Important limitations of this study were the 
convenience sampling technique used to recruit participants and the use of self-
reported instruments to gather data (Holzemer, Human, Arudo, Rosa, Hamilton, 
Corless, Robinson, Nicholas, Wantland, Moezzi, Willard, Kirksey, Portillo, Sefcik, 
Rivero-Méndez & Maryland 2009: 162). But Holzemer does produce evidence to 
argue that internalised HIV stigma seems to produce a negative impact on the 
QoL of men and women (Lee et al. 2002: 318).  
 
2.4.2 Measurements of quality of life 
 
Various tools and instruments have been designed by researchers to measure 
quality of life.  Some of them are generic, such as the Medical Outcome Study 
Short Form 36 item health survey (MOS-SF-36), and can be applied in 
measuring QoL in people living with cancer, chronic diseases, physical disability 
or HIV (Ware & Sherbourne 1992). Using a generic tool has the advantage of 
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allowing comparisons between different diagnostic groups (Robinson 2004: 15S; 
Wiebe, Guyatt, Weaver, Matijevic & Sidwell 2003: 52). However, people being 
tested with a generic instrument can dislike the general questions and have the 
feeling that they are being disconnected from their own experience of the 
disease. Also, they are considered less accurate when changes in clinical 
condition occur (Skevington & O’Connell 2003: 332). One of the most widely 
used generic quality of life instruments available is the WHOQOL-BREF. The 
instrument was designed by the World Health Organisation and has been used in 
various studies throughout different settings such as Brazil, Taiwan, Rwanda, 
India and Nigeria (Dos Santos et al. 2007; Fang, Chang, Hsu, Twu, Chen, Chen, 
Huang, Hwang & Wang 2007; Mutimura, Stewart, Crowther, Yarasheski & Cade  
2008; Nirmal, Divya, Dorairaj & Venkateswaran 2008; Ola, Adewuya, Ajayib, 
Akintomide, Oginni & Ologun 2006). 
 
Since the end of the nineteen eighties, a range of instruments has been designed 
to specifically measure the quality of life of PLWHIV (Remple, Hilton, Ratner & 
Burdge 2004: 947). A review by Robinson (2004) identified six such instruments. 
Here are two of the most used HIV and AIDS-related QoL instruments: 
 
The Multidimensional Quality of Life Questionnaire for Persons with HIV/AIDS 
(MQOL-HIV) is a 40-item questionnaire encompassing ten domains: mental 
health, physical functioning, physical health, social support, social functioning, 
cognitive functioning, financial status, partner intimacy, sexual functioning and 
medical care. It has been validated for use in male and female populations 
(Remple et al. 2004: 948). So far the instrument has been used mostly in 
developed countries such as Spain, the United States and Japan (Carballo, 
Cadarso-Suarez, Carrera, Fraga, De la Fuente, Ocampo & Ojea 2004; 
Osowiecki, Cohen, Morrow, Paul, Carpenter, Flanigan & Boland 2000; 
Watanabe, Ishihara, Nishimura & Oka 2000). 
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The HIV/AIDS-targeted quality of life (HAT-QOL) is a self-report instrument 
designed to measure QoL in PLWHIV and people who have AIDS. It is 
considered valid (Taylor et al. 2008: 553). Studies using the HAT-QOL were first 
conducted in the United States on a sample of mostly male and 
homosexual/bisexual PLWHIV (Holmes & Shea 1998), then Brazilian women 
(Galvão, Cerqueira & Marcondes-Machado 2004) and more recently on patients 
in American health centres (Kudel, Farber, Mrus, Leonard, Sherman & Tsevat 
2006). 
 
In the current study, a generic instrument, the WHOQOL-BREF has been chosen 
to measure QoL. The reason for this choice is that very few studies have used 
the MQOL-HIV or the HAT-QOL presented above, and choosing these 
instruments would have limited the potential for comparison between studies. 
 
2.5 HBC SERVICES FOR PEOPLE LIVING WITH HIV 
 
HBC is a model of health care and support delivery. It usually includes physical, 
psychological, social, palliative, and spiritual elements (World Health 
Organisation 2002). Management of opportunistic infections, referral, 
counselling, support for carers, training, nutritional and treatment adherence 
advice are some of the most common activities implemented within HBC 
programmes. Furthermore, in relation to HIV and AIDS-related stigma, HBC 
services have to provide more than “empathy inducement” measures, as this has 
proved to be ineffective (Maluwa et al. 2002: 12). 
 
The provision of HBC services has many advantages in a setting where hospital 
care is often inaccessible and/or expensive (Nsutebu, Walley, Mataka & Simon 
2001: 240).  For example, direct support from HBC programme volunteers can 
help women and girls (who usually provide most of the care giving), allowing 
them to gather resources for the family and continue their education (Opiyo, 
Yamano & Jayne 2008). It can also reduce nosocomial transmission of 
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tuberculosis from PLWHIV to other patients and vice-versa (Nsutebu et al. 2001: 
240). Another positive effect of community health worker programmes is their 
success with ARV treatment implementation (Tolle 2009: 669). 
 
Home-based care service provision as a strategy for PLWHIV in Africa is now 
implemented in countries such as Zimbabwe, Zambia, Malawi, Uganda, 
Botswana and Mozambique. These initiatives started to emerge in the late 
eighties (Blinkhoff, Bukanga, Syamalevwe & Williams 1999: 9; Bowie, Kalilani, 
Marsh, Misiri, Cleary & Bowie 2005; Floriano 2007; Ngwenya & Kgathi 2006; 
Nsutebu et al. 2001: 240; Weidle, Wamai, Solberg, Liechty, Sendagala, Were, 
Mermin, Buchacz, Behumbiize, Ransom & Bunnell 2006).  
 
2.5.1 The socio-economic context of HBC services 
 
In order to understand the importance of HBC services for PLWHIV in Africa, the 
socio-economic context of families affected by HIV must be taken into account. 
Compared to the situation in developed countries, African families cannot count 
on the State to take care of their ill. Therefore economic factors play a significant 
role in the type of care that can be provided to people and their families affected 
by HIV and AIDS. 
 
The micro-economic impacts of HIV and AIDS in Africa are the most visible, as 
they affect the very fabric of communities and cause changes in the behaviour of 
individuals and families. One of the most immediate impacts of HIV and AIDS is 
to reduce the income of affected households (Whiteside 2001: 80, Casale & 
Whiteside 2006: 5). Because AIDS-related illnesses threaten the productive 
members of the household, there is a risk that family income might fall below the 
poverty line (Isaksen, Songstad & Spissoy 2002: 11). In Botswana for example, 
the poorest quartile of households affected by HIV and AIDS saw their per capita 
household income drop by 13%, and income-earners having to care for four 
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more dependents as a direct result of a family member living with HIV and AIDS. 
(Casale 2006: 5). 
 
For households caring for someone who is ill with AIDS, this drop in income is 
often accompanied by increased expenditures (Casale & Whiteside 2006: 5; 
Whiteside 2001: 80). In order to cope with the immediate needs of the person 
with AIDS, households might divert resources to AIDS care, which can amount to 
up to 1/3 of household income (Casale & Whiteside 2006: 6; Whiteside 2001: 
85). To illustrate this, a study in Rwanda showed that households with an AIDS 
patient spend 20 times more on average on health care than households without 
an AIDS patient. (Isaksen et al. 2002: 11). Other households embark upon the 
sale of productive assets (livestock, tools) to meet short term needs, frustrating 
income generation for the future and perhaps leading to the need to rely on 
borrowed funds to survive. (Casale & Whiteside 2006: 8).  
 
The diversion of household resources from long-term assets to short term needs 
has many economic impacts because it influences household savings and 
modifies investment decisions (Casale & Whiteside 2006: 7). Initially the 
reallocation of resources means lower household savings as the decrease in 
household consumption achieved by the family is nevertheless not equal to the 
reduction of household income brought by the inability of the ill family member to 
work. (Booysen, Geldenhuys & Marinkov 2003: 5). Fewer savings can mean, for 
instance, that a family cannot buy or maintain the productive assets it needs to 
cultivate the land, make long term investments in housing or create a safety 
buffer to protect itself from reduced agricultural yields due to weather cycles or 
pests.  
 
Hard choices have to be made between tending the fields and taking care of the 
ill family members (Whiteside 2001: 80). In many cases, this means lower 
productivity in subsistence labour (Casale & Whiteside 2006: 5). To illustrate this, 
a study in Tanzania reports that a woman with an ill husband spends 60% less 
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time on agricultural activities than she would normally do. (Isaksen et al. 2002: 
11). In Zimbabwe, there is evidence that households that had lost a member 
because of AIDS experience a reduction of 40% to 60% of their crops as a result. 
(Isaksen et al. 2002: 77).  
 
As more and more people are infected, get ill and die, the costs of funerals can 
quickly become a major problem (Whiteside 2001: 81, Casale & Whiteside 2006: 
5). For example, a study in Kagera in Tanzania reported that an AIDS-related 
death in the household spent on average 50% more on funerals than on medical 
care (Isaksen et al. 2002: 11). 
 
As the affected families sell productive assets and cultivate less land, the 
availability of food is affected (Casale & Whiteside 2006: 6). Some countries are 
expected to lose as much as 25% of their agricultural workforce by 2020 
(Schneider & Moodie 2002: 5). When family members can’t help in the fields 
because they are too ill, especially during crucial periods of planting or 
harvesting, this can cause a significant reduction in the size of the harvest 
(Bollinger and Stover 1999: 5).Simultaneously, households try to cope with this 
reduced production by reducing their consumption, which leads to a drop in 
quantity and quality of their food intake (Isaksen et al. 2002: 11).  
 
When a family member is affected by AIDS-related illnesses, other members of 
the household may not be allowed to go to school or might work less so they can 
provide care. Daughters and wives are usually the ones having to miss school or 
work (Bollinger & Stover 1999: 4). As a result of HIV and AIDS affecting mostly 
adults, this transfer from dependency on productive middle generations to 
dependency on children and the elderly to provide welfare and care is creating a 
cascade of consequences. (Casale & Whiteside 2006: 8). What is more, fewer 
resources like time, money and care directed towards children’s development 
and preparation for the future (Casale & Whiteside 2006: 7), means bleak 
prospects for the next generation’s ability to pull itself out of poverty. 
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There is hope, however. The provision of antiretroviral therapy might mean a 
recuperation of human capital, as Thirumurthy, Graff Zivin & Goldstein (2005: 27) 
discovered. In their study, they uncovered evidence showing that child labour 
decreases after parents embark on ARV treatment. This could translate into 
children being relieved of their duty as income generators and being able to 
return to school. 
 
HBC services are thus provided in a context of poverty, and the decisions made 
by families are often not based on a wide range of choices, but on limited 
alternatives dictated mostly by economic considerations. These choices are 
made not only to provide care to the family member affected by HIV and AIDS 
but also to ensure the survival of the whole group. 
 
2.5.2 HBC services within the local health system 
 
In Mozambique, health care is the responsibility of the Ministry of Health. In many 
communities, and especially in rural areas, the resources available from the local 
health system are scarce. In these communities, the State cannot reach the 
population with the whole scope of services theoretically available to all 
Mozambicans, and the provision of public health services is actually minimal. In 
this context, health options are not confined to the mainstream public health 
system offered by the Ministry of Health, but also include other possibilities of 
care. Kleinman (1980: 50-51), as shown in the Figure 2.2, has suggested a 
framework consisting of three areas of health care: the popular, folk and 
professional sectors. 
  
 37 
 
 
Figure 2.2: Local health care systems: Internal structure (Kleinman 1980: 
50) 
 
 
 
The popular sector is considered by Kleinman as being the entrance point of 
health care, and the one in which most care is given. Popular health care can be 
provided by the ill person itself, according to prevalent cultural beliefs. The family 
can help to validate the state of the person, to effectively label it as “illness” or, 
alternatively, identify it as “normal” and not worth paying attention to. Based on 
the results of this investigation process undertaken with family, friends, 
neighbours or advisors, the person can decide to move on to another level of 
health care, and seek either folk or professional care providers. Also, the author 
points out that the role of popular health care is not only related to the concept of 
illness, but also is closely linked to the maintenance of a good health. Therefore, 
traditional principles and beliefs concerning health and how to remain healthy 
can be included in the popular sector of health care (Kleinman 1980: 50-53). 
 
According to Kleinman’s theory, the folk sector consists of a heterogeneous 
group of non-professional health practitioners with or without religious affiliation 
Folk	Professional	
Popular	
Health	care	system
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(Stollberg 1993: 239). In Mozambique, traditional healers, called curandeiros or 
médicos tradicionais, are the most prominent members of this group. 
 
Finally, the professional sector includes the scientific practitioners of health 
care, like doctors, nurses and other professionals trained in schools and 
universities (Kleinman 1978: 87). 
 
There are many types of HBC programmes encountered in the field. Some are 
provided only by health workers from the professional sector. In Mozambique 
however, as is the case with Salama, the organisation implementing the HBC 
programme that is the target of this study, the three sectors often overlap. Care 
providers are family members, community health workers, traditional healers 
and, of course, nurses at the health post. In this model, each component of the 
health care continuum has a specific and unique role to play, and the success of 
the endeavour lies on the collaborative effort of all. 
 
2.5.3 HBC services in Mozambique 
 
In 2004, former president of Mozambique, Joaquim Chissano, declared HIV and 
AIDS to be a “national emergency” (African Presidential Archives and Research 
Center 2004: 81). However, total expenditure on health as a percentage of gross 
domestic product has remained low, at 4.7% (United Nations 2006: 182). This 
translates into a per capita expenditure on health care (in USD$ at average 
exchange rates) of between $7.78 and $12 (United Nations 2006: 188; United 
Nations Population Fund 2005: 74). This is much lower than what is considered 
to be the minimum recommended investment in health care for developing 
countries.  The Commission of Macroeconomics and Health, an institution 
created by the World Health Organisation in 2000 which includes some of the 
world’s most influential economists and policy makers,  “…estimates that $30-40 
per capita per year is the minimum required for essential health interventions in 
low-income countries. Much of this expenditure requires public funding 
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particularly to provide services for the poor” (United Nations Population Fund 
2005: 74). 
 
The low level of funding in health care is relevant to this study as financial 
resources are limited for these communities, and because there is an increasing 
number of PLWHIV in Mozambique: growing from 1.1 million in 2004 to 1.8 
million in 2006 (International Labour Organisation 2004: 11; United Nations Joint 
Programme on HIV/AIDS 2006: 412). In this context, lower-cost alternatives to 
institutional care are actively sought to ensure available resources are used not 
only for treatment and care of PLWHIV, but also for HIV prevention. However, 
before committing financial, human and material resources to any alternative, 
governments and civil society organisations need to be convinced that the 
intervention is cost efficient and effective.  
 
Increasingly, HBC programmes for PLWHIV are viewed around the world as a 
viable alternative to institutional care provided in hospitals (Arambam 2002; 
Chandler, Decker & Nziyige 2004; Sekirassa, Grosskurth, Mayala, Mayaud, 
Laukamm-Josten & Le Jacq 1993). HBC services have several advantages over 
conventional, institutional care like hospitalisation. Lower cost is the most 
obvious; in resource-poor settings, similar to those found in rural Mozambique, it 
is often the only way to deliver services to PLWHIV (Nam 2005: 5). For this 
reason, HBC services have been a crucial care and support intervention in 
Uganda (Walker, Aceng, Tindyebwa, Nabyonga, Ogwang & Kiiza 2003: 2).  
 
Faced with limited resources and a burden of care created by increasing 
numbers of PLWHIV, the Ministry of Health of Mozambique has decided to get 
more involved in community HBC programmes as a way of delivering health 
services to PLWHIV (Republic of Mozambique 2004: 91). 
 
Acknowledging its importance and outreach, the Ministry of Health has a 
publicised objective to extend the network of HBC programmes with the support 
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of local NGOs, religious organisations, family members of PLWHIV and activists. 
This strategic decision was made because the Ministry believes that the home is 
the most practical and convenient place for the ill to get better quickly and also 
calculates this will result in lesser hospitalisation expenses (Republic of 
Mozambique 2002:6). However, PLWHIV and those who are AIDS-ill, as with any 
other chronic diseases, experience relapses and uncertain recoveries, a reality 
that might clash with the Ministry’s vision of the ill being able to quickly improve 
their health status at home. 
 
2.5.4 HBC services and HIV and AIDS-related stigma 
 
Most of the research on HBC and HIV and AIDS-related stigma has concentrated 
its efforts on the stigma and discrimination from the carers’ point of view, not the 
PLWHIV they care for (Campbell & Foulis 2004, Mwinituo & Mill 2006). 
 
So far, few studies have looked specifically at the link between HBC service 
provision and the reduction of HIV and AIDS-related stigma. In their study 
undertaken in 1987-1990 in rural Zambia, Chela, Siankanga, Bailey & Mwilu 
(1991) uncovered the essential role played by HBC services in the reduction of 
stigma associated with AIDS. The study concluded that physical, psychological, 
social and spiritual needs of PLWHIV are better catered for in a home 
environment than in a hospital, provided a network of support is in place. 
 
In a study with families supporting PLWHIV in Kenya, the researchers found that 
there is a relationship of unidentified directionality between improved care and 
knowledge of available support acquired through educational interventions on the 
one hand and expressed stigma on the other. In turn, decreased stigma will 
improve the quality of support by changing the care provider’s perceptions about 
the quality and intensity of care and support required by PLWHIV (Hamra et al. 
2005: 921). 
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In Zambia, one quasi-experimental study with young peer educators, reported 
qualitative changes between the baseline and the end-of-project in fear 
reduction, interest in caring for PLWHIV and acceptance (Esu-Williams, Geibel, 
Motsepe & Schenk 2003: 7). Another study (Letamo 2003: 347), found that “the 
more tolerant attitudes towards a family member with HIV/AIDS appeared to be 
promoted by the fact that family members have been and continue to care for 
their ill members through a government project called Community Home-based 
Care aiming at relieving public hospitals of their HIV/AIDS patients”.  
 
The literature review could not yield any specific study looking at a relation 
between HBC programmes versus HIV and AIDS-related stigma in Mozambique. 
By comparing mean HIV and AIDS-related and QoL scores between a group of 
PLWHIV on ART participating in a HBC programme and a a group of PLWHIV on 
ART not participating in a HBC programme, this study’s purpose was to fill that 
research gap. 
 
2.6 PROFILE OF THE ORGANIZATION THAT HAS DEVELOPED AND 
IMPLEMENTED THE HBC PROGRAMME FOR PEOPLE LIVING WITH HIV 
 
2.6.1 General presentation of Salama and origins of the HBC programme 
 
Based in Northern Mozambique, Salama is a national, non-profit, 
community health organisation founded in 1995.  It was formed by a group 
of local health workers when a project led by the Canada-Mozambique 
Cooperation (COCAMO) was phased out. It undertakes activities in 
Ribáuè, Malema and Mecuburi Districts and currently is involved in 
community health, HIV prevention and HBC services for PLWHIV. At a 
local level, Salama works with parteiras (traditional midwives), curandeiros 
(healers), activistas (community health workers) and community leaders 
(Salama 2004: 3). 
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In 2005, Olinda Sebastião Magaia, a nurse managing Salama’s 
community health programme, noticed an increase in the number of 
people staying at home because of a chronic illness. At that time, HIV 
testing was virtually unknown in the rural areas covered by the 
programme. After involving local leaders, community health workers and 
healers in a survey, the nurse realised that a significant number of people 
living with a chronic illness were showing signs in accordance with the 
clinical framework of AIDS-related treatment. Nurse Magaia decided to 
create a community home-based programme aiming at assisting PLWHIV 
and secured funding from COCAMO, PWRDF (Primate’s World Relief 
Development Fund) and Trôcaire, all international development NGOs 
working in Mozambique. In the first year, 2006, more than 100 people 
benefited from the programme and received material, logistical and 
spiritual support. 
 
2.6.2 Objectives of Salama’s HBC programme 
 
Salama’s HBC programme has three objectives: 
 
1) Provide home-based support to 500 ill people or people with 
symptoms in accordance with the clinical framework of AIDS and 
secure continued health care by their primary carers (family members 
at home) 
2) Contribute to the nutritional improvement of 500 PLWHIV 
3) Raise awareness in the community and promote the involvement of 
people and community groups in the support and integration of 
PLWHIV in the active life of the community (Salama 2005: 5). 
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2.6.3 Elements of Salama’s HBC programme 
 
The World Health Organisation (2002) has identified the necessary core 
elements of any HBC programme.  In Table 2.1, the activities included in 
each element are described. The third column shows which of these 
activities are implemented by Salama in its HBC programme.  
 
Table 2.1: Core HBC programme activities (World Health Organisation 
2002) 
 
Core Elements Core Activities 
Activities 
implemented 
by Salama 
Provision of care 
(Service package) 
Basic physical care YES 
Palliative care NO 
Psychosocial support and counselling YES 
Treatment of tuberculosis and opportunistic 
infections YES 
Food supplementation Very occasionally 
Administration Network of services and resources YES 
Ensuring access to referral services YES 
 Transportation to referral services Very occasionally 
 Payment waivers (ability to pay) YES 
Coordination with facilities 
 Discharge planning YES 
 Written referral YES 
Benefits to families: cash allowances, care-giver 
compensation (in-kind, honorarium) YES 
Supply and storage of HBC kits, necessary drugs 
and commodities, and equipment YES 
Staffing: supervision, recruitment, staff rotation 
between HBC and community clinic 
to avoid burn-out 
YES 
Budget and financial management including 
income-generating activities YES 
Monitoring and evaluation 
 Quality assurance YES 
 Monitoring and supervision YES 
 Evaluation YES 
Education/Training 
(Target groups: 
PLWHA, family 
members, community 
health workers, 
community 
volunteers, 
administrative staff) 
Curriculum development YES 
Educational management and curriculum delivery NO 
Outreach activities YES 
Education to reduce stigma YES 
Mass media involvement NO 
Evaluation of education NO 
 44 
 
2.6.4 Results obtained by the programme 
 
As of October 2008 about 465 people living with HIV, many of whom were 
undergoing ARV treatment, were enrolled in the HBC programme in the 
districts of Malema and Ribáuè. According to the annual report produced 
in 2008, before the start of the programme, the community considered 
taking care of a person living with HIV as taboo, and most people did not 
want to receive ARV treatment. As a result of Salama’s work, some 
PLWHIV are now getting involved and being trained in HBC services 
themselves. They want to act as agents of change by talking about their 
own experience of living with HIV (Salama 2008: 9). 
 
2.6.5 Challenges for the future 
 
In informal discussions with the manager and volunteers from the 
programme, it became clear to the researcher of the current study that the 
issue of stigma experienced by the beneficiaries is important. The HBC 
volunteers can identify instances where PLWHIV suffering from stigma 
and discrimination have, after receiving support from the programme, 
seen their psychosocial situation greatly improve and felt integrated once 
again in their own communities and families.  
 
2.7 THEORETICAL POINT OF DEPARTURE 
 
The following synthesis was used as a theoretical point of departure for this 
study.  
 
Drawing on the work of Rintamaki, Davis, Skripkauskas, Bennett & Wolf (2006: 
360) and their sociocognitive model, as well as Bos, Schaalma and Pryor (cited 
in Stutterheim 2008: 10) with their cognitive-emotional model, it is proposed to 
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use a conceptual framework for the study which encompasses the relations 
between stigma and QoL (See Figure 2.3).  
 
The social-cognitive theory (SCT) focusses on a dynamic, three-way, continuous 
and reciprocal relationship between personal, environmental and behavioural 
factors (Redding, Rossi, Rossi, Velicer & Prochaska 2000: 185). According to 
this theory, each factor constantly influences the other two. In the proposed 
framework for this study, individual beliefs and social values can influence the 
behaviour of the individual and vice-versa. For example, when a PLWHIV 
believes that HIV is the consequence of a sin, and the society puts a premium on 
following religious principles, the behaviour of the PLWHIV could be to withdraw 
from social interactions and refrain from disclosing his or her HIV status.  
 
Albert Bandura, a Canadian psychologist, is a major tenet of the social cognitive 
theory. According to Bandura (2002: 269), there are three types of actions that 
human beings can put in motion in a context of development and adaptation to 
change. The first one is individual action. In the conceptual framework presented 
in Figure 2.3, an example of this type of action would be when a person decides 
to stop seeing a friend who has HIV because he believes he is at risk of being 
infected. The second type of action is achieved by using a proxy, meaning that 
the individual will influence others to realise the action in order to attain a certain 
desired outcome. This could be illustrated when parents complain to the school 
principal that a pupil has HIV, believing that this child will put their own children at 
risk of HIV infection. The third type is collective action and can be defined as an 
action undertaken by a group of people working together to reach a common 
goal. When PLWHIV are beaten or isolated by groups of people, a collective 
action described by Bandura is a consequence of the stigmatisation process and 
creates the impacts on mental health and physical health shown in Figure 2.3. 
 
The cognitive-emotional model described by Bos, Schaalma & Pryor (2008) 
examines the relationship between cognitive, emotional and behavioural factors 
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impacts of stigma on mental and physical health of PLWHIV are measured with 
the Berger Stigma Scale and the WHOQOL-BREF is used to evaluate the QoL of 
PLWHIV on ART, both inside and outside the HBC programme. The views of 
PLWHIV in the study are created by the socio-cognitive dynamics of their own 
experience, producing a vision of themselves (the “Self” section in the conceptual 
framework) which interacts with the beliefs, values and socio-legal systems of the 
society (the “community” section in the conceptual framework). 
 
In addition, any conceptual framework for stigma would benefit from 
acknowledging the emic/etic dichotomy, in which emic is defined by the field 
corresponding to the “insiders’ perspective” within a certain cultural group and 
etic to the “outsiders’ perspective”, characterised by professionals or scientific 
observers (Weiss, Doongaji, Siddhartha, Wypij, Pathare, Bhatawdekar, Bhavem 
Sheth & Fernandes 1992: 820).  
 
In this study, the “emic” perspective meant that the views expressed by PLWHIV 
were used as primary data. It has been collected from an “emic” position as it is a 
reflection of thoughts and feelings of “insiders” who are part of the socio-cultural 
context being studied.The “etic” perspective was provided by the literature on 
HIV and AIDS stigma. The analysis of this data is conducted from an “etic” 
perspective as the researcher does not come from the same socio-cultural 
context as the participants in the study. 
 
2.8 CONCLUSION 
 
The links between HBC services, HIV and AIDS-related stigma, and QoL in 
PLWHIV are complex and multidimensional. There is a large quantity of literature 
on each of these components but little research has been done to integrate them 
all, especially in sub-Saharan Africa. An HBC programme such as the one 
implemented by Salama is an ideal opportunity to examine how PLWHIV 
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undergoing ARV treatment in Northern Mozambique perceive their QoL and how 
they experience stigma in their day-to-day activities. 
 
In the next chapter, we will look at the methodology used to conduct the current 
study, including an overview of the research design, sampling design and the 
measurement of variables. 
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CHAPTER 3 : METHODOLOGY 
 
3.1 INTRODUCTION 
 
The third chapter discusses the methodological considerations of the study. The 
research design is introduced, including the type of study, data and sources 
used. The research hypotheses are outlined. The key variables and the 
instruments used for data-gathering are described. Finally, ethical considerations 
are discussed. 
 
3.2 THE CHOSEN RESEARCH DESIGN 
 
3.2.1 Type of study 
 
The study is a cross-sectional, quantitative investigation. It was designed to test if 
there are differences in the mean scores for HIV and AIDS-related stigma and 
QoL measurements for PLWHIV on ART in Ribáuè and Malema, whether they 
are receiving HBC services or not. The design was chosen based on a number of 
considerations. The first is related to the resources available to conduct the 
study. The design of the study had to take into account the limited resources 
available to the researcher, both in terms of time and financial inputs. The time 
factor made a longitudinal study unrealistic as the data needed to be collected 
within a short time frame as it was a requirement for the completion of a graduate 
programme. Also, the researcher had limited financial resources which did not 
allow for an expensive study design. 
 
The design was also selected because the study is not looking for causality, but 
for a possible correlation between the key variables: participation in a HBC 
programme as an independent variable and stigma/QoL levels as a dependent 
variable. In that context, correlationality can be defined as a “… systematic 
association between different aspects of two phenomena. […] Correlation does 
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not imply that a phenomenon is the cause of the other” (Gauthier 1986: 515). The 
design chosen is the most effective way to find preliminary evidence of a 
difference between the two groups studied, so that other studies could move 
ahead to a more specific study examining a potential causal relationship between 
participation in a HBC programme on one hand and QoL and stigma levels on 
the other. In other words, it would not be scientific to look for a causal effect of 
HBC programmes on HIV and AIDS-related stigma scores and QoL 
measurements in PLWHIV, when no evidence of a difference between PLWHIV 
in the HBC programme versus PLWHIV not in the HBC programme had yet been 
found.  
 
3.2.2 Type of data and sources used 
 
The study gathered and analysed quantitative data related to HIV and AIDS-
related stigma and QoL. Using quantitative data permitted comparisons with 
other studies about HIV and AIDS-related stigma that used the same survey 
tools.  
 
Data were collected via face-to-face interviews with PLWHIV on ART in the 
Malema and Ribáuè districts who also receive HBC services from the HBC 
programme implemented by Salama. The data were also collected in face-to-
face interviews with PLWHIV on ART in the Malema and Ribáuè districts who do 
not receive assistance from the HBC programme, because they resided in a 
section of town outside the designated programme area.  
 
As the HBC intervention was already ongoing at the time of the commencement 
of the study, it was not possible to create a sample of randomly selected 
research participants from amongst PLWHIV receiving ART in Malema and 
Ribáuè. Also, the researcher could not assign cases of ART recipients in these 
areas in an experimental and a control group as one might desire to do for a 
randomised trial because detailed lists of ART recipients could not be accessed.  
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It was assumed, however that the study design would not create a significant 
selection bias as most PLWHIV on ART in Malema and Ribáuè districts were 
included in the sample.   
 
3.3 RESEARCH HYPOTHESES 
 
In the study, the independent variable is participation in the HBC programme, 
and the dependent variables are the level of HIV and AIDS-related stigma and 
QoL in PLWHIV on ART. The three objectives of the study (see Chapter 1) were 
tested based on the hypotheses described in this section. 
 
3.3.1 Hypothesis related to objective 1 
 
The first objective of the study was to answer the following question: Is there a 
difference in the level of HIV and AIDS-related stigma experienced by PLWHIV 
on ART receiving HBC services and the level experienced by PLWHIV on ART 
but not receiving HBC services? 
 
The null hypothesis for objective 1 is: 
H0 : μ1 = μ2 
μ1 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART receiving 
HBC services in Ribáuè and Malema. 
μ2 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART not 
receiving HBC services in Ribáuè and Malema. 
 
The alternative hypothesis for objective 1 is:  
H1 : μ1 ≠ μ2 
μ1 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART receiving 
HBC services in Ribáuè and Malema. 
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μ2 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART not 
receiving HBC services in Ribáuè and Malema. 
 
3.3.2 Hypothesis related to objective 2 
 
The second objective of the study was expressed in the following question: Is 
there a difference in the self-reported QoL scores for PLWHIV on ART receiving 
HBC services and the scores for PLWHIV on ART not receiving HBC? 
 
The null hypothesis for objective 2 is: 
H0 : μ1 = μ2 
H0 = the null hypothesis 
μ1 = Mean scores for quality of life of PLWHIV on ART receiving HBC services in 
Ribáuè and Malema. 
μ2 = Mean scores for quality of life of PLWHIV on ART receiving HBC services in 
Ribáuè and Malema 
 
The alternative hypothesis for objective 1 is:  
H1 : μ1 ≠ μ2 
μ1 = Mean scores for quality of life of PLWHIV on ART receiving HBC services in 
Ribáuè and Malema. 
μ2 = Mean scores for quality of life of PLWHIV on ART not receiving HBC 
services in Ribáuè and Malema 
 
3.3.3 Hypothesis related to objective 3 
 
The third objective of the study was to answer the following question: Is there a 
correlation between stigma and self-reported QoL? 
 
The null hypothesis for objective 3 is: 
H0 : There is no correlation between the variables at α=0.01 
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The districts’ inhabitants share similar socio-cultural characteristics, as there is 
only one ethnic group, the Makua, and one local language, Emakua (Republic of 
Mozambique 2005a: 12; Republic of Mozambique 2005b: 12). 
 
In the following table, socio-demographic indicators for both districts are 
presented: 
 
Table 3.1: Socio-demographic indicators for Ribáuè and Malema districts 
(Republic of Mozambique 2005a; Republic of Mozambique 2005b) 
 
 Ribáuè Malema 
Population (2005) 153,794 149,782 
Percentage of the population under 15 
years old 48% 46% 
Urbanisation rate 12% 26% 
Health installations (hospital, health posts) One per 19,000 
people 
One per 20,000 
people 
Professional health technicians One per 2,600 
people 
One per 4,500 
people 
Religion:   
Muslims 46.0% 41.8% 
Catholics 27.0% 24.7% 
Evangelicals 18.3% 18.4% 
Animists: 10.2% - 
Other 11.1% 15.1% 
Illiteracy percentage (1997)   
Men 63.0% 58.9% 
Women 87.3% 83.7% 
Total 75.3% 71.5% 
 
The information presented in Table 3.1 shows that the two districts are similar in 
terms of socio-demographic indicators, except for the urbanisation rate, which is 
twice as high in Malema as in Ribáuè 
 
3.5 SAMPLING DESIGN AND PROCEDURES 
 
The HBC programme which was studied is implemented by Salama, a local 
NGO. As of October 2008, about 465 PLWHIV, many of whom are also 
undergoing ART, were enrolled in the HBC component of the programme in the 
districts of Malema and Ribáuè. The following tables, provided by the districts’ 
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Health Departments to Salama’s head nurse (Olinda Magaia, October 2008, 
personal communication) show the number of PLWHIV in Ribáuè and Malema. 
In bold typeface are the numbers of PLWHIV that formed the universe of 
potential participants for the study: 
 
Table 3.2: Number of PLWHIV in Malema district in October 2008 (Olinda 
Magaia, October 2008, personal communication) 
 
 Men Women 
PLWHIV 
(according to 
data 
collected by 
the VCT 
facility) 
On antiretroviral 
treatment 
On Salama’s HBC programme 50 109 
Outside Salama’s HBC programme 7 - 
Not on antiretroviral 
treatment 
On Salama’s HBC programme 25 192 
Outside Salama’s HBC programme 297 637 
  TOTAL 379 938 
 
Table 3.3: Number of PLWHIV in Ribáuè District in October 2008 (Olinda 
Magaia, October 2008, personal communication) 
 
 Men Women 
PLWHIV 
(according to 
data 
collected by 
the VCT 
facility) 
On antiretroviral 
treatment 
On Salama’s HBC programme 7 9 
Outside Salama’s HBC 
programme 
150 144 
Not on antiretroviral 
treatment 
On Salama’s HBC programme 31 42 
Outside Salama’s HBC 
programme 
90 158 
  TOTAL 278 353 
 
The universe for the study was thus composed of 476 PLWHIV, comprising of 
175 patients benefiting from the HBC programme and 301 not involved in the 
programme. Of the 175 PLWHIV on ART in the HBC programme either in Ribáuè 
or Malema, 120 were sampled using a method describe below and 119 valid 
questionnaires were collected. Using the data shown in Table 3.2 and 3.3, 119 
PLWHIV on ART from Ribáuè and Malema who were not in Salama’s HBC 
programme were sampled out of 301 potential participants, producing a total of 
118 valid questionnaires from that sample. It was thus possible to interview 239 
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PLWHIV on ART and obtain 237 completed questionnaires, corresponding to 
49.8% of the potential respondents. 
 
As we have seen in chapter 2, the extent and prevalence of HIV and AIDS-
related stigma perceptions and experiences in Mozambicans living with HIV has 
not been measured yet in a study. Considering an unknown difference (u1 – u2) 
between the HIV and AIDS-related stigma levels between the groups studied, a 
power of 80% and an error level of 5%, a large enough sample in each group 
was needed in order to detect an eventual difference. In addition, the sample had 
to be sufficient to compute a regression model including various explicative 
variables (age, gender, education level, number of people living in the patient’s 
house, number of months since HIV diagnosis, membership/attendance of 
support groups, marital status and religious affiliation). The regression model 
allowed the researcher to observe the differences between the groups studied 
and to determine if they were statistically significant.  
 
In the case of this study, no comparable data from other research existed that 
could have helped in defining the standard deviation of the variable between the 
groups. Sample size also had to take into account the limited financial, human 
and time resources available to the researcher. Concerning the minimal sample 
size needed to conduct a study such as this one, it was stated by MacCallum, 
Widaman, Zhang & Hong (1999: 96) that the minimal number of participants in a 
study depends on the variables used and the design of the study, rendering 
general guiding principles “not valid or useful”. Also, given a normal distribution, 
central limit theorem applies to samples of over 30 individuals (Norman & 
Streiner 2008: 32). In this study, a sample of 120 PLWHIV on ART receiving 
HBC services and 120 PLWHIV on ART not receiving HBC services, for a total of 
240 research participants, was planned. However, due to the rejection of two 
questionnaires because two respondents were under 18 years of age and a 
miscalculation of the number of completed questionnaires in the non-HBC 
programme group, the final number of valid questionnaires was 119 in the HBC 
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programme group and 118 in the non-HBC programme group, for a total of 237 
completed questionnaires. The two groups studied were sampled from the 
universe of potential participants described above. 
 
PLWHIV on ART have to attend a VCT facility every month in order to receive 
their medication. Those not involved in the HBC programme were asked by the 
VCT counsellor if they had an interest in participating in the study. The request 
was made at the end of a normal counselling session. The purpose of the study 
was explained and it was made clear that participation was voluntary, unpaid and 
that refusal to participate would not have any negative consequences. After 
agreeing to participate, a separate appointment was made for the volunteers 
outside normal clinic hours so that the interview would not replace normal 
counselling being given to the patient.  The VCT staff’s collaboration and 
commitment to the study were essential. The first 120 PLWHIV using ARV and 
not involved in the HBC programme who agreed to take part duly signed the 
informed consent form and were enrolled in the study.  
 
As explained, a specific time was planned for the interview, at a moment that did 
not influence normal clinic activities and the counsellor made sure patients 
understood that the study interview was an event separate from counselling, and 
that normal counselling would continue as usual. The interviewer, in this case the 
VCT counsellor, used pre-prepared forms for the study and did not communicate 
names of the respondents to anyone. In some cases, and in order to ensure 
conformity between the interviews which were undertaken by two different 
counsellors, the head nurse of the HBC programme participated in the interview 
as an observer. This was done only after securing the patient’s agreement to this 
arrangement. If the patient did not agree to the presence of the head nurse, but 
agreed to the interview with the counsellor, the head nurse did not participate as 
an observer and the interview was conducted with the counsellor as the only 
other person present. 
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Respondents on ART and receiving HBC services were selected randomly by the 
nurse supervising the programme. The selected respondents were contacted by 
a programme volunteer or the head nurse and introduced to the research. They 
read (or someone did the reading for them) the informed consent form. A specific 
date and time was decided for the interview. The head nurse conducted the 
interviews, in the presence of a programme volunteer who helped to make the 
participants feel at ease. The beneficiaries of the HBC programme were told that 
this was a separate visit from the normal HBC visits and that these would 
continue as planned, without interference by the study interview. The true names 
of the respondents were known to the head nurse, but no names were revealed 
to the researcher, thus preserving the confidentiality of the respondents. 
 
The following table shows the sampling frame and criteria for inclusion in the 
study: 
Table 3.4: Sampling decisions 
 
 Group 1 - PLWHIV on ART receiving 
HBC services in Salama’s HBC 
programme 
Group 2- PLWHIV on ART not 
receiving HBC services in Salama’s 
HBC programme 
Number of 
participants 
120 (out of 175 potential participants) 120 (out of 301 potential participants) 
Criteria for 
inclusion 
 18 years old or older 
 Living with HIV 
 Receiving ART from local testing and 
counselling facility in Malema or Ribáuè 
 Receiving support from Salama’s HBC 
programme (for at least the previous 3 
months) 
 Received thorough explanation of the 
purpose of the study, their rights as 
participant and signed the informed 
consent form 
 18 years old or older 
 Living with HIV 
 Receiving ART from local testing and 
counselling facility in Malema or Ribáuè 
 Had never received support from 
Salama’s HBC programme 
 Received thorough explanation of the 
purpose of the study, their rights as 
participant and signed the informed 
consent form 
Interviewer 
HBC programme nurse and a local 
programme volunteer as an observer 
Counsellor at the local VTC and HBC 
programme nurse (if agreed to by the 
participant) as an observer 
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 Group 1 - PLWHIV on ART receiving 
HBC services in Salama’s HBC 
programme 
Group 2- PLWHIV on ART not 
receiving HBC services in 
Salama’s HBC programme 
Sampling 
technique 
 A list of all the PLWHIV receiving ART 
who were beneficiaries of the HBC 
programme was produced by the head 
nurse of the programme. Each person 
was assigned a number and 120 
numbers were randomly selected during 
a draw. The head nurse noted the 120 
names. 
 Potential participants were approached 
by the head nurse of the HBC 
programme, and were given an 
explanation of the purpose of the study. 
If interested, each potential participant 
consented verbally and then signed the 
informed consent form. 
 A list of all the PLWHIV receiving ART 
who were not beneficiaries of the HBC 
programme was produced by the 
counsellor at the VCT. Each person was 
assigned a number and 120 numbers 
were randomly selected during a draw. 
The counsellor noted the 120 names. 
 Potential participants were approached at 
the end of a routine meeting with their 
usual counsellor at the VCT, and were 
given an explanation of the purpose of 
the study. If interested, each potential 
participant consented verbally and then 
signed the informed consent form. 
 
3.6 ACCESS, AUTHORISATION AND CLEARANCE 
 
Clearance was sought and secured by the researcher from the Department of 
Sociology’s Ethics Committee at the University of South Africa (UNISA). Since 
the researcher was not present in Mozambique when data was gathered, the 
Ministry of Health officials at district level were informed of the process by 
Salama’s head nurse, on behalf of the researcher. This is standard procedure for 
activities involving Salama, used for example when the organisation collects 
baseline data to evaluate its HIV/AIDS or community health programmes. The 
district officials received verbal information related to the study and provided the 
necessary authorisation for the study to proceed. Other verbal authorisations 
were granted from local leaders from the communities concerned during informal 
meetings held by Salama’s head nurse. 
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3.7 INSTRUMENTATION 
 
In order to gather data on HIV and AIDS-related stigma and QoL, a selection of 
quantitative instruments was assembled. Quantitative data was collected using 
the tools described below. 
 
3.7.1 The Berger Stigma Scale 
 
Berger’s Stigma Scale consists of 40 items and is a standardized instrument 
designed to measure stigma (Berger et al. 2001). It examines stigma 
experienced on the following subscales: Personalised stigma, disclosure, 
negative self-image and public attitudes. Berger et al. (2001: 526) claim that the 
tool is “reliable and valid with a large, diverse sample of people with HIV”.  The 
Berger Stigma Scale has been chosen because it is a multiple item questionnaire 
specifically designed for measuring various aspects of stigma. As Kalichman et 
al. (2005: 135) point out, “… multiple item measures have several advantages 
over single item measures, including increased reliability, greater variability, 
better sensitivity to change, and greater construct representation”. 
 
3.7.2 WHOQOL-BREF  
 
This is the World Health Organisation’s generic tool to measure quality of life 
(Canavarro, Simões, Pereira & Pintassilgo 2005; World Health Organisation 
1996). The 26-item instrument collects data in four different domains: Physical 
health, psychological health, social relationships and the environment. Each 
domain contains facets of life describing the situation of the person. In the 
context of this study, the WHOQOL-BREF was selected as the QoL instrument 
as it has been used previously in Africa and proved reliable and valid in different 
settings (Dos Santos et al. 2007; Fang et al. 2007; Mutimura et al. 2008; Nirmal 
et al. 2008; Ola et al. 2006). As it is a generic instrument, it allows comparisons 
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with other studies which could prove to be useful in future research (Robinson 
2004: 15S; Wiebe et al. 2003: 52). 
 
3.7.3 Translation of the questionnaires 
 
The questionnaire was produced in two versions: Portuguese and the local 
language, Emakua. The questionnaire was translated into Portuguese by the 
researcher and double-checked by Salama’s head nurse, who is a native 
speaker. The questionnaire in Emakua was translated by a committee consisting 
of Salama’s staff members, under the direct supervision of the researcher who 
spent two days in February of 2008 with the staff members to do the translation. 
The involvement of local staff members in the translation of the instruments used 
was considered an essential step so that questions would be “unambiguous and 
culturally shared” (Bowling 2005: 419) a method suggested by the author to 
ensure proper cultural equivalence. The staff members were explained the 
purpose of the work and were told that the questionnaires would be used in a 
study conducted by the researcher as a requirement for a Master’s degree. The 
staff members were paid by the researcher for the work done on the 
questionnaires. The researcher’s role in the translation phase was to explain the 
meaning of the questions in the various questionnaires to make sure the 
translation was based on the right interpretation of the Portuguese version. The 
Emakua questionnaire was back-translated into Portuguese by one of Salama’s 
HIV/AIDS programme manager, who was paid by the researcher from his 
personal money to check for consistency. 
 
3.7.4 Training of the interviewers 
 
The questionnaires were introduced to the head nurse of Salama’s HBC 
programme and the counsellors from the VCTs in Ribáuè and Malema. These 
people were selected by the researcher because they were able to speak the 
local language, Emakua and were already known by the PLWHIV in the 
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communities. For their work as interviewers, they were paid by the researcher’s 
own money. The researcher trained the head nurse over the phone on the use of 
the study’s questionnaires and carefully explained how to conduct the interviews. 
As the researcher had previously worked with Salama’s head nurse in data-
collecting events, ethical issues related to community surveys and precautions 
needed to avoid introducing bias while conducting the interviews had already 
been explained and integrated. The head nurse then trained the two VCT 
counsellors on the use of the questionnaire and was asked to refine the interview 
techniques. The training was conducted in July of 2009 after the researcher’s 
supervisor at UNISA gave her authorisation to proceed with the interviews. Every 
question was reviewed and the head nurse gave explanations when needed. The 
main objective was to make sure that all the interviewers would ask the same 
questions in the same way and write down the answers in a consistent and 
coherent manner. Linguistic issues regarding the questionnaires which had been 
translated into Emakua were addressed, to ensure that the meaning of 
Portuguese expressions was accurately conveyed in Emakua. 
 
3.7.5 Pre-testing of the instruments 
 
The first step of the pre-testing phase was to make a list of all the PLWHIV on 
ART and enrolled in the HBC programme. The list was provided by the head 
nurse as it already existed in the HBC programme database. The sampling 
procedures were designed by the researcher (See Table 3.4) then explained to 
the head nurse. For practical reasons, as the researcher was not physically 
present when the sampling was done, the head nurse wrote the names from the 
list on pieces of paper and put them in a bag.  The first 10 names randomly 
picked were assigned to the group of “pre-test” and the next 120 names were 
assigned to the “study” group, in accordance with the sampling framework of the 
study. The names selected for each group were put on a separate sheet of 
paper, and kept only by the head nurse in charge of the programme to preserve 
the anonymity of the participants. The remaining pieces of paper were destroyed. 
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For the next group, PLWHIV on ART but not participating in the HBC 
programme, the first 10 PLWHIV who went to the VCT for their monthly visits and 
agreed to sign the consent form for the study were asked by the counsellor to 
answer the questionnaires as a way to pre-test the questionnaires. The criteria 
used to select the participants were the same as the study’s criteria, as shown in 
Table 3.4. For their participation in the pre-test phase, the 20 PLWHIV were 
reimbursed the cost of a meal (2$US), an amount that was paid by the 
researcher with his personal money.  
 
Before they tested the questionnaires, the VCT counsellors were trained by 
Salama’s head nurse to use the tools consistently. Starting in July of 2009, the 
questionnaires to be used in the study were formally tested in the districts of 
Malema and Ribáuè in Northern Mozambique. After a first round of tests with 20 
PLWHIV (10 from the PLWHIV in the HBC programme and 10 PLWHIV not in the 
HBC programme), the VCT counsellors met with the head nurse and discussed 
administering the questionnaires. Suggestions to improve quality were 
formulated and changes were made by the researcher to the questionnaires to 
improve clarity.  Changes included adding the word “resources” to the question 
12 in the WHOQOL-BREF questionnaires to adapt to the fact that very few 
people in the rural area manipulate paper money, but use resources such as 
food and other goods instead of money to evaluate their economic status. The 
question 13 of the same questionnaire had to be changed also, because it 
measured the level of information that PLWHIV can have access in their 
everyday life. That question made little sense to the people interviewed, so the 
researcher decided to add some examples of the types of information that could 
be needed, such as health-related or information about rights. Finally, question 
11 in the Berger Stigma Scale had to be changed by the researcher because the 
counsellors reported that it was puzzling to the PLWHIV interviewed in the test 
phase. The original question was labelled “It is easier to avoid new friendships 
than worry about telling someone that I have HIV” (Berger et al. 2001). After 
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discussion with the head nurse, the researcher re-labelled the question to “I 
prefer not to make friends because I am afraid I will have to tell them I have HIV” 
which was more easily understood by the PLWHIV. 
 
During the testing phase, the staff noted that administering each questionnaire 
took between one hour and one hour and forty-five minutes. This proved to be 
difficult for some of the participants who became tired after forty-five minutes. To 
make sure that participants were able to answer questions to the best of their 
ability, the interviewing team had to break up the interview into two parts to allow 
participants some time to rest. 
 
Also, as the Emakua language is prone to local interpretations, the use of a local 
volunteer during the interview helped the participants to feel at ease. The 
introduction of a local volunteer, to which the participants agreed, was a way to 
double-check the accuracy of the answers and make sure that the answer written 
on the form reflected the opinion of the participant. 
 
After the testing rounds, an updated version of the instrument was produced and 
final reviews were made by the interviewers to make sure that all problems had 
been resolved. Another training session was held to explain the changes made to 
the questionnaires and to fine-tune interview techniques. 
 
The supervisors of the study (Dr. Gretchen du Plessis and Mr. Leon Roets) were 
informed of the results of the testing and granted final authorisation for the main 
data collection to begin. 
 
3.8 DATA COLLECTION PROCEDURES 
  
The interviews with PLWHIV included in the HBC programme were conducted by 
Salama’s head nurse, accompanied by a local volunteer in the HBC programme. 
PLWHIV not included in the HBC programme were interviewed by the HIV/AIDS 
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counsellor at the HIV testing and counselling facility over a three month period. 
Both the head nurse and the counsellors at the VCT were paid by the 
researcher’s own money, but the programme volunteers were not paid. As they 
had to spend a few hours with the interviewer, participants were reimbursed the 
cost of a meal (2$US), an amount that was paid by the researcher with his 
personal money. 
 
The data collected was coded, checked and computerised in an Excel 
spreadsheet. After checking, two questionnaires had to be eliminated from the 
analysis because the ages of the respondents were younger than 18 years. One 
of the questionnaires rejected was of a PLWHIV in the HBC programme (case 
#127) and the other was of a PLWHIV not in the HBC programme (case #246). 
The data in the spreadsheet was analysed using SPSS statistical software.  
 
3.9 DATA ANALYSES 
 
Data was collected about socio-demographic variables such as age, gender, 
education level, number of people in the research participant’s household, 
number of months since HIV diagnosis, membership/attendance of support 
groups, marital status, employment status and religious affiliation. The 
information gathered was then processed by an analysis of variance (ANOVA) in 
order to understand the relationship between the variables and to extract 
significant differences between the two groups. Differences between these 
findings and existing literature are discussed and compared in chapter 4. Data in 
that chapter is presented using graphs and tables which clearly show the 
strength of the relationship between the different variables. 
 
 
3.10 LIMITATIONS OF THE STUDY 
 
The study has various limitations. In this section, they are described and 
discussed. 
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3.10.1 External validity 
 
Based on the study design and limited sample, the conclusions of the study 
cannot be generalised to refer to every PLWHIV in Mozambique, or indeed 
elsewhere. The data collection was conducted using a sample of PLWHIV on 
ART in Ribáuè and Malema, so it would be imprudent to reach the conclusion 
that the current study would be applicable even to the situation of PLWHIV in 
Maputo, for example. Further research will be needed to verify if similar results 
could be uncovered in different settings. 
 
3.10.2 Value of self-reported measurements 
 
One of the issues that could be viewed as contentious is the value of self-
reported measurements in the field of HIV and AIDS-related stigma QoL. The 
main questions in this regard are: a) Were the participants able to understand the 
questions and provide the information asked and b) Were they honest in their 
answers? 
 
The ability to understand the question was given much attention in the testing 
phase of the questionnaires. Because the interviewers reported some 
respondents had difficulties in answering some questions, modifications were 
made to the problematic sentences to increase the interviewees’ comprehension. 
However, given that HIV itself can impair judgement when it attacks the 
neurological system (Owe-Larsson, Säll, Salamon & Allgulander  2009: 116), 
partial loss of cognitive capabilities such as memory and self-awareness could 
have prevented some participants from fully understanding the questions asked. 
Assessing whether or not a participant was suffering from neurological 
impairments would have been a massive undertaking that was not contemplated 
for this study, given the level of clinical observation needed to diagnose patients 
and the limited scope of the study. The prevalence of neurological complications 
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for a general population of PLWHIV in Africa is not known, but a study of 5000 
homosexual men in the United States place it at about 15% (McArthur, Brew & 
Nath 2005: 543). However, it is known that ART can reduce the incidence of 
neurological problems and even reverse their effects for at least 50% of PLWHIV 
(McArthur et al. 2005: 543). All the respondents of the study were on ART when 
they were interviewed, which possibly contributed to reduce the impact of 
neurological impairments on the answers given. 
 
The question of honesty in the answers given is important because of the context 
of the study. Personal observations made by the researcher tend to support the 
hypothesis that some people might give answers in a way they think will lead 
them to acquire more services or resources, a process know as “strategic 
answering” (Macours 2002: 2). In some cases, reporting worse health could be 
interpreted by the respondent as a way to attract the attention of carers or 
programme donors. The effects of this were considered to be equal for both 
groups, but it might be argued that the participants in the study coming from the 
group not benefiting from the HBC programme might be more tempted to answer 
in a strategic way to attract the services that they cannot currently access. More 
research would be needed to confirm or deny this hypothesis. 
 
3.10.3 Social desirability effect 
 
Another issue of note is the fact that interviews were conducted in a face to face 
situation with an interviewer. This method was chosen because literacy rates are 
low in the region studied, at 28% in the District of Malema and 25% in the District 
or Ribáuè (Republic of Mozambique 2005a: 13; Republic of Mozambique 2005b: 
16). In such a context, written questionnaires might have severely limited the 
number of respondents. The downside of this is that face to face interviews might 
have affected the answers given because of the social desirability effect. As 
Muldoon, Barger, Flory & Manuck (1998: 544) point out, “… some people have 
response biases that lead them to give the answers they think are most socially 
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acceptable or cast them in a favourable light”. To reduce the effect of social 
desirability, a neutral attitude for interviewers at all times while conducting 
interviews was promoted, and the confidential nature of the answers was given 
emphasis. 
 
3.10.4 Study design 
 
In order to thoroughly examine the differences between the two groups studied, a 
longitudinal study would have yielded the largest amount of information. A 
randomized, controlled trial would also have been a design of choice as it would 
have allowed measuring the impact of the HBC programme on QoL and stigma 
levels in PLWHIV on ART. In the context of the study and given the resources 
available, a cross-sectional study was considered to be an adequate alternative. 
The main disadvantage of the cross-sectional design of the current study is that it 
does not allow the establishment of a causal link between the involvement in a 
HBC programme and HIV and AIDS-related stigma and QoL. However, it 
provides sufficient information to point out differences between the groups and 
suggest avenues for future research. 
 
Also, the sampling methods used in the study were not completely random. The 
reason for the non-random sampling of the participants is that there was no list 
available to identify PLWHIV not in the HBC programme. The selection of the 
participants had to be conducted as PLWHIV were fetching their medicine at the 
local VCT, resulting in a “first come, first to have a probability of participating in 
the study” sampling method for that specific group. On the other hand, the 
presence of a list of PLWHIV in the HBC programme allowed for a randomized 
sample in that group, meaning that every PLWHIV on ART in the HBC 
programme had the same probability of being selected as a participant in the 
study. 
 
 
 69 
 
3.10.5 Variables not measured 
 
Significant and potentially confounding factors based on objective health status 
measures such as CD4 count and weight, were not collected nor measured. A 
specific instrument to measure health status was not available and health-related 
information such as HIV diagnosis date and occurrences of previous 
opportunistic infections was self-reported. The emphasis of the study was put on 
a subjective, self-reported assessment of QoL and HIV and AIDS-related stigma, 
and validation of the respondent’s perception against objective measurements of 
health was not in the scope of the study. 
 
3.10.6 Use of instruments not validated in the specific socio-cultural 
context 
 
Finally, the quantitative instruments that were used have not been tested in the 
socio-cultural context of Northern Mozambique, and do not have a standardized 
Portuguese or Emakua version. Extra attention was paid to the way the 
questionnaires were translated and adapted to ensure they were well understood 
by the respondents and that items corresponded to their socio-cultural reality. 
 
3.11 STRENGTHS OF THE STUDY 
 
3.11.1 Internal validity 
 
Studies looking at interaction between two phenomena, such as the presence or 
absence of participation in the HBC programme versus levels of stigma and QoL 
scores, need to establish internal validity (Fortin 1996: 132). Internal validity is 
defined as the relationship between the programme and the observed outcome 
(Bernard 2000: 108). In the case of this study, there was no intention of proving 
causality between the HBC programme and the stigma and QoL scores.  It was 
necessary, however, to have relatively high confidence that any potential 
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difference between the two groups would not be biased because of the existence 
of a concurrent HBC programme or similar intervention with the group of people 
not involved in Salama’s HBC programme. 
 
In the case of Malema District, few interventions in the field of HIV/AIDS have 
been conducted by other organizations. In Ribáuè, HIV/AIDS interventions 
outside Salama’s HBC programme were exclusively of a preventive nature, and 
no other HBC programme had been implemented at the time of the study.  
 
Another threat to validity would have been a difference between the two groups. 
The first group consisted of PLWHIV on ART receiving HBC services, and the 
second of PLWHIV on ART not receiving HBC services. Apart from their 
participation in the HBC programme, both groups were considered to be similar. 
 
3.11.2 Selection of participants 
 
A large percentage of known PLWHIV was included in the study and according to 
the counsellors at the VCT and Salama’s head nurse who conducted the 
interviews, no one refused to take part in the study which reduces the effects of 
selection bias. However, in two cases in Ribáuè and three in Malema, PLWHIV 
selected to participate in the study lost their lives before they could be 
interviewed. These participants were substituted the same way they were 
selected in the first place. The sample of PLWHIV not participating in the HBC 
programme was formed of patients taken from outside the HBC catchment area, 
not of PLWHIV who lived in the catchment area but did not want to be included in 
the HBC programme.  
 
3.12 ETHICAL CONSIDERATIONS 
 
In 2007, UNISA published ethical guidelines for the research conducted by its 
students (University of South Africa 2007). The document established four “moral 
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principles”, namely: autonomy, beneficence, non-maleficence and justice. As a 
complement to these principles, the guidelines stated ten “general ethical 
principles”. In this section, those principles will be reviewed and a description of 
what has been done to ensure they were respected during the preparation and 
implementation of the current study will be provided. 
 
3.12.1 “Essentiality and relevance” 
 
The study includes a review of the existing literature on the topic of HIV and 
AIDS-related stigma, QoL and their relation to home-based care for PLWHIV. No 
other study exploring these concepts was found to be comparable to the current 
study. This study explores the subject in a way that could uncover new evidence 
and yield positive benefits for programmes designed for PLWHIV.  
 
3.12.2 “Maximisation of public interest and of social justice” 
 
Any findings relevant to the population studied will be communicated to Salama’s 
staff so they can be integrated into the HBC programme. The results of the 
research will be shared with interested parties, including stakeholders and policy-
makers involved in HBC services in Mozambique. Original research documents 
and articles will be provided on request. 
 
3.12.3 “Competence, ability and commitment to research” 
 
The researcher had already completed all necessary requirements to obtain the 
MA degree (except the production of the dissertation), and is committed to the 
field of study.  
 
 
 
 
 72 
 
3.12.4 “Respect for and protection of participants’ rights” 
 
The notion of confidentiality was explained to the participants, as well as the 
purpose and time needed for the interview. Data collected during the interview 
was not shared with other people, and only the researcher and the interviewers 
handled the completed questionnaires.  
 
Training of Salama’s head nurse on the use of the study’s questionnaires was 
done over the phone as the researcher was in Canada at the time. The 
researcher made a comprehensive review of how the interview would have to be 
conducted with Salama’s head nurse. The researcher had previously trained 
Salama’s head nurse during successful community data-collecting events 
between 2002 and 2005, so ethical issues related to community surveys and 
precautions needed to avoid introducing bias while conducting the interviews had 
already been explained and integrated. Salama’s head nurse proceeded to train 
the two VCT counsellors on the use of the questionnaire and was asked to refine 
their interview techniques. Every question was read and discussed, and further 
explanations were given by the head nurse when needed. This was done to 
ensure that the interviewers would ask the same questions consistently and 
register the answers coherently without interfering or introducing bias.  
 
During data collection, each questionnaire was identified with a number in order 
to make it impossible to connect the questionnaires with a specific participant. 
Only socio-demographic characteristics were noted. After all the questionnaires 
were collected by Salama’s head nurse, they were packed and sent to the 
researcher in Canada through DHL, a courier company. The completed 
questionnaires were kept by the researcher in a locked file cabinet, and will be 
destroyed upon the completion of the dissertation.  
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3.12.5 “Informed and non-coerced consent” 
 
The interviewers explained the purpose of the study and stated clearly the rights 
of the participant (see informed consent form in annex). Participants gave their 
consent verbally and were presented with an informed consent form for them to 
sign. They kept one form and the other remained with the interviewer. After 
signing the form, a date and time was set up for the interview. 
 
3.12.6 “Respect for cultural differences” 
 
The researcher provided questionnaires in the language of the participants and 
used the help of local informers and interviewers to ensure the cultural relevancy 
and sensitiveness of the instruments used. Permission to visit PLWHIV at home 
was granted by the local authorities before the start of data collection.  
 
3.12.7 “Justice, fairness and objectivity” 
 
The participants in the study were selected based on objective criteria and were 
not burdened with repetitive interviews and tests. 
 
3.12.8 “Integrity, transparency and accountability” 
 
The research was conducted in a spirit of intellectual honesty and openness. The 
limitations of the study were clearly thought-through and contributions 
acknowledged. The researcher achieved no personal gain from the process, 
apart from the conclusion of the academic degree. 
 
3.12.9 “Risk minimisation” 
 
In the case of PLWHIV participating in the HBC programme, the interviews were 
delivered in the participants’ homes; as they already received visits from the 
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programme volunteers, this was considered the best approach to minimise 
discomfort from travelling. The PLWHIV not participating in the HBC programme 
were interviewed at the Salama facility by their normal counsellor, so their 
identity would remain secret. This ensured that the participants clearly 
understood that the study interview was different from the usual services they 
received at the VCT. Salama’s facility is a quiet and secluded setting and 
provided ideal conditions for confidentiality. The participants were provided with 
names of counsellors working in nearby VCT facilities in case the interview left 
the participant with questions or feelings of stress. As the interview did not 
include physical examination, there were no possibilities of physical harm. 
However, if the respondent felt tired during the course of the interview, it was 
possible to stop and start again at a more convenient time. Also, breaks to take 
medicine or go to the bathroom were accommodated by the interviewer. 
 
3.12.10 “Non exploitation” 
 
No community member was exploited during the completion of this study. 
Salama’s head nurse, the questionnaire translators and the VCT counsellors who 
helped with the collection of data were paid by the researcher, so their time was 
compensated. PLWHIV are vulnerable people and all precautions were taken to 
guarantee their protection from harm. Also, the conclusions of the study will be 
used to improve the current HBC programme, so the participants and the local 
communities will benefit from the knowledge uncovered as a result of the study. 
 
3.13 CONCLUSION 
 
In the preceding chapter, the methodological aspects of the study were 
described. This included sections on research design, research hypotheses and 
respondent selection. The quantitative instruments used in the study were 
described. The last section of the chapter was dedicated to the ethical 
considerations that guided every step of the research process. 
 75 
 
 
The next chapter will be dedicated to the research findings, including a 
description of the research sample. 
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CHAPTER 4 : FINDINGS 
 
4.1 INTRODUCTION 
 
This chapter comprises a presentation and discussion of the findings of the 
study, based on the data gathered in the Ribáuè and Malema districts. As 
mentioned in Chapter 1, the questions that guided the study were: 
 
1) Is there a difference in the level of HIV and AIDS-related stigma 
experienced by PLWHIV on ART receiving HBC services and the level 
experienced by PLWHIV on ART not receiving HBC services? 
2) Is there a difference in the self-reported QoL scores for PLWHIV on ART 
receiving HBC services and the scores for PLWHIV on ART not receiving 
HBC services? 
3) Is there a correlation between stigma and self-reported QoL? 
 
Before testing these hypotheses, the characteristics of the sample are presented. 
This is followed by a report on the collated score analyses for the stigma scale 
and QoL scale for the sample. In the third section of this chapter, the three 
hypotheses are tested. 
 
4.2 CHARACTERISTICS OF THE SAMPLE 
 
The data collection process was conducted between July and November 2009. 
237 valid questionnaires out of the 239 originally issued were collected by the 
interviewers.  
 
Table 4.1 shows the distribution of the respondents between the HBC group and 
the non-HBC group. It shows that 119 valid questionnaires were collected in the 
HBC group, and 118 in the non-HBC group, amounting to 99.2% realisation of 
the expected sample.  
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Table 4.1: Distribution of respondents in the HBC and non-HBC groups 
 
Group Frequency % 
In HBC 119 50.2 
Not in HBC 118 49.8 
Total 237 100.0 
 
Figure 4.1 shows the distribution of respondents according to gender. 65% of the 
respondents interviewed in the study were women (154/237), while the universe 
of potential respondents for the study had a gender breakdown of 55% women 
(262/476) and 45% men. Further analysis of the data shows that the gender 
imbalance was present in both the HBC and the non-HBC groups, with the 
number of men in the HBC group being slightly higher than in the non-HBC group 
(38.7% vs. 31.4% respectively). This is congruent with other home-based care 
studies undertaken in Africa, such as Apondi, Bunnell, Awor, Wamai, Bikaako-
Kajura, Solberg, Stall, Coutinho & Mermin (2007: 71) in which 72% of 
respondents were women. Amuron, Coutinho, Grosskurth, Nabiryo, Birungi, 
Namara, Levin, Smith & Jaffar (2007: 26) also noted that in Uganda more women 
than men access ART. 
 
A higher percentage of women in the study is also coherent with the notion of 
feminisation of the epidemic, according to which women are more likely to 
become infected with HIV (Himmelgreen, Romero-Daza, Turkon, Watson, 
Okello-Uma & Sellen 2010: 404). In Mozambique, according to data published by 
the Joint United Nations Programme on HIV/AIDS (2008a: 4), about 54% of 
people living with HIV are women. 
 
Gender differences between the HBC and non-HBC, however, were not found to 
be statistically significant2(1, N = 237) = 1,39, p > .05. 
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Table 4.2: Mean age of the respondents 
 
 
N Minimum Maximum Mean Std. 
Deviation 
In HBC 119 18 49 32.4 7.9
Not in HBC 117 18 55 30.2 7.7
 
In terms of place of residence (See Table 4.3), the respondents were evenly 
distributed between Malema and Ribáuè, the two districts studied. 117 
respondents were interviewed in Malema (59 in the HBC group and 58 in the 
non-HBC group) and 120 in Ribáuè (60 in the HBC group and 60 in the non-HBC 
group).  
 
Table 4.3: Distribution of respondents by residence 
 
Group Frequency % 
In HBC Malema 59 49.6 
Ribáuè 60 50.4 
Total 119 100.0 
Not in HBC Malema 58 49.2 
Ribáuè 60 50.8 
Total 118 100.0 
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Table 4.4: Distribution of respondents by the level of formal educational 
attainment 
 
Group Level of education Frequency % 
In HBC No education 39 33,3 
Primary level 
Grade 1-4 39 33,3 
Grade 5-6 27 23,1 
Secondary level Grade 7-9 12 10.3 
Total for the HBC group 117 100.0 
Not in HBC No education 49 41.5 
Primary level 
Grade 1-4 32 27.1 
Grade 5-6 20 16.9 
Secondary level 
Grade 7-9 13 11.0 
Grade 10-12 4 3.4 
Total for the non-HBC group 118 100.0
 
As can be seen in Table 4.4, the group of PLWHIV not in the HBC programme 
had more people without any formal education than the HBC group (41.5%, and 
33.3% respectively). In the HBC group, 10.3 % of the respondents had reached 
secondary level whereas only 14.4% of the respondents in the non-HBC had 
attained the same level. A Chi-square test and a Fischer Exact Test (used 
because 20% of the cells had a count under 5) were undertaken and revealed 
that there was no significant difference between the HBC and non-HBC groups, 
in terms of levels of education as 2(4, N = 235) = 6,91, p > .05. It is important to 
note that two respondents in the HBC group did not provide an answer to the 
question about the level of education attained and were thus taken out of the 
analysis for the variable. This explains the discrepancy between the data 
presented in Table 4.1 and Table 4.4 in terms of respondents in the HBC group. 
 
The distribution of the respondents by marital status in Figure 4.2 shows that 
35.3% of the respondents in the HBC group were single compared to 45.8% in 
the non-HBC group. Also 46.2% (55/119) of the PLWHIV in the HBC group were 
married, a figure almost three times higher than in the non-HBC group where 
15.3% (18/118) declared themselves to be married. These differences were 
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no respondent had disclosed to more than 15 people. The mean number of 
people to whom the respondents had disclosed their HIV status was between 16-
30 people for the HBC group and between 1-5 people for the non-HBC group. 
The differences between the two groups in the number of people to whom the 
respondent’s HIV status had been disclosed to were statistically significant, as 
evidenced by a Chi-square test where2(4, N = 237) = 130,18 , p <  .05. 
 
As shown in Figure 4.3, 94.1% of the PLWHIV in the HBC group had disclosed 
their HIV status to someone else whereas only 81.4% of the PLWHIV in the non-
HBC group had disclosed their HIV status to someone else (See Figure 4.4).   
 
While further research would be needed in order to understand how much the 
disclosure rate is a consequence of participating in the HBC programme, it is 
possible to postulate that respondents who agreed to be visited by HBC 
volunteers exposed themselves to some degree of involuntary disclosure. As the 
programme became well known in the communities, neighbours and friends 
correctly assumed that there was a good chance that the person receiving HBC 
visits had HIV.  
 
A higher disclosure rate in the HBC group could additionally mean that the 
PLWHIV receiving HBC visits felt comfortable enough to risk telling others about 
their HIV status, as they would still have what some researchers (Roura, Busza, 
Wringe, Mbata, Urassa & Zaba 2009: 207) call a “replacement social support 
network” contributing to increased self-efficacy even if their family members 
reacted adversely to the news. Also, a study by Greeff, Phetlhu, Makoae, 
Dlamini, Holzemer, Naidoo, Kohi, Uys & Chirwa (2008: 319) showed that 
PLWHIV can sometimes disclose their status to people when the community as a 
whole expresses a need for more information about HIV and AIDS. In that 
context, they feel that their contribution as PLWHIV would be important to others, 
which gives them a reason to disclose. In the case of Salama’s programme, the 
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diagnosis differed between the two groups. PLWHIV in the non-HBC group has 
been diagnosed more recently (514.6 days on average) than PLWHIV in the 
HBC group, who had been diagnosed for an average of 801.2 days. This was 
confirmed by an ANOVA, which showed that the differences between the groups 
were statistically significant. Because homogeneity of variance was not assumed, 
a Brown-Forsythe test was applied, which reached the same conclusion as the 
ANOVA, which is that F (1,234) = 61,76, p < .05. 
 
Table 4.5: Mean number of days since HIV diagnosis 
 
Group N Minimum Maximum Mean Std. 
Deviation 
In HBC 119 249 1345 801.2 246.4 
Not in HBC 117 112 1551 514.6 310.7 
 
As Table 4.6 shows, the mean number of days since the respondents started 
ART differed between the HBC and the non-HBC groups. PLWHIV in the HBC 
have been, on average, taking ARV for the equivalent of 683.5 days compared to 
369.2 days for the PLWHIV in the non-HBC group. The difference between the 
groups was found to be significant based on an ANOVA, as F (1,233) = 96,02, p 
< .05. 
 
The difference between the two groups could be explained by the fact that the 
areas where the HBC programme first started were closer to the health centres, 
meaning that people in those areas could have had access to information, testing 
and ART sooner than people outside the catchment’s area of the HBC 
programme. There are, however, people inside the HBC programme areas who 
preferred not to participate in the programme, but the study did not collect data 
about this. Further research would be needed to know exactly how many 
PLWHIV not in the HBC programme would have been eligible because they 
resided in areas covered by the programme.  
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Table 4.7: Reliability Coefficients for the Berger HIV Stigma Scale and 
Subscales 
 
Scale 
Number 
of items 
 
 
Coefficient Alpha  
(n=318) in original 
study by Berger et 
al. (2001: 527) 
Coefficient 
Alpha (n=237) in 
current study 
HIV Stigma scale total score 40 .96 .97 
Personalized stigma subscale  18 .93 .96 
Disclosure subscale   10 .90 .95 
Negative self-image subscale  13 .91 .88 
Public attitudes subscale   20 .93 .96 
 
The Cronbach’s alpha values for the WHOQOL-BREF, when performed 
according to the specifications from the World Health Organisation, were 
acceptable for 3 out of the 4 subscales. In the social relationships subscale, one 
question (number 22) was found to be unrelated to the two other questions 
forming the subscale. Including question 22 in that subscale caused the 
Cronbach’s alpha to be unacceptable at .39. It was thus decided to drop the 
question from the subscale, which raised the Cronbach’s alpha for that subscale 
to a more acceptable value of .73. 
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Table 4.8: Reliability Coefficients for the WHOQOL-BREF 
 
Scale Number of items 
Coefficient Alpha  
(n=11830)a study 
by Skevington, 
Lofty & O’Connell 
(2004: 304) 
Coefficient 
Alpha  (n=237) 
in current study 
General QoL 2 Not mentioned .88 
Physical health 7 .82 .93 
Psychological health 6 .81 .91 
Social relationships 2 .68 (based on the 3 original items) .73 
Environment 7 .80 .90 
 
4.4. DIFFERENCES IN HIV AND AIDS-RELATED STIGMA LEVELS 
BETWEEN THE HBC AND THE NON-HBC GROUP 
 
Stigma levels measured with the Berger Stigma Scale were divided into four 
subscales and a general stigma score.  Table 4.9 shows the results for the HBC 
group. 
 
Table 4.9: Berger Stigma Scale in the HBC group 
 
Scale 
Possible 
Scale 
interval
N Minimum Maximum Mean Std. 
Deviation 
Personalised 
stigma subscale 18- 72 119 19 55 32.0 6.8 
Disclosure 
subscale 10- 40 119 11 40 18.9 5.7 
Negative self-
image subscale 13- 52 119 17 47 26.8 4.9 
Public attitudes 
subscale 20- 80 119 24 64 37.9 7.4 
HIV Stigma scale 
total score 40-160 119 50 138 77.4 15.4 
 
Data originating from respondents in the non-HBC group is displayed in Table 
4.10. 
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Table 4.10: Berger Stigma Scale in the non-HBC group 
 
Scale 
Possible 
Scale 
interval
N Minimum Maximum Mean Std. Deviation 
Personalised 
stigma subscale 18- 72 118 10 62 45.6 7.5 
Disclosure 
subscale 10- 40 118 15 36 29.5 3.2 
Negative self-
image subscale 13- 52 118 16 45 33.3 5.5 
Public attitudes 
subscale 20- 80 118 32 70 53.8 7.4 
HIV Stigma scale 
total score 40-160 118 65 134 106.6 13.5 
 
After analysing the data presented in Table 4.9 and 4.10, statistically significant 
differences were found between the HBC and non-HBC groups for the four 
subscales and the total stigma score. The ANOVA performed on the 
personalized stigma subscale results in F (1,235) = 212,823, p < .05, which 
signals a statistically significant difference in the HBC and non-HBC groups for 
that subscale. The same conclusion can be extracted from an ANOVA conducted 
on the disclosure subscale (F (1,235) = 308,931, p < .05), the negative self-
image subscale (F (1,235) = 92,552, p < .05), the public attitudes subscale (F 
(1,235) = 275,628, p < .05) and finally the total stigma score (F (1,235) = 
241,158, p < .05) 
 
4.5 DIFFERENCES IN QUALITY OF LIFE SCORES BETWEEN THE HBC AND 
THE NON-HBC GROUP 
 
QoL scores calculated with the WHOQOL instrument yielded measurements in 
four subscales and a general QoL score. Results from the HBC group are shown 
in Table 4.11.  
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Table 4.11: WHOQOL scores in the HBC group 
 
Scale Possible Scale interval N Minimum Maximum Mean 
Std. 
Deviation
Physical health 0-100 119 25 79 68.8 9.9 
Psychological 
health 0-100 119 50 92 73.0 9.0 
Social 
relationships 0-100 119 0 50 26.0 10.3 
Environment 0-100 119 25 69 47.2 7.9 
General QoL 0-100 119 25 75 63.9 12.5 
 
Quality of life scores for the non-HBC group are shown in Table 4.12. 
 
 
Table 4.12: WHOQOL scores in the non-HBC group 
 
Scale Possible Scale interval N Minimum Maximum Mean 
Std. 
Deviation
Physical health 0-100 118 4 96 52.5 23.0 
Psychological 
health 0-100 118 0 92 48.0 24.7 
Social 
relationships 0-100 118 0 58 31.4 15.9 
Environment 0-100 118 0 78 39.2 23.7 
General QoL 0-100 118 0 100 53.7 26.5 
 
In order to examine differences between the HBC and non-HBC groups 
presented in Table 4.11 and 4.12, a series of ANOVAs were executed. The 
physical health score was found to be statistically different in the two groups, as 
F (1,235) = 49,824, p < .05. All the other QoL scores were also found to differ 
significantly between the two groups studied; psychological health (F (1,235) = 
106,704, p < .05), social relationships (F (1,235) = 9,731, p < .05), environment 
(F (1,235) = 12,151, p < .05) and the general quality of life score (F (1,235) = 
14,175, p < .05). 
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4.6 HYPOTHESIS TESTING 
 
In the next section, the three hypotheses of the study will be tested. 
 
4.6.1 Hypothesis testing for research question 1 
 
The first objective of the study was to answer the following question:  
 
Is there a difference in the level of HIV and AIDS-related stigma experienced by 
PLWHIV on ART receiving HBC services and the level experienced by PLWHIV 
on ART who do not receive HBC services? 
 
The null hypothesis for objective 1 was: 
H0 : μ1 = μ2 
μ1 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART receiving 
HBC services in Ribáuè and Malema. 
μ2 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART not 
receiving HBC services in Ribáuè and Malema. 
 
The alternative hypothesis for objective 1 was:  
H1 : μ1 ≠ μ2 
μ1 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART receiving 
HBC services in Ribáuè and Malema. 
μ2 = Mean scores for HIV and AIDS-related stigma of PLWHIV on ART not 
receiving HBC services in Ribáuè and Malema. 
 
To test the hypotheses, a series of ANOVAs were executed on the mean scores 
for each subscale of the Berger Stigma Scale instrument, as well as for the score 
on the global stigma scale. Figure 4.7 shows the mean scores of the two groups 
on the Berger Stigma Scale. 
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The null hypothesis for objective 2 was: 
H0 : μ1 = μ2 
H0 = the null hypothesis 
μ1 = Mean scores for QoL of PLWHIV on ART receiving HBC services in Ribáuè 
and Malema. 
μ2 = Mean scores for QoL of PLWHIV on ART not receiving HBC services in 
Ribáuè and Malema 
 
The alternative hypothesis for objective 2 was:  
H1 : μ1 ≠ μ2 
μ1 = Mean scores for QoL of PLWHIV on ART receiving HBC services in Ribáuè 
and Malema. 
μ2 = Mean scores for QoL of PLWHIV on ART not receiving HBC services in 
Ribáuè and Malema 
 
To test the hypotheses, a series of ANOVAs were executed on the mean scores 
for each subscale of the WHOQOL-BREF instrument, as well as for the score on 
the global QoL scale. Figure 4.8 shows the mean scores of the two groups on the 
WHOQOL-BREF. 
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Is there a correlation between stigma and self-reported quality of life? 
 
The null hypothesis for objective 3 was: 
H0 : There is no correlation between the variables at α=0.01 
 
The alternative hypothesis for objective 3 was:  
H1: There is a correlation between the variables at α=0.01 
 
In order to measure the correlation between the “stigma” and “quality of life” 
variables, Pearson Correlation’s Coefficient test was conducted on the subscales 
and the total scores for the Berger Stigma Scale and the WHOQOL-BREF. 
 
The interpretation of the correlation between the variables studied is based on 
Fox’s (1999: 273) definition, which states that the threshold for strong correlation 
is 0.80 (or -0.80 in the case of a negative relation), 0.60 (or -0.60) for a moderate 
correlation and 0.40 (or -0.40) for a weak correlation. As shown in Table 4.13, no 
correlation could be considered to be strong between the stigma and the quality 
of life variables, using the 0.80 threshold. 
 
There were, however, a number of moderate correlations between the following 
variables: 
 
 WHOQOL-BREF Physical health and Berger’s Personalized stigma 
subscale: r=-0,629(235), p (two-tailed) < .01. 
 WHOQOL-BREF Physical health and Berger’s Public attitudes subscale: 
r=-0,612(235), p (two-tailed) < .01. 
 WHOQOL-BREF Psychological health and Berger’s Negative self image 
subscale: r=-0,685(235), p (two-tailed) < .01. 
 WHOQOL-BREF Psychological health and Berger’s Public attitudes 
subscale: r=-0,704(235), p (two-tailed) < .01. 
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 WHOQOL-BREF Psychological health and Berger’s total score: r=-
0,685(235), p (two-tailed) < .01. 
 
In relation to the testing of the hypothesis for objective 3, it is possible to reject 
the null hypothesis, as there seems to be a correlation between some stigma and 
quality of life variables. However, the results show that the correlation is 
moderate to weak for most variables.  
 
Table 4.13: Pearson’s Correlation Coefficient between the stigma and 
quality of life variables 
 
 
STIGMA 
SCALE - 
Personalised 
stigma 
subscale 
STIGMA 
SCALE - 
Disclosure 
subscale 
STIGMA 
SCALE - 
Negative self-
image 
subscale 
STIGMA 
SCALE - 
Public 
attitudes 
subscale 
STIGMA 
SCALE  - 
TOTAL 
WHOQOL - 
GENERAL 
Pearson 
Correlation 
-.500 -.270 -.569 -.490 -.494 
Sig. (2-tailed) .000 .000 .000 .000 .000 
WHOQOL - 
PHYSICAL 
HEALTH 
Pearson 
Correlation 
-.629 -.374 -.605 -.612 -.597 
Sig. (2-tailed) .000 .000 .000 .000 .000 
WHOQOL - 
PSYCHOLOGICAL 
HEALTH 
Pearson 
Correlation 
-.699 -.468 -.685 -.704 -.685 
Sig. (2-tailed) .000 .000 .000 .000 .000 
WHOQOL - 
SOCIAL 
RELATIONSHIPS 
Pearson 
Correlation 
-.259 .112 -.378 -.214 -.213 
Sig. (2-tailed) .000 .085 .000 .001 .001 
WHOQOL - 
ENVIRONMENT 
Pearson 
Correlation 
-.524 -.189 -.560 -.505 -.488 
Sig. (2-tailed) .000 .004 .000 .000 .000 
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4.7 DISCUSSION: SUMMARY AND INTERPRETATION 
 
4.7.1 Summary 
 
The study has found that statistically significant differences exist between the 
HBC and non-HBC groups for the four subscales of the Berger Stigma Scale as 
well as for the total stigma score.  
 
Also, the results highlighted that PLWHIV report a higher perceived quality of life 
if they are in the HBC group compared to the non-HBC group on three of the 
WHOQOL-BREF subscales as well as on the overall score. The scores on one of 
the subscales, social relationships, indicated lower perceived QoL for PLWHIV in 
the HBC group than in the non-HBC group. 
 
The participants in both groups were comparable in terms of gender, residence, 
education and compliance to ART. Statistically significant differences, however, 
existed between the HBC and non-HBC groups in relation to age, marital status, 
number of people to whom the respondents have disclosed their HIV status, 
mean number of days since HIV diagnosis and mean number of days since the 
start of ART. 
 
Finally, a weak to moderate, negative correlation was discovered between stigma 
scores and QoL scores. This suggests that people with lower perceived QoL also 
report feeling more stigmatised than PLWHIV with a higher perceived QoL.  
 
The next section will be dedicated to the discussion of the results. 
 
4.7.2 Discussion of the findings 
 
This section will compare the results of the study with the existing literature, in 
the context of the objectives identified in chapter 1. 
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4.7.2.1 Difference in the level of HIV and AIDS-related stigma 
experienced by PLWHIV on ART receiving HBC services and the level 
experienced by PLWHIV on ART not receiving HBC services 
 
The results of the study suggest that PLWHIV on ART receiving HBC services 
experience less HIV and AIDS-related stigma than PLWHIV on ART who do not 
receive HBC services. This conclusion applies to the different aspects of stigma 
measured by the Berger Stigma Scale: personalised stigma, disclosure, negative 
self-image and public attitudes. These results are in accordance with the few 
studies uncovered in the literature review which focussed on this topic, such as 
Chela et al. (1991).  
 
Some stigma subscales seem to be especially linked to HBC, such as the 
disclosure subscale mean scores, which are 55% higher in the non-HBC group 
than the HBC group, indicating more perceived stigma related to disclosure for 
PLWHIV not reached by a HBC programme. This could be linked to the higher 
number of people to whom PLWHIV in the HBC programme disclose to, either 
voluntarily or unvoluntarily, as data shows 78.2% of PLWHIV in the HBC have 
disclosed to more than five people, compared to 8.5% in the non-HBC group.  It 
is very interesting to note that even with an increased risk of stigmatisation after 
disclosure, PLWHIV in the HBC group actually experienced the opposite and felt 
less stigma associated with disclosure than people in the non-HBC group. In the 
HBC group, stigma related to disclosure seems to be partially short-circuited. The 
results are congruent with a recent study in Mozambique (Pearson, Micek, 
Pfeiffer, Montoya, Matediane, Jonasse, Cunguara, Rao & Gloyd 2009) which 
indicated that, over a 12 month period following the start of ART, lower stigma 
scores were significantly associated with the disclosure of the patient’s HIV 
status to large numbers of people, especially friends and co-workers. 
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The scope of the current study was not designed to investigate what causes 
levels of disclosure within a group, but a study by Esu-Williams et al. (2003:7) 
has shown that HBC could help reduce fear and create a more tolerant 
environment in which PLWHIV learn to feel understood and protected, enabling 
them to be more assertive and disclose to increasing numbers of people who are 
not family members. 
 
The personalised stigma subscale showed more moderate differences between 
the HBC and the non-HBC groups, with mean scores being 42.56% higher in the 
non-HBC group. This was also the conclusion of a study by Kaai, Sarna, 
Luchters, Geibel, Munyao, Mandaliya, Shikely, Temmerman & Rutenberg 
(2007:4) which revealed a decrease in personalised stigma for people that have 
been on ART for 12 months. As people in the HBC group have been on ART for 
a longer period of time than people in the non-HBC group (683 days on average 
for the HBC group compared to 369 days on average for the non-HBC group), it 
could hypothesized that a lowering personalised stigma score over time is part of 
the “natural history” of stigma, and that HBC might not completely explain the 
difference observed between the groups. 
 
4.7.2.2 Difference in the self-reported QoL scores for PLWHIV on ART 
receiving HBC services and the scores for PLWHIV on ART not receiving 
HBC services 
 
Overall, the results of the study show that there is a statistically significant 
difference between the mean QoL scores of the HBC and non-HBC groups. This 
is congruent with Jha, Mills, Hanson, Kumaranayake, Conteh, Kurowski, Nguyen, 
Cruz, Ranson, Vaz, Yu, Morton & Sachs (2002: 2038) and the World Health 
Organisation (2002: 9) who proposed that care and support, along with ART, can 
have a positive effect on the quality of life of patients. In this study, the largest 
difference is found in the psychological health subscale, in which the PLWHIV in 
the HBC group report a mean score of a perceived quality of life that is 34.19% 
higher than the mean score of the non-HBC group.  
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In terms of physical health, the mean QoL scores for PLWHIV in the HBC group 
are 23.6% higher than the corresponding scores in the non-HBC group. A 
possible explanation for this difference could be related to easier access to 
health services for PLWHIV in the HBC group. HBC volunteers are trained to 
refer their users to the local health centre as soon as the situation indicates a 
deterioration of health based on the observation of clinical signs. As the 
volunteers personally know the nurses working at the health centre and often find 
themselves accompanying the PLWHIV, there is reason to believe that PLWHIV 
in the HBC group are more likely to quickly consult and thus, are less likely to 
suffer physical discomforts resulting from opportunistic infections. The HBC 
volunteers also distribute a limited number of medicines to PLWHIV which also 
helps to reduce pain or infection, a service that is not available to PLWHIV in the 
non-HBC group unless they go to the health centre. 
 
A moderate difference also exists between the QoL mean scores of PLWHIV in 
the HBC and non-HBC group in relation to satisfaction with their environment. 
The results of the study show that PLWHIV in the HBC group report mean QoL 
scores 16.86% higher than their counterparts in the non-HBC group. These 
results could be interpreted in the light of the activities undertaken by the HBC 
volunteers, which can range from helping with cleaning clothes, sweeping around 
the house, collecting and burning garbage, providing soap, giving advice to 
family members (about everything from latrine construction to nutrition) and 
distributing bed-nets and warm blankets. All of these activities seem to contribute 
to a higher perceived QoL related to the patient’s environment. It is interesting 
however to note that these mostly material contributions, which could be thought 
of as the most obvious benefit of participation in the HBC programme, do not 
contribute as much to a higher perceived quality of life for PLWHIV as the 
elements improving psychological health, as shown in the paragraph above.  
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The social relationship subscale, however, showed a negative difference in mean 
scores between PLWHIV in the HBC and the non-HBC group confirming that 
PLWHIV in the HBC group feel their QoL is lower in relation to that aspect than 
their counterparts in the non-HBC group. A possible cause for this could be 
linked to a reduction in the number of friends caused by disclosure. Pearson et 
al. (2009: 1193) have suggested that less social support could cause depression, 
which would have an impact on the perceived quality of life. This is not, however, 
what the results suggest in this study, as perceived QoL is higher in the HBC 
group, despite the lower satisfaction with social relationships. A possible 
explanation could be that PLWHIV in the HBC group have a lower number of 
friends, which is perceived as negative. On the other hand, the remaining friends 
are much closer which, in conjunction with the support provided by the HBC 
volunteers, helps to prevent the depression mentioned by Pearson et al. (2009: 
1193). Further research would be needed to confirm this hypothesis. 
 
 
4.7.2.3 Correlation between stigma and self-reported quality of life  
 
The analysis of the correlation coefficients between stigma and self-reported QoL 
conducted in the current study is in accordance with the latest research reviewed 
in chapter 2, such as studies by Greef et al. (2009), Holzemer (2009, Lee et al. 
(2002) and Suit (2005: 82). In essence, there is weak to moderate, negative 
correlation between the two constructs. 
 
At this point, however, it is not possible to determine what proportion of the QoL 
scores presented in the study is explained by stigma. Further research on the 
subject would be necessary to quantify the contribution of stigma to the reduction 
in perceived quality of life. 
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CHAPTER 5 : RECOMMENDATIONS AND CONCLUSION 
 
5.1 INTRODUCTION 
 
In this last chapter, the main findings and limitations of the study are discussed, 
followed by recommendations for further research. Also, recommendations for 
policy and practice are highlighted, along with a brief conclusion. 
 
5.2 MAIN FINDINGS 
 
The study aimed at finding an answer to three research questions. The first 
question was to examine if there was a difference in the level of HIV and AIDS-
related stigma experienced by PLWHIV on ART receiving HBC services and the 
level experienced by PLWHIV on ART not receiving HBC services. After 
analysing the data collected from 237 PLWHIV in Malema and Ribáuè districts, it 
was found that statistically significant differences exist between the HBC and 
non-HBC groups for the four subscales of the Berger Stigma Scale as well as for 
the total stigma score.  
 
The idea that a relation between stigma and HBC exist is congruent with the 
theoretical models which were used as a basis for this study. The “Elements 
needed for a successful policy in the field of HIV and AIDS-related stigma” 
described by Morrison (2006: 9) in chapter 2 have been incorporated in a large 
part by Salama in its HBC programme, so the results of this study can be 
interpreted as being logical and in-line with Morrison’s model.  
 
The results are also in accordance with the few studies uncovered in the 
literature review which investigated the links between HBC and stigma, such as 
Chela et al. (1991), Esu-Williams et al. (2003: 7), Kaai et al. (2007:4), Letamo 
(2003: 347) and Pearson et al. 2009. 
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The second research question was related to the exploration of potential 
differences in the self-reported QoL scores for PLWHIV on ART receiving HBC 
services and the scores for PLWHIV on ART who are not receiving HBC 
services. The results highlighted that PLWHIV report a higher perceived quality 
of life if they are in the HBC group compared to the non-HBC group on three of 
the WHOQOL-BREF subscales as well as on the overall score.  The positive 
effect of HBC on QoL had been previously identified by the World Health 
Organisation (2002:9). Whilst the scope of this study was not to confirm a “cause 
and effect” between HBC and QoL, the results would not exclude, a priori, the 
possibility of such a relation between the variables.  
 
The scores on the social relationships subscale, however, indicated lower 
perceived QoL for PLWHIV in the HBC group than in the non-HBC group. 
Pearson et al. (2009: 1193) have suggested that less social support could cause 
depression, which would have an impact on the perceived quality of life. This is 
not what the results suggest in this study, as perceived QoL is higher in the HBC 
group, despite the lower satisfaction with social relationships. The lower scores 
on the relationships subscale were also found in the study conducted by Dos 
Santos et al. (2007) and described in chapter 2. 
 
The third question aimed at investigating the correlation between stigma and self-
reported quality of life. In relation to that research question, a weak to moderate, 
negative correlation was discovered between stigma scores and QoL scores. 
This suggests that people with lower perceived QoL also report feeling more 
stigmatised than PLWHIV with a higher perceived QoL.  
 
The analysis of the correlation coefficients between stigma and self-reported QoL 
conducted in the current study is in accordance with the latest research reviewed 
in chapter 2, such as studies by Greef et al. (2009), Holzemer (2009), Lee et al. 
(2002) and Suit (2005: 82).  
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Going back to chapter 2 and the theoretical point of departure of the study, the 
correlation found between stigma and self-reported quality of life can be 
explained by our model which proposed an integration of both concepts. 
Furthermore, the results of the study validate the relevance of consolidating the 
socio-cognitive model developed by Rintamaki et al. (2006: 360) with the socio-
emotional framework used by Bos, Schaalma and Pryor (cited in Stutterheim 
2008: 10) as was proposed in the study. 
 
5.3 LIMITATIONS OF THE STUDY 
 
The present study has certain limitations that need to be taken into account when 
assessing its contributions. It is important to acknowledge them so that the 
conclusions can be evaluated critically.  
 
The participants in both groups were comparable in terms of gender, residence, 
education and compliance to ART. Statistically significant differences, however, 
existed between the HBC and non-HBC groups in relation to age, marital status, 
number of people to whom the respondents have disclosed their HIV status, 
mean number of days since HIV diagnosis and mean number of days since the 
start of ART. The fact is that these differences could be due to a selection bias 
constitute a threat to internal validity, meaning that any difference in QoL and HIV 
and AIDS-related stigma levels could be due to the characteristics of the two 
groups (PLWHIV receiving or not HBC services) and not related to HBC services 
at all (Jüni, Altman & Egger 2001:43). 
 
Also, based on the study design and limited sample, the conclusions of the study 
cannot be generalised to refer to every PLWHIV in Mozambique, or indeed 
elsewhere. The data collection was conducted using a sample of PLWHIV 
receiving ART in Ribáuè and Malema, so it would be imprudent to reach the 
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conclusion that the current study would be applicable in a different socio-cultural 
context. 
 
Other limitations include the use of self-reported measurements, the possible 
influence of the social desirability effect on the results due to the data collection 
method chosen, the use of instruments which were not validated in the specific 
socio-cultural context of the study and the existence of potentially confounding 
variables which were not controlled, such as CD4 count and weight. 
 
5.4 SUGGESTIONS FOR FURTHER RESEARCH 
 
This section is devoted to a non-exhaustive description of research avenues that 
emerged as possibilities during and after the realisation of this study. 
Investigating these research problems could help to move forward the topics of 
stigma, quality of life in the context of HBC and provide answers to topics not 
covered by the scope of this study. 
 
As the study has shown, the PLWHIV on ART in Salama’s HBC programme have 
a higher perceived quality of life and lower stigma levels than PLWHIV on ART 
not in a HBC programme. The study, however, was not designed to determine if 
the HBC programme was, in fact, causing the differences in perceived QoL and 
stigma levels between the two groups. In other words, there are may be factors 
beyond HBC that may influence both quality of life and stigma. Of course, there 
also seems to be some correlation between quality of life and stigma that 
confounds the causal patterns. To be able to gauge a clearer picture of the 
causal links between the care-giving environment (such as HBC) and subjective 
experiences, a proper randomized controlled trial should be set in place before a 
HBC programme is implemented in a community to yield data on the impacts of 
HBC on stigma and QoL (Tilling, Sterne, Brookes & Peters 2005). 
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In this study, the situation of PLWHIV on ART was described and analysed. 
Further research could be conducted to find out if PLWHIV not on ART who are 
participating in a HBC programme are also experiencing less HIV and AIDS-
related stigma and have a higher perceived QoL than PLWHIV not on ART who 
are not participating in a HBC programme.  
 
Also, the study has uncovered a weak to moderate association between stigma 
and quality of life. Another step would be to look at how much of the QoL score 
could be explained by the stigma experienced by a PLWHIV, as was partially 
described in Suit (2005: 92). 
 
Despite the care taken by the researcher in selecting respondents so that the two 
groups could be comparable based on a number of key variables, the mean 
scores for age, marital status, number of people to whom the respondents have 
disclosed their HIV status, mean number of days since HIV diagnosis and mean 
number of days since the start of ART between the two groups showed 
statistically significant differences. It would be interesting to investigate if the 
differences between the groups for these variables (except the age variable) 
could have been caused by HBC itself, and not represent the result of selection 
bias (Martin 2005: 147).  
 
5.5 RECOMMENDATIONS FOR POLICY AND PRACTICE 
 
The results of the study provide valuable information on the life of PLWHIV on 
ART in Mozambique. The following recommendations could be used to improve 
the provision of HBC services to PLWHIV in Mozambique. The first three are 
directly related to the study’s research questions, while the next four are 
discoveries made possible by a closer analysis of the data collected. 
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5.5.1 Results related to the study’s research questions 
 
5.5.1.1 Look for ways to increase satisfaction with social 
relationships in PLWHIV receiving HBC services 
 
The results of the study clearly indicate that PLWHIV receiving HBC services 
are less satisfied with the way they interact with their family and friends than 
PLWHIV not receiving HBC services.  
 
In this study, the social cognitive model proposed a framework that could 
provide an explanation as to why PLWHIV receiving HBC services have a 
lower satisfaction level in relation to their social relationships. In chapter 2, the 
three-way relationship between personal, environmental and behavioural 
factors was described as being a central feature of the social cognitive model 
(Redding et al. 2000: 185). In the group of PLWHIV receiving HBC services, 
the environmental factors could be understood as the new context in which 
some members of the community are now aware that the beneficiary of HBC 
is infected with HIV. The community members become aware that the 
beneficiary of HBC is infected with HIV because the PLWHIV tells them or 
because they observe proxy signs such as home visits by the HBC providers 
or material support given by the programme (Mazzeo & Makonese 2010: 447; 
Wringe, Cataldo, Stevenson & Fakoya 2010: 7). The personal factors could 
include the feelings of the PLWHIV toward that new situation: initial shock and 
self-blame, fear of disclosing but at the same time hope that it will bring some 
much needed support, preoccupation in the face of the progression of the HIV 
infection, hope to get better and resume normal activities or worries about 
being rejected by other community members (Bernays, Rhodes & Barnett 
2007; Habib & Rahman 2010: 81; Kasenga, Hurtig & Emmelin 2010: 32; 
Norman, Chopra & Kadiyala 2007: 1780; Monjok, Smesny, Mgbere & Essien 
2010 : 26). The behavioural factors could be social withdrawal as a coping 
strategy or deciding to terminate old friendships in favour of new ones as 
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disclosure of HIV status to the former friends seems too complicated (Carr & 
Gramling 2004: 36; Koopman, Gore-Felton, Marouf, Butler, Field, Gill, Chen, 
Israelski & Spiegel 2000: 664; Miller & Rubin 2007:592).  
 
In the example above, the three components of the social cognitive model are 
at work to explain why some PLWHIV who have disclosed to a greater 
number of people can have lower satisfaction levels related to their social 
relationships. At this stage, this explanation is just an hypothesis that needs 
to be put to the test, and the factors used as an example could be different 
than in reality, but the basic principle remains: environmental, personal and 
behavioural factors in the social cognitive model can provide an explanation 
as to why PLWHIV receiving HBC services do not seem to enjoy their social 
relationships as much as PLWHIV not receiving HBV services. 
 
Whatever the actual causes, poor social support can lead to depression 
(Pearson et al 2009: 1193), and depression can cause lower ART adherence 
(Starace, Ammassari, Trotta, Murri, De Longis, Izzo, Scalzini, Antonella, Wu 
& Antinori 2002). The results of the study do not suggest higher levels of 
depression nor lower levels of ART adherence in PLWHIV receiving HBC 
services, but then the instruments used to measure quality of life in the study 
could be unable to comprehensively detect clinical-level depression in the 
setting studied. Also, self-declared adherence measurements can be subject 
to recall bias and social desirability and have been shown to usually provide 
an overestimate of how PLWHIV adhere to their treatment (García de Olalla, 
Knobel, Carmona, Guelar, López-Colomés & Caylà 2002: 108; Torpey, 
Kabaso, Mutale, Kamanga, Mwango, Simpungwe, Suzuki & Mukadi 2008: 8).  
 
Thus, as a precautionary measure until more is known about the causes of 
the lower levels of satisfaction with social relationships uncovered in the 
group of PLWHIV receiving HBC services, attention should be given to 
promotion of healthy social relationships and detection of PLWHIV who seem 
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to have fewer social contacts. When PLWHIV suffering from isolation, social 
withdrawal or depression are identified, the provision of an adequate 
response should be a priority. Increasing community activities, support group 
initiatives and putting more emphasis on the importance of maintaining 
meaningful social and personal contacts are some of the activities known to 
provide social support and stimulate empowerment that need to be 
implemented by HBC programmes such as Salama’s to help reverse the 
situation (Brown et al. 2003: 53; Ribble 1989: 54; Simbayi, Kalichman, 
Strebel, Cloete, Henda & Mqeketo 2007:1830). 
 
5.5.1.2 Involve PLWHIV in the provision of HBC services as an 
empowerment strategy 
 
At the service-delivery level, the empowerment of PLWHIV to play a bigger 
role in the provision of HBC, especially in the planning, delivery and 
evaluation phases is recommended. Garko (2007: 126) suggests that 
empowering PLWHIV could help them realize that their life is not over after an 
HIV diagnosis.  In fact, the results of this study point in that direction as they 
show that PLWHIV on ART can attain an acceptable level of perceived QoL 
and positively contribute to the well-being of their families and communities. 
Also, empowerment is a major factor in Morrison’s model, described in 
chapter 2, for effective policies to reduce stigma, and it has been an essential 
aspect of Salama’s programme to date (Morrison 2006:9). 
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5.5.1.3 Continue to dispense HBC services to PLWHIV even when the 
HBC programme has limited potential to improve their material 
and environmental conditions, as the potential impacts of the 
HBC programme on physical and psychological health of 
PLWHIV could be more relevant to the overall QoL levels. 
 
According to the data collected, the mean scores for perceived QoL related to 
physical and psychological health are much higher in the group of PLWHIV 
receiving HBC services (34,2% higher for psychological health and 23,6% 
higher for physical health, respectively).  Also, a moderate difference also 
exists between perceived QoL mean scores in relation to satisfaction with 
their environment, with PLWHIV receiving HBC services reporting mean 
scores 16.86% higher than their counterparts in the non-HBC group. This 
reveals that although material and environmental support is important, the 
most important differences between the groups in terms of QoL levels are 
related to physical and psychological support. This is congruent with the work 
of Farham (2003: 690), who considers psychological support to be especially 
important “… when dealing with issues such as stigmatisation, fears from 
other family members and multiple losses and bereavement”, which is the 
case with the HBC programme examined in this study. Also, a study by 
Gordillo, Fekete, Platteau, Antoni, Schneiderman & Nöstlinger (2009: 523) 
proposes “… that emotional support is strongly associated with physical and 
psychological adjustment in persons living with HIV/AIDS”. The type of 
support provided by the volunteers in Salama’s HBC programme is often 
more related to emotional support than on the provision of material and 
environmental conditions, and this could be the reason why it is more relevant 
to the construction of global perceived QoL. 
 
In the context of Salama’s HBC programme, which runs on very limited funds, 
this comes as a very relevant piece of information, as costs of providing 
physical and psychological support are less important than the costs of 
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dispensing ways to change the material and environmental conditions of the 
PLWHIV receiving HBC services. 
 
These results could be due to a selection bias, but they could also hint at 
potential effects of HBC services on PLWHIV. This conclusion is also linked 
to the conceptual framework used by this study, in which the social-cognitive 
theory proposes a three-way relationship between personal, environmental 
and behavioural factors in the creation of HIV and AIDS-related stigma and 
the development of QoL (Redding et al. 2000: 185). In this case, it is possible 
that the influence of the personal and behavioural factors is more important to 
PLWHIV than environmental factors in the process of acquiring and maintaing 
acceptable levels of QoL. If further research shows that the differences in 
QoL discovered in this study are due to HBC services, it could also be argued 
that the areas most likely to be impacted by HBC services are QoL levels 
related to psychological and physical health.  
 
5.5.2 Discoveries made possible by a closer analysis of the data 
collected 
 
5.5.2.1 Address the gender imbalance in the provision of HBC 
services 
 
An analysis of the study’s sample shows that more women than men receive 
HBC services, as the universe of potential respondents for the study had a 
gender breakdown of 55% women and 45% men. This can be due to a 
number of factors including a potential selection bias. However, as was 
discussed in chapter 4, it is increasingly clear that more women than men are 
now at risk of HIV infection in Southern African countries, a phenomenon 
called the “feminisation” of the HIV pandemic (Himmelgreen et al. 2010: 404). 
The percentage of men was higher in the HBC group (38,7%) compared to 
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the non-HBC group (31,4%), indicating that perhaps a smaller number of men 
are reached by the HBC programme than expected. 
 
Thus, a number of initiatives could be put in place in order to stimulate the 
identification and inclusion of men in the HBC programme. According to Mills, 
Ford & Mugyenyi (2009: 276), the promotion of support groups for men living 
with HIV could be a solution. In chapter 2, it was mentioned that AIDS 
threatens the productive members of the household and is often 
accompanied by a drop in income (Casale & Whiteside 2006: 5; Whiteside 
2001: 80; Isaksen et al. 2002:11). Also, it was found that HBC programmes 
providing only “empathy inducement” measures are ineffective (Maluwa et al. 
2002: 12). Acknowledging this in the creation of male support groups 
providing a space for sharing health information, adherence advice and 
support in setting up a small business, these groups specifically designed to 
attract men could be used to gradually introduce men to HBC services. Such 
as strategy could partially offset the gender imbalance in HBC programmes 
and generate a new momentum in the communities where HBC services are 
provided. 
 
5.5.2.2 Pay attention to the causes of post-HIV diagnosis 
divorce/separation rates and develop strategies to reduce their 
impact 
 
The data collected shows that there is statistically significant imbalance 
between the group of PLWHIV receiving HBC services and the group of 
PLWHIV not receiving HBC services in relation to marital status. In fact, 
46.2% of the PLWHIV in the HBC group were married, a figure almost three 
times higher than in the non-HBC group where 15.3% declared themselves to 
be married. A closer look at the data reveals that 21,2% of the PLWHIV in the 
non-HBC group are either separated or divorced, compared to only 8% in the 
HBC group. As discussed in chapter 3, the imbalance could be due to 
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selection bias, but this hypothesis is unlikely given the fact that PLWHIV were 
recruited on a neighbourhood basis and there is no evidence that people 
living in specific areas of the districts have a higher divorce rate than others. 
Also, it would be interesting to know if PLWHIV receiving HBC services 
remarry more than PLWHIV not receiving HBC services, which could be an 
alternative explanation to the higher rates of divorced PLWHIV in the non-
HBC group. In retrospect, including a question in the study’s questionnaire 
about the time of the divorce in relation to disclosure of HIV status to the 
partner would have been useful in pinpointing the reason for the differences 
between the groups.  
 
According to Boileau, Clark, Bignami-Van Assche, Poulin, Reniers, Watkins, 
Kohler & Heymann (2009: i27), life transitions such as divorce and 
widowhood are correlated to HIV status. Another study by Murray, Haworth, 
Semrau, Singh, Aldrovandi, Sinkala, Thea & Bolton (2006: has found HIV 
status to be “…closely associated to patterns of violence and abuse”. 
Furthermore, a study by Ezechi, Gab-Okafor, Onwujekwe, Adu, Amadim & 
Herbertson (2009: 745) with pregnant women living with HIV in Nigeria has 
discovered that 65.8% of them had reported abuse from a spouse, and in 
74% of the cases, there was no abuse before the HIV diagnosis was made. 
 
Why is it then that causes married PLWHIV receiving HBC services to remain 
in a relationship while PLWHIV not receiving HBC services are more likely to 
have divorced or separated? The central question here is: is counselling 
provided at home by HBC volunteers having an impact on the health of the 
relationship of married PLWHIV compared to counselling provided by a VCT 
counsellor to PLWHIV not receiving HBC services? This question would need 
a study of its own, but based on the data collected in this study, there is a 
difference and we can hypothesize that something in the HBC services has 
an influence on this. Thus, apart from recommending further research on the 
subject, it is also suggested that the VCT counsellor to discuss aspects 
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related to the conjugal relationships of PLWHIV and develop a strategy to 
reduce post-HIV diagnosis divorces and separations.  
 
5.5.2.3 Improve the information transfer to PLWHIV in HBC 
programmes so they can make informed choices 
 
At the programmatic level, the researcher suggests the improvement of the 
instruments and tools used to transfer information to PLWHIV in the HBC 
programme, so they will become more knowledgeable about the options 
available to them and will make informed choices. As indicated by Hamra et 
al. (2005: 921), improved knowledge about support and care acquired 
through educational interventions could have an effect on expressed stigma. 
 
5.5.2.4 Increase the number of HBC initiatives in communities most 
affected by HIV to reduce stigma and improve QoL in PLWHIV 
 
At the level of policy, the findings of this study seem to point to the value of 
increasing the number of community-driven, flexible, integrated and adapted 
HBC initiatives in the areas most affected by HIV in order to impact stigma 
and increase quality of life for PLWHIV (Mohammad & Gikonyo 2005: 21; 
Ogden, Esim & Grown 2006: 339). While more research would be needed to 
adequately assess the influence of HBC on HIV and AIDS-related stigma and 
QoL levels of PLWHIV, the differences in QoL and stigma levels between the 
groups of PLWHIV receiving HBC services or not discovered in this study 
suggest that HBC services could have an influence on these variables.  
 
5.6 CONCLUSION 
 
The results of the study suggest that PLWHIV on ART receiving HBC services 
experience less stigma and have a higher perceived QoL than PLWHIV also on 
ART but who are not receiving HBC services. This conclusion could be 
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considered to be obvious to the numerous health workers involved in the 
provision of HBC for PLWHIV. However, backing this impression with quantitative 
data comes as an important step, as the absence of a difference between the 
groups would have meant a lesser probability of the impact of HBC programmes 
on stigma and perceived QoL. As mentioned earlier, it does not, however, imply 
that the HBC programme is actually causing the higher perceived QoL and lower 
stigma. 
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APPENDICES 
Appendix A: Consent form in English 
INFORMED CONSENT FORM 
Dear participant,  
My name is Alexandre Massicotte and I currently completing a Master’s degree in Social Behaviour 
Studies in HIV/AIDS at the University of South Africa (UNISA). As a requirement for the degree, I have to 
conduct a research study about the response to HIV and AIDS in Africa. 
The purpose of the study is to better understand how people living with HIV and using 
antiretroviral treatment cope with their situation. For this reason, the study will measure some aspects of 
your life, such as quality of life, stigma and discrimination. 
 
This is an invitation to participate in this study. If you agree to do so, you will be asked to respond 
to questions about you and your experience in an interview that will last about two hours. Two hundred 
other participants in the community will also be asked to participate in this study. Your participation is 
voluntary and you will not be penalised in any way should you decide not to participate. This means that 
whether or not you participate in the study, you will still continue to receive the services of the counsellor at 
the ATS. And, if you are part of the home-based care project, you will still continue to receive visits at 
home. However, without your kind co-operation, we cannot gather scientific data that will help people 
rendering ARV services to continue planning and improving these services.  This is therefore an urgent 
appeal to you to please participate. Let me give you assurances about the extent of your participation: 
 
 You will note that we won’t ask your name during the interview. This is because nobody 
outside the research team has to know who answered what. After the questionnaires are 
completed, they will be sent to the researcher, who won’t be able to ascertain the names of 
the participants in the study. Everything you will discuss during the interview will be kept 
between you and the person asking the questions. So you can feel free to answer the 
questions as honestly as possible without fear that someone will know what you have said. 
You will be asked to sign the consent form, however, and the signed forms will be kept 
separate from the questionnaires in a locked safe and destroyed 3 years after the study has 
been completed. 
 
 Also, you can stop your participation at any time if you feel like you don’t want to be part of 
the study anymore. If, however, you want to be part of the study, the interviewer will discuss 
a possible date and time for the interview and ask you to sign this document in two copies: 
one will remain with you and the other one will be kept by the interviewer. 
 
If you need psychological support after answering the questions, please don’t hesitate to ask for help. The 
person who will be able to listen and give help is your normal advisor at the testing and counselling facility, 
or if you are part of the HBC programme, you can contact Olinda Magaia at Salama’s office. 
I have read and understood this consent form, and I agree to participate in this 
study. 
Participant’s signature:  Interviewer’s name: 
   
Signature  Signature 
   
Date  Date 
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Appendix B: Consent form in Portuguese 
TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO 
Prezado (a) participante,  
Meu nome é Alexandre Massicotte e neste moment estou a concluir um mestrado em Estudos do 
Comportamento Social e HIV-SIDA na Universidade da Africa do Sul (UNISA). Como exigência do programa, 
tenho que conduzir uma pesquisa social sobre um aspecto da resposta ao HIV e SIDA em Àfrica. 
O propôsito deste estudo e de conhecer melhor como diferentes pessoas vivendo com HIV 
recebendo antiretrovirais se adaptam a sua situação. Por esta razão, a pesquisa vai medir alguns aspectos 
da sua vida, como a sua qualidade de vida, o estigma e discriminação. 
 
Este é um convite para participar na pesquisa. Se aceitar, você deverá responder à um questionário 
sobre si e sua experiência, numa entrevista que levará umas duas horas. Duzentas outras pessoas da 
comunidade serão também selecionadas para participar neste estudo. A sua participação é de livre vontade 
e você não será penalizado se tomar a decisão de não participar. Isso significa que, participando na 
pesquisa como não, você continuará à se beneficiar dos serviços do conselheiro no ATS. Se neste momento 
você recebe voluntários do projecto de cuidados domiciliários, você continuará à receber as visitas em casa. 
Portanto, sem a sua colaboração, não poderemos juntar os dados que permitirão às pessoas que 
providenciam serviços ligados aos antiretrovirais de continuar o planeamento e melhorar estes serviços. Este 
é um apelo urgente para sua participação neste estudo. Gostaria de explicar melhor o que a sua 
participação ao estudo implica: 
 
 Você poderá notar que não vamos precisar de conhecer o seu nome durante a entrevista. A razão 
é simples: ninguém para além do grupo de pesquisadores poderá saber quem respondeu o qué. 
Depois de serem preenchidos, os formulários serão enviados ao pesquisador, e ele não conhecerá 
os nomes dos participantes da pesquisa. Tudo o que for dito durante a entrevista ficará entre você 
e o entrevistador. Por isso, você pode se sentir a vontade e responder honestamente às perguntas 
sem temer que alguém possa conhecer das suas respostas. Você deverá assinar o formulário de 
consentimento, e este formulário será conservado separadamente do questionário num lugar 
trancado e tudo será destruido 3 anos depois da conclusão do estudo. 
 
 Também, você pode retirar a sua participação na pesquisa a qualquer momento se quiser. 
Portanto, se quiser participar na pesquisa, o entrevistador vai marcar uma hora e uma data para a 
entrevista e pedir para que você assinasse este documento em dois exemplários: uma cópia ficará 
com você e a outra com o pesquisador. 
 
Se precisar de apoio psicológico depois da entrevista, não hesite em pedir ajuda. A pessoa que 
poderá escutar e dar apoio neste sentido é o seu conselheiro normal no ATS, ou, se você faz parte do 
programe de cuidados domiciliários, pode contactar Olinda Magaia no escritório da Salama.  
Li e entendi este termo de consentimento, e aceito participar nesta 
pesquisa.  
Nome do participante:  Nome do entrevistador: 
   
Assinatura  Assinatura 
   
Data  Data 
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Appendix C: Consent form in Emakua 
EKANYERYO YOTTHUNA  VOHIKHANYERERIHIWA NI YOLELEYA. 
Namakhalela ophenteia, 
N’sinanaka Alexandre Massicotte nanano va, kinmaliha ossoma makhalelo atthu vamos’a ni HIV-
SIDA,Escola wulupale eri ossulu wa W’africa, eniriwa (UNISA) Ntoko vantthuneyaia muteko owo, kihana 
wettiha ni oholela muteko wowehaweha muhin’a watthu,enamuna womwakhula HIV ni SIDA elapo ya 
Wafrica. Etthwaya yossoma ela, eri ossuwela orattene, mana xeni atthu ovirikana, ekhalaka ni HIV, ni 
yakhelaka mirette  sininkhulumula mwaxitthu olá, mota oniraya okhala ni n’xankiho olá. Tivó, yowehaweha 
ela enrowa ophima makhalelo khamosa khamosa, yorerela, ohiphaveliwa ni othanyiwa.  
N’no, olattuliwa wi mwire n’pantta  muteko ola Mwatthuna vale, nyuwo muhana wakhula sokohiwa 
mwa nyuwo, ntoko sinsuwelanyu yokoha enrowa okuxa iwora pili. Atthu ophiyeraka imiya pili 
ankomunidadeni walá anmuttettheni, anrowa othanliwa wira yire n’pantta muteko ene yola..Wira n’pantta 
mutekola, kahiyo wokhanyererihiwa, masí votthuna wanyu ni nyuwo khamunlamuliwa mwahitthune 
okhalela. Eyo enihimya wira,okhalela walá n’nari, nyuwo munotthikela wakhela miteko sa mulipa a miruku, 
weiwe omwaleiwa mutthu votthuna wawe..Nenla vakhala wira munniwakhela  mavoluntário a mwalano wo 
wakhaliherya arretta, nyuwo munrowa wotoliwaka ninlelo owani. Tivó ohikhanle mukhalihero anyu, 
khaninwerya otakhaniha yorerela wi atthu Yale avanhe miteko sololwana ni mirette, opwahera oholo ni 
oreriha miteko iya. N’la, nikano nowakuveya, wira mukhalele muteko olá. Kaniphavela  woleliheryani 
orattene  okhalela wanyu muteko olá enruhelaya: 
 
 N’yuwo munoweha  wi  khaninrowa ophavela osuwela n’sina nanyu okathi wa sokoha. Etthwaya 
tila: khavo, wahiya ale anrowa oholela muteko olá, onrowa  osuwela tani akhunle exeni. Samalá 
olepiwa ipaphelo  sinrowa  ovahiwa mulupa oholela  owehaweha iwo, nave owo khanrowa osuwela 
masina ale yirale n’pantta muteko olá. Sothene sinrowa ohinmwa okathi  wokohiwa,, sinrowa 
okhala ni nyuwo nule onrowa okoha. Tivó, nyuwo muhana wikhalela ni wakhula vorerela sokohiwa, 
vohova wi okhala onrowa oswela sakhunlyanyu. Nyuwo muhana olepa epaphelo yotthuna, ni 
epaphelo eyo enrowa osukiwa wovalanyiwa ni epaphelo ya sokoha, ni enrowa otthukeliwa, ni  
sothene sinrowa ohononiwa sivinrene iyakha ttharú omalihiwene muteko olá.  
 
 Nave nyuwo poti wikumiha, muhina wa muteko olá, okathi muntthunanyu. Tivó, mwatthuna 
okhalela, namakoha onrowa ohimya  nihiku ni okathi onrowawe wira sokoha iyo, ni munnivekeliwa 
wira  muhele ekanyero  walá n’sina , epaphelo pili, emosa enrowa ohala ni nyuwo ekina ni mulipa 
owehaweha sossoma..  
 
Mwaphavela okhaliheriwa ni miruku omanlele muteko wokohiwa, muhovelele ovekela. Mutthu 
onrowa wowiriyanani ni wokhaliheryani n’pantta owo, mulipanyu yole a miruku a mahiku othene, walá 
mwairaka n’pantta wa mutthenketjo wowakhaliherya aretta, mulume ni mai Olinda Sebastião Magaia, 
Osalama.  
Kossoma ni kohiwa sana epaphelo ela yotthuna, ni kokupali wira 
n’pantta muteko owo.  
 
N’sina na mulipa okhalela:  N’sina na mulipa ókoha: 
   
Ekanyero  Ekanyero 
   
Nihiku  Nihiku 
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Appendix D :  Questionnaire in English 
 
SOCIO-DEMOGRAPHIC QUESTIONNAIRE 
 
The purpose of the study is to help us understand how different people 
living with HIV and receiving antiretroviral treatment cope with their situation. 
You have been randomly selected for participation in this study. Your name is 
not asked and will not be written down on the questionnaire. You therefore 
remain anonymous. 239 other people living with HIV and receiving ARV-
treatment will also participate in this study. After the information has been 
collected, the data will be analysed together and this means that individual 
information will be reported together and cannot be linked to you personally. 
Only the research team sees the completed questionnaires. This means that all 
information you provide in answering these questions are confidential. You will 
be asked to respond to a few questions in 3 short questionnaires: one is on your 
personal background, the second asks questions about your quality of life and 
the third about stigma and discrimination. This would take about 90 minutes. I 
kindly ask you to help me by answering the following questions. 
 
Please circle the answer given by the participant to the following 
questions or write down the information requested: 
 
QUESTIONNAIRE 
NUMBER  
DATE  
NAME OF INTERVIEWER  
 
Beneficiary of Salama´s HBC programme 1 
Starting date on the programme (MONTH, YEAR) 
Non-Beneficiary of Salama´s HBC programme 2 
 
1 Gender Male 1 Female 2 
 
2 How old are you?  Age (years) 
 
3 
What is your 
highest level 
of education? 
None 1 
1-4th Grade 2 
5-6th Grade 3 
7-9th Grade 4 
10-12th Grade 5 
Post secondary school/ College/University 6 
 
4 What is your area of residence? 
Malema 1 
Ribáuè 2 
 
 153 
 
5 
 What is your 
current 
marital 
status? 
Single 1 
Married 2 
Separated 3 
Divorced 4 
Widowed 5 
 
6 
Do you 
belong to a 
church?  
Yes 1 
No 2 
 
7 
If “yes” to 
Question 6, 
please 
indicate to 
which church 
you currently 
belong. If 
“no” Please 
skip to 
Question 8. 
Catholic 1 
Twelve apostles 2 
Sion 3 
God’s assembly 4 
Christ Evangelical 5 
Old Apostles 6 
Jehovah’s witnesses 7 
Muslim 8 
Rainbow 9 
Anglican 10 
Presbyterian 11 
Other (which one?) 12 
 
8 
How often do 
you go to 
church? 
Every day 1 
A few times a week 2 
Once a week 3 
A few times a month, but less than once a week 4 
Once a month 5 
Never 6 
 
9 Do you have children? (0-18 years old) 
Yes 1 
No 2 
 
10 If yes, how many? If no, record 00.  
 
11 How many people are living in your household?  
 
12 When have you been diagnosed with HIV? (month, year) 
Month 
(MM) 
Year  
(YYYY) 
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13 
Have you ever been 
hospitalized because of 
HIV? 
Yes 1 
No 2 
 
14 
Have you ever had an 
opportunistic infection? 
(Interviewer: Refer to list 
of opportunistic 
infections) 
Yes 1 
No 2 
Don’t know 3 
 
15 
Do you have an 
opportunistic infection at 
the moment? 
(Interviewer: Refer to list 
of opportunistic 
infections) 
Yes 1 
No 2 
Don’t know 3 
 
16 
If yes, which 
opportunistic infection do 
you have at the moment? 
If no, skip to Question 18.
More than 10% body weight loss with 
diarrhoea or fever, intermittent or constant for 
at least 1 month
1 
Cryptococcal meningitis 2 
Pulmonary or extra-pulmonary tuberculosis 3 
Kaposi’s sarcoma 4 
Neurological impairment that is sufficient to 
prevent independent daily activities, not 
known to be due to a condition unrelated to 
HIV infection (for example, trauma, or 
cerebrovascular accident).
5 
Oral candiasis with difficulty in swallowing. 6 
Pneumonia 7 
Invasive cervical cancer 8 
Don’t know 9 
 
17 
If yes, for how long have you been suffering from this 
infection (the one mentioned in Question 16)?  Give the 
number of days, please. 
 
 
18 When did you start the antiretroviral treatment? (month, year) 
Month 
(MM) 
Year 
(YYYY) 
  
 
19 Have you ever stopped taking your ARV medication since the first time you started?  
Yes 1 
No 2 
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20 
What situation 
among these is 
best describing 
the way you use 
the treatment, at 
the moment? 
I use them exactly as the doctor told me 1 
I use them almost as the doctor told me, because 
sometimes I don’t take them or am late in taking them 2 
I am not using them as the doctor told me, because 
often I don’t take them or am late in taking them 3 
 
21 
Without counting health staff, 
how many other people know 
you have HIV? 
Nobody knows 1 
1-5 people 2 
6-15 people 3 
16-30 people 4 
More than 30 people 5 
 
22 
Who are 
the people 
who know 
you are HIV 
positive? 
Please mark all possibilities Yes No 
Husband/wife or boyfriend/girlfriend 1 2 
Children 1 2 
My mother and/or father 1 2 
Other family members 1 2 
Friends 1 2 
Neighbours 1 2 
People who gather at the same church 1 2 
Others (who? Please specify) 
 
 
23 Are you receiving visits from a home-based care project? 
Yes 1 
No 2 
 
24 
If yes, how often 
do you receive 
visits from the 
home-based care 
project 
volunteers? 
Every day 1 
A few times a week 2 
Once a week 3 
A few times a month, but less than once a week 4 
Once a month 5 
Other ( Please specify) 6 
 
 
25 - Do you have any comments to make about the study? 
 
 
 
 
 
Thanks, this is the end of the first questionnaire; we’ll now start on the 
second one 
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WHOQOL-BREF 
The following questions ask how you feel about your quality of life, health, or other 
areas of your life. I will read out each question to you, along with the response options. 
Please choose the answer that appears most appropriate. If you are unsure 
about which response to give to a question, the first response you think of is often the 
best one.  
  
Please keep in mind your standards, hopes, contentment and concerns. I ask 
that you think about your life in the last four weeks.  
 
 
Very 
poor  Poor  
Neither 
poor 
nor 
good   
Good  Very good  
1 
(G1)  
How would you rate your 
quality of life? 1  2  3  4  5  
 
  
Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied  Very satisfied 
2 
(G4)  
How 
satisfied are 
you with 
your 
health? 
1  2  3  4  5  
 
The following questions ask about how much you have experienced certain 
things in the last four weeks.  
  
Not at 
all  
A 
little  
A 
moderate 
amount  
Very 
much  
An 
extreme 
amount 
3 
(F1.4)  
To what extent do you 
feel that physical pain 
prevents you from doing 
what you need to do?  
1  2  3  4  5  
4 
(F11.3)  
To what extent do you 
need any medical 
treatment to function in 
your daily life?  
1  2  3  4  5  
5 
(F4.1)  
How much do you enjoy 
life?  1  2  3  4  5  
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 Not at 
all  
A 
little  
A 
moderate 
amount  
Very 
much  
An 
extreme 
amount 
6 
(F24.2)  
To what extent do you 
feel that your life is 
meaningful?  
1  2  3  4  5  
7 
(F5.3)  
How well are you able to 
concentrate?  1  2  3  4  5  
8 
(F16.1)  
How safe do you feel in 
your daily life?  1  2  3  4  5  
9 
(F22.1)  
How healthy is your 
physical environment?  1  2  3  4  5  
The following questions ask about how completely you experience or were able 
to do certain things in the last four weeks.  
 
  Not 
at 
all 
A 
little Moderately Mostly  Completely 
10 
(F2.1)  
Do you have enough 
energy for everyday life? 1  2  3  4  5  
11 
(F7.1)  
Are you able to accept 
your bodily appearance?  1  2  3  4  5  
 
  Not 
at 
all 
A 
little Moderately Mostly  Completely 
12 
(F18.1)  
Do you have enough 
money/resources to 
meet your needs?  
1  2  3  4  5  
13 
(F20.1)  
To what extent do you 
have easy access to 
information (about 
your health, rights, 
etc)?  
1  2  3  4  5  
14 
(F21.1)  
To what extent do you 
have the opportunity 
for leisure activities?  
1  2  3  4  5  
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Very 
poor  Poor  
Neither 
poor 
nor 
good   
Good  Very good  
15 
(F9.1)  
How well are you able 
to get around? 1  2  3  4  5  
 
  
Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied  
Satisfied  Very satisfied 
16 
(F3.3)  
How satisfied 
are you with 
your sleep?  
1  2  3  4  5  
17 
(F10.3)  
How satisfied 
are you with 
your ability to 
perform your 
daily living 
activities?  
1  2  3  4  5  
18 
(F12.4)  
How satisfied 
are you with 
your capacity 
for work?  
1  2  3  4  5  
19 
(F6.3)  
How satisfied 
are you with 
yourself?  
1  2  3  4  5  
20 
(F13.3)  
How satisfied 
are you with 
your personal 
relationships?  
1  2  3  4  5  
21 
(F15.3)  
How satisfied 
are you with 
your sex life?  
1  2  3  4  5  
22 
(F14.4)  
How satisfied 
are you with 
the support 
you get from 
your friends?  
1  2  3  4  5  
23 
(F17.3)  
How satisfied 
are you with 
the conditions 
of your living 
place?  
1  2  3  4  5  
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Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied  
Satisfied  Very satisfied 
24 
(F19.3)  
How satisfied 
are you with 
your access 
to health 
services?  
1  2  3  4  5  
25 
(F23.3)  
How satisfied 
are you with 
your 
transport?  
1  2  3  4  5  
The following question refers to how often you have felt or experienced certain 
things in the last four weeks.  
  
Never Seldom Quite often  
Very 
often  Always 
26 
(F8.1)  
How often do you have 
negative feelings such as 
blue mood, despair, anxiety, 
depression? 
1  2  3  4  5  
Do you have any comments about the assessment?  
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BERGER HIV STIGMA SCALE 
 
This study asks about some of the social and emotional aspects of having HIV.  For most of the 
questions, just circle the letters or numbers that go with your answer.  There is no right or wrong 
answer.  Feel free to write in comments as you go through the questions. 
 
This first set of questions asks about some of your experiences, feelings, and opinions as to how 
people with HIV feel and how they are treated.  Please do your best to answer each question. 
 
For each item, circle your answer:  Strongly disagree (SD), disagree (D), agree (A), or strongly 
agree (SA). 
  Strongly disagree Disagree  Agree 
Strongly 
agree 
1 In many areas of my life, no one knows that I have HIV □ □ □ □ 
2 I feel guilty because I have HIV □ □ □ □ 
3 People's attitudes about HIV make me feel worse about myself □ □ □ □ 
4 Telling someone I have HIV is risky □ □ □ □ 
5 People with HIV lose their jobs when their employers find out □ □ □ □ 
6 I work hard to keep my HIV a secret □ □ □ □ 
7 I feel I am not as good a person as others because I have HIV □ □ □ □ 
8 I never feel ashamed of having HIV □ □ □ □ 
9 People with HIV are treated like outcasts □ □ □ □ 
10 Most people believe that a person who has HIV is dirty □ □ □ □ 
11 
I prefer not to make friends 
because I am afraid I will have to 
tell them I have HIV 
□ □ □ □ 
12 Having HIV makes me feel unclean □ □ □ □ 
13 
Since learning I have HIV, I feel set 
apart and isolated from the rest of 
the world 
□ □ □ □ 
14 Most people think that a person with HIV is disgusting □ □ □ □ 
15 Having HIV makes me feel that I'm a bad person □ □ □ □ 
16 Most people with HIV are rejected when others find out □ □ □ □   
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  Strongly disagree Disagree Agree 
Strongly 
agree 
17 I am very careful who I tell that I have HIV □ □ □ □ 
18 Some people who know I have HIV have grown more distant □ □ □ □ 
19 
Since learning I have HIV, I worry 
about people discriminating against 
me 
□ □ □ □ 
20 Most people are uncomfortable around someone with HIV □ □ □ □ 
21 I never feel the need to hide the fact that I have HIV □ □ □ □ 
22 I worry that people may judge me when they learn I have HIV □ □ □ □ 
23 Having HIV in my body is disgusting to me □ □ □ □ 
 
 Many of the items in this next section assume that you have told other people that you 
have HIV, or that others know.  This may not be true for you.  If the item refers to something 
that has not actually happened to you, please imagine yourself in that situation.  Then give your 
answer ("strongly disagree," "disagree," "agree," "strongly agree") based on how you think you 
would feel or how you think others would react to you. 
 
  Strongly disagree Disagree Agree 
Strongly 
agree 
24 I have been hurt by how people reacted to learning I have HIV □ □ □ □ 
25 I worry that people who know I have HIV will tell others □ □ □ □ 
26 I regret having told some people that I have HIV □ □ □ □ 
27 As a rule, telling others that I have HIV has been a mistake □ □ □ □ 
28 Some people avoid touching me once they know I have HIV □ □ □ □ 
29 People I care about stopped calling after learning I have HIV □ □ □ □ 
30 
People have told me that getting 
HIV is what I deserve for how I 
lived my life 
□ □ □ □ 
31 
Some people close to me are afraid 
others will reject them if it becomes 
known that I have HIV 
□ □ □ □ 
32 People don't want me around their children once they know I have HIV □ □ □ □ 
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  Strongly disagree Disagree Agree 
Strongly 
agree 
33 
People have physically backed away 
from me when they learn I have 
HIV 
□ □ □ □ 
34 Some people act as though it's my fault I have HIV □ □ □ □ 
35 
I have stopped socializing with 
some people because of their 
reactions to my having HIV 
□ □ □ □ 
36 I have lost friends by telling them I have HIV □ □ □ □ 
37 
I have told people close to me to 
keep the fact that I have HIV a 
secret 
□ □ □ □ 
38 People who know I have HIV tend to ignore my good points □ □ □ □ 
39 People seem afraid of me once they learn I have HIV □ □ □ □ 
40 When people learn you have HIV, they look for flaws in your character □ □ □ □ 
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Appendix E: Questionnaire in Portuguese 
QUESTIONÁRIO SOCIO-DEMOGRÁFICO 
O propôsito deste estudo e de conhecer melhor como diferentes pessoas 
vivendo com HIV recebendo antiretrovirais se adaptam a sua situação. Você foi 
seleccionado de maneira aleatória para participar à este estudo. Não vamos 
precisar de conhecer o seu nome e esta informação não aparecerá no 
questionário. Assim, você ficará anônimo. 239 outras pessoas vivendo com HIV e 
recebendo tratamento antiretroviral vão também participar neste estudo. Depois 
de juntar as informações, os dados serão analizados em conjunto, o que significa 
que a informação individual será reportada em conjunto com a informação dos 
outros participantes e não poderá ser ligada à você. Somente a equipa de 
pesquisa poderá ver os questionários preenchidos. Isso significa que toda a 
informação proveniente das perguntas feitas ; confidencial. Você deverá 
responder às perguntas contidas em três curtos questionários: um deles tem à 
ver com a sua situação pessoal, o segundo tem a ver com a sua qualidade de 
vida e o terceiro está ligado ao estigma e discriminação. O processo levará mais 
ou menos 90 minutos. Peço a sua ajuda respondendo à seguintes perguntas. 
 
Por favor, assinalar a resposta dada pelo participante ou escrever 
a informação requirida: 
 
NÚMERO DO 
QUESTIONÁRIO 
 DATA  
Nome do entrevistador  
 
Beneficiário do programa de CD da Salama 1
Data de ingresso no programa de CD da 
Salama (Mês, ano):  
Não Beneficiário do programa de CD da Salama 2
 
1 Gênero Homem 1 
Mulher 2 
 
2 Quantos anos tem?  Idade (anos) 
 
3 
Qual é o 
último nível 
atingido no 
sistema de 
educação? 
Nenhum 1 
1-4a classe 2 
5-6ª classe 3 
7-9ª classe 4 
10-12ª classe 5 
Nível superior (estudos pós-secundários, universidade, etc.) 6 
 
4 
Qual é o seu 
local de 
residência? 
Malema 1 
Ribáuè 2 
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5 
Qual é o seu 
estado civil 
actual? 
Solteiro 1 
Casado 2 
Separado 3 
Divorciado 4 
Viúvo 5 
 
6 Você pertence à uma igreja? 
Sim 1 
Não 2 
 
7 
Se “sim”, qual 
igreja? Se 
não, pode 
avançar até a 
pergunta 8 
Católica 1 
Doze apóstolos 2 
Sione 3 
Assembleia de Deus 4 
Evangélica de Cristo 5 
Velhos apóstolos 6 
Testemunhos de Jeová 7 
Muçulmana 8 
Arco-Íris 9 
Anglicana 10 
Presbiteriana 11 
Outra (qual?) 12 
 
8 
Com que 
frequência 
você 
frequenta a 
igreja? 
Todos os dias 1 
Umas vezes por semana 2 
Uma vez por semana 3 
Algumas vezes por mês, mas menos do que uma vez por 
semana 4 
Uma vez por mês 5 
Nunca 6 
 
9 Você tem crianças? (0-18 anos) Sim 1 
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Não 2 
 
10 Se sim, quantas? Se não, escreve 00.  
 
11 Quantas pessoas vivem na sua casa?  
 
12 Quando é que você foi diagnisticado com HIV? (mês, ano) 
Mês  
(MM) 
Ano  
(AAAA) 
  
 
13 Alguma vez você ficou hospitalizado por causa do HIV? 
Sim 1 
Não 2 
 
14 
Alguma vez você teve uma infecção oportunista? 
(entrevistador: referir às infecções oportunistas 
mencionadas na pergunta 16) 
Sim 1 
Não 2 
Não sei 3 
 
15 
Você tem uma infecção oportunista neste 
momento? (entrevistador: referir às infecções 
oportunistas mencionadas na pergunta 16) 
Sim 1 
Não 2 
Não sei 3 
 
16 
Se sim, qual é a infecção 
oportunista que tem 
neste momento?. 
Mais de 10% de perca de peso com diarreia 
ou febre, intermitente ou constante durante 
pelo menos 1 mês
1 
Meningite (Criptococose) 2 
Tuberculos (pulmonária ou extra- 
pulmonária) 3 
Sarcoma de Kaposi 4 
Deficiência neurológica que é suficiente para 
impedir as actividades quotidianas, mas que 
não é causada por uma condição não 
relacionada com a infecção ao HIV (por 
exemplo, um acidente ou trauma 
cerebrovascular) 
5 
Candídiase oral com dificuldade em engolir 6 
Pneumonia 7 
Cancro de colo uterino invasivo 8 
Não sei 9 
 
17 
Você tem esta infecção oportunista há quanto tempo? 
(a infecção mencionada na pergunta 16)?  Por favor, 
menciona o número de dias.
 
 
18 Quando é que você começou a fazer o tratamento antiretroviral (Mês, ano) 
Mês  
(MM) 
Ano  
(AAAA) 
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19 Alguma vez parou o tratamento desde que o começou? 
Sim 1 
Não 2 
 
20 
Qual é a situação 
que expressa 
melhor a 
maneira como 
você usa os 
medicamentos 
antiretrovirais, 
neste momento. 
Tomo correctamente como fui orientado pelo médico 1 
Tomo quase correctamente, pois às vezes deixo de 
tomar ou atraso o horário dos remédios 2 
Não estou à tomar correctamente, pois muitas vezes 
deixo de tomar ou atraso o horário dos remédios 3 
 
21 
Sem contar os profissionais de 
saúde, quantas pessoas sabem 
que você é seropositivo(a)? 
Nenhuma 1 
1-5 pessoas 2 
6-15 pessoas 3 
16-30 pessoas 4 
Mais de 30 pessoas 5 
 
22 
Quais são as 
pessoas que 
sabem que 
você é 
seropositivo? 
Por favor assinalar todas as respostas 
mencionadas Yes No 
Esposo(a) ou namorado(a) 1 2 
Meu (s) filho (s) 1 2 
Minha mãe e/ou meu pai 1 2 
Outra (s) pessoa (s) da família 1 2 
Amigo (s) 1 2 
Vizinho (s) 1 2 
Pessoas da mesma igreja 1 2 
Outros (quem?) 
 
23 
Você recebe visitas de um 
projecto de cuidados 
domiciliários? 
Sim 1 
Não 2 
 
24 
Se sim, com que 
frequência você 
recebe visita dos 
voluntários do 
projecto de 
cuidados 
domiciliários? 
Todos os dias 1 
Algumas vezes por semana 2 
Uma vez por semana 3 
Algumas vezes por mês, mas menos do que uma vez 
por semana 4 
Uma vez por mês 5 
Outro ( Por favor especifique) 6 
 
25 - Você tem algum comentário à fazer em relação à este estudo?? 
 
 
 
Obrigado, já chegamos ao fim do primeiro questionário; agora vamos 
começar o segundo. 
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WHOQOL-BREF 
Este questionário procura conhecer a sua qualidade de vida, saúde, e outras 
áreas da sua vida. Por favor, responda a todas as perguntas. Se não tiver a certeza da 
resposta a dar a uma pergunta, escolha a que lhe parecer mais apropriada. Esta pode 
muitas vezes ser a resposta que lhe vier primeiro à cabeça.  
Por favor, tenha presente os seus padrões, expectativas, alegrias e 
preocupações. Pedimos-lhe que tenha em conta sua vida nas quatro últimas semanas. 
Por exemplo, se pensar nestas quatro últimas semanas, pode ter que responder à 
seguinte pergunta: 
 
 Nada Pouco Moderadamente Bastante 
Completa
mente 
Recebe das outras pessoas o tipo 
de apoio que necessita? 1  2  3  4  5  
 
Deve pôr um círculo à volta do número que melhor descreve o apoio que 
recebeu das outras pessoas nas quatro últimas semanas. Assim, marcaria o número 4 se 
tivesse recebido bastante apoio, ou o número 1 se não tivesse tido nenhum apoio dos 
outros nas quatro últimas semanas. Por favor leia cada pergunta, veja como se sente a 
respeito dela, e ponha um círculo à volta do número da escala para cada pergunta que 
lhe parece que dá a melhor resposta.  
 Muito 
Má Má 
Nem 
Boa 
Nem Má 
Boa Muito Boa 
1 (G1)  Como avalia a sua qualidade de vida?  1  2  3  4  5  
 
 
Muito 
Insatisfeito Insatisfeito
Nem 
satisfeito 
nem 
insatisfeito
Satisfeito Muito Satisfeito
2 
(G4)  
Até que ponto 
está 
satisfeito(a) 
com a sua 
saúde?  
1  2  3  4  5  
 
As perguntas seguintes são para ver até que ponto sentiu certas coisas nas quatro 
últimas semanas.  
  
Nada Pouco
Nem 
muito 
nem 
pouco 
Muito Muitíssimo
3 (F1.4)  
Em que medida as suas dores 
(físicas) o (a) impedem de 
fazer o que precisa de fazer?  
1  2  3  4  5  
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4 
(F11.3)  
Em que medida precisa de 
cuidados médicos para fazer a 
sua vida diária?  
1  2  3  4  5  
5 (F4.1)  Até que ponto gosta da vida?  1  2  3  4  5  
6 
(F24.2)  
Em que medida sente que a 
sua vida tem sentido?  1  2  3  4  5  
 
 Nada Pouco Nem muito nem pouco Muito Muitíssimo
7 
(F5.3)  
Até que ponto se 
consegue concentrar?  1  2  3  4  5  
8 
(F16.1)  
Em que medida se 
sente em segurança no 
seu dia-a-dia?  
1  2  3  4  5  
9 
(F22.1)  
Em que medida é 
saudável o seu 
ambiente físico?  
1  2  3  4  5  
 
As seguintes perguntas são para ver até que ponto experimentou ou foi capaz de fazer 
certas coisas nas quatro últimas semanas.  
 Nada Pouco Moderadamente  Bastante  
Complet
amente  
10 
(F2.1)  
Tem energia suficiente 
para a sua vida diária?  1  2  3  4  5  
11 
(F7.1)  
É capaz de aceitar a sua 
aparência física?  1  2  3  4  5  
12 
(F18.1)  
Tem dinheiro/recursos 
suficientes para 
satisfazer as suas 
necessidades?  
1  2  3  4  5  
13 
(F20.1)  
Até que ponto tem fácil 
acesso às informações 
(sobre sua saúde, seus 
direitos, etc.)?  
1  2  3  4  5  
14 
(F21.1)  
Em que medida tem 
oportunidade para 
realizar actividades de 
lazer?  
1  2  3  4  5  
 
 
  Muito 
Má  Má 
Nem 
boa 
nem má 
Boa Muito Boa  
15 
(F9.1)  
Como avaliaria a sua mobilidade 
[capacidade para se movimentar e 
deslocar por si próprio(a)]?  
1  2 3  4  5  
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As perguntas que se seguem destinam-se a avaliar se se sentiu bem ou satisfeito(a) em 
relação a vários aspectos da sua vida nas quatro últimas semanas.  
  
Muito 
Insatisfeito Insatisfeito
Nem 
satisfeito 
nem 
insatisfeito 
Satisfeito Muito Satisfeito
16 
(F3.3)  
Até que ponto está 
satisfeito(a) com o 
seu sono?  
1  2  3  4  5  
 
 Muito Insatisfeito Insatisfeito
Nem 
satisfeito 
nem 
insatisfeito 
Satisfeito Muito Satisfeito 
17 
(F10.3)  
Até que ponto 
está satisfeito(a) 
com a sua 
capacidade para 
desempenhar as 
actividades do 
seu dia-a-dia?  
1  2  3  4  5  
18 
(F12.4)  
Até que ponto 
está satisfeito(a) 
com a sua 
capacidade de 
trabalho?  
1  2  3  4  5  
19 
(F6.3)  
Até que ponto 
está satisfeito(a) 
consigo 
próprio(a)?  
1  2  3  4  5  
20 
(F13.3)  
Até que ponto 
está satisfeito(a) 
com as suas 
relações 
pessoais?  
1  2  3  4  5  
21 
(F15.3)  
Até que ponto 
está satisfeito(a) 
com a sua vida 
sexual?  
1  2  3  4  5  
22 
(F14.4)  
Até que ponto 
está satisfeito(a) 
com o apoio que 
recebe dos seus 
amigos?  
1  2  3  4  5  
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  Muito Insatisfeito Insatisfeito
Nem 
satisfeito 
nem 
insatisfeito 
Satisfeito Muito Satisfeito
23 
(F17.3)  
Até que ponto 
está 
satisfeito(a) 
com as 
condições do 
lugar em que 
vive?  
1  2  3  4  5  
24 
(F19.3)  
Até que ponto 
está 
satisfeito(a) 
com o acesso 
que tem aos 
serviços de 
saúde?  
1  2  3  4  5  
25 
(F23.3)  
Até que ponto 
está 
satisfeito(a) 
com os 
transportes que 
utiliza?  
1  2  3  4  5  
 
As perguntas que se seguem referem-se à frequência com que sentiu ou 
experimentou certas coisas nas quatro últimas semanas.  
 Nunca Poucas vezes 
Algumas 
vezes Frequentemente Sempre
26 
(F8.1)  
Com que 
frequência tem 
sentimentos 
negativos, tais 
como tristeza, 
desespero, 
ansiedade ou 
depressão?  
1  2  3  4  5  
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Escala de Berger sobre estigmatização das pessoas vivendo com HIV 
 
Você deve assinalar o número que corresponde melhor ao que você sente. Caso você 
concorde totalmente com a frase, você assinalará com um “X” o número 4, caso você discorde 
totalmente da frase, você assinalará o número 1. Se sua opinião é diferente dessas duas opções, 
marque 2 ou 3, conforme ela seja. 
 
Não há respostas certas ou erradas. O que importa é o que você acha que combina mais 
com seus sentimentos. Se você quiser, sinta-se à vontade para acrescentar qualquer observação 
ou comentário, à medida em que for respondendo as perguntas. Por favor, esforce-se para 
responder cada uma das perguntas da melhor forma possível, sem deixar nenhuma em branco. 
 
O primeiro grupo de perguntas trata das suas experiências, sensações e opiniões sobre 
como as pessoas com o HIV se sentem e sobre como elas são tratadas. 
 
 
 Discordo 
Totalmente 
(1) 
Discordo 
(2) 
Concordo 
(3) 
Concordo 
Totalmente 
(4) 
1 
Em muitas áreas da minha 
vida, ninguém sabe que eu 
tenho o HIV. 
□ □ □ □ 
2 Eu me sinto culpado por ter o HIV. □ □ □ □ 
3 
As atitudes das pessoas em 
relação ao HIV fazem com 
que eu me sinta pior comigo 
mesmo. 
□ □ □ □ 
4 Dizer a alguém que eu tenho o HIV é um risco. □ □ □ □ 
5 
As pessoas que têm o HIV 
perdem o emprego quando 
os patrões descobrem. 
□ □ □ □ 
6 
Eu me esforço muito para 
que as pessoas não saibam 
que eu tenho o HIV. 
□ □ □ □ 
7 
Eu não me sinto uma pessoa 
tão boa quanto as outras, 
porque eu tenho o HIV 
□ □ □ □ 
8 Eu nunca tenho vergonha de ter o HIV. □ □ □ □ 
9 
Pessoas que têm o HIV são 
tratadas como pessoas 
excluídas 
□ □ □ □ 
10 
A maioria das pessoas 
acredita que alguém que 
tem o HIV tem muitos 
parceiros sexuais. 
□ □ □ □ 
 172 
 
 
 Discordo 
Totalmente 
(1) 
Discordo 
(2) 
Concordo 
(3) 
Concordo 
Totalmente 
(4) 
11 
Prefiro nao criar mais 
amizades porque tenho 
receio de contar que tenho 
HIV 
□ □ □ □ 
12 Ter o HIV faz com que eu me sinta sujo (a) □ □ □ □ 
13 
Desde que eu soube que 
tinha o HIV, eu me sinto 
isolado(a) e excluído(a) do 
resto do mundo. 
□ □ □ □ 
14 
A maioria das pessoas acha 
que uma pessoa que tem o 
HIV é nojenta. 
□ □ □ □ 
15 
Ter o HIV faz com que eu 
me sinta uma pessoa 
péssima. 
□ □ □ □ 
16 
A maioria das pessoas que 
têm o HIV é rejeitada 
quando as outras pessoas 
descobrem. 
□ □ □ □ 
17 
Eu tomo bastante cuidado 
ao decidir a quem eu digo 
que tenho o HIV. 
□ □ □ □ 
18 
Algumas pessoas que sabem 
que eu tenho o HIV se 
distanciaram de mim. 
□ □ □ □ 
19 
Desde que eu soube que 
tinha o HIV, eu fico 
preocupado(a) se as pessoas 
vão me discriminar. 
□ □ □ □ 
20 
A maioria das pessoas não 
se sente a vontade quando 
está com alguém que tem o 
HIV. 
□ □ □ □ 
21 
Eu nunca sinto a 
necessidade de esconder o 
fato de que eu tenho o HIV. 
□ □ □ □ 
22 
Eu penso que as pessoas 
podem me julgar quando 
elas sabem que eu tenho o 
HIV. 
□ □ □ □ 
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 Discordo 
Totalmente 
(1) 
Discordo 
(2) 
Concordo 
(3) 
Concordo 
Totalmente 
(4) 
23 Ter o HIV em meu corpo me causa nojo. □ □ □ □ 
 
Muitas das afirmações abaixo partem da hipótese de que você já contou a outras 
pessoas que você é portador (a) do HIV ou que outras pessoas já sabem disso. Pode ser que 
este não seja o seu caso. Mesmo assim, se a afirmação relatar fatos ou situações que não 
aconteceram em sua vida, pedimos que você tente se imaginar nessas situações e dê a sua 
opinião, baseada em como você acha que se sentiria ou como você acha que as pessoas 
reagiriam nas situações descritas. Lembre-se, a forma de marcação das respostas continua igual 
à anterior: 
 
 Discordo 
Totalmente 
(1) 
Discordo 
 
(2) 
Concordo 
 
(3) 
Concordo 
Totalmente 
(4) 
24 
Eu me sinto magoado(a) 
pela maneira como as 
pessoas reagiram quando 
souberam que eu tinha o 
HIV.   
□ □ □ □ 
 
 
 Discordo 
Totalmente 
(1) 
Discordo 
 
(2) 
Concordo 
 
(3) 
Concordo 
Totalmente 
(4) 
25 
Eu fico preocupado(a) com o 
fato de que as pessoas que 
sabem que eu tenho HIV 
possam contar a outras 
pessoas. 
□ □ □ □ 
26 
Eu me arrependo de ter 
contado a algumas pessoas 
que eu tenho o HIV. 
□ □ □ □ 
27 
De forma geral, contar a 
outras pessoas que eu tenho 
o HIV foi um erro. 
□ □ □ □ 
28 
Algumas pessoas evitam me 
tocar quando sabem que eu 
tenho o HIV. 
□ □ □ □ 
29 
As pessoas que eu considero 
importantes para mim 
pararam de me ligar depois 
que souberam que eu tenho 
o HIV. 
□ □ □ □ 
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 Discordo 
Totalmente 
(1) 
Discordo 
 
(2) 
Concordo 
 
(3) 
Concordo 
Totalmente 
(4) 
30 
As pessoas me disseram que 
eu mereci ter adquirido o 
HIV por causa do modo 
como eu estava a viver. 
□ □ □ □ 
31 
Algumas pessoas próximas a 
mim têm medo de ser 
rejeitadas se todos ficarem a 
saber que eu tenho o HIV. 
□ □ □ □ 
32 
As pessoas não querem que 
eu tenha contato com seus 
filhos ou filhas depois que 
elas sabem que eu tenho o 
HIV. 
□ □ □ □ 
33 
As pessoas evitam contato 
físico comigo depois que 
sabem que eu tenho o HIV. 
□ □ □ □ 
34 
Algumas pessoas agem 
como se eu fosse culpado(a) 
por ter o HIV. 
□ □ □ □ 
35 
Eu parei de me encontrar 
com algumas pessoas por 
causa da reação delas ao 
fato de eu ter o HIV. 
□ □ □ □ 
36 
Eu perdi amigos quando 
contei para eles que eu tinha 
o HIV. 
□ □ □ □ 
37 
Eu pedi às pessoas próximas 
a mim que não contassem a 
ninguém que eu tenho o 
HIV. 
□ □ □ □ 
38 
As pessoas que sabem que 
eu tenho o HIV têm a 
tendência de ignorar minhas 
qualidades. 
□ □ □ □ 
39 
As pessoas sentem medo de 
mim quando sabem que eu 
tenho o HIV. 
□ □ □ □ 
40 
Quando alguém sabe que 
você tem o HIV, procura 
defeitos em seu caráter. 
□ □ □ □ 
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Appendix F: Questionnaire in Emakua 
Sokohaya sa  m´muttetthene 
Ophaveleya wa yossoma ela, eri para osswela orattene, enamuna atthu 
ovirikana ekhalaka ni HIV-SIDA ni yakhelaka mirette, onikhalelaya ni muxankiho 
ola. N’yuwo   mothanliwa wira mwire n’pamtta  wa yossoma elai. Khaninnrowa 
ophavela osswela n’sina nanyu, ni  muhupi olá  khunrowa okhumela n’papheloni 
ya sokoha. Siso, n’yuwo munrowa ovitheya.Atthu akina ophiyeraka emiya pili 
ekhalaka ni HIV-SIDA ni yakhela mirette, anrowqa nawo wira n’pantta wa 
yossoma ela. Numalá otakanihiwa mihupi, sinrowa wululiwa ni owehiwa orattene 
vamosá, eyo piyo, yohimiya ya mutthu n’mosá enrowa ohinmwaka puromosa 
niye sakina, masi kinrowa owassani. Anrowa pahi oweha ipaphelo sa sokoha, ti 
makhulupale Yale ari oholo wa yossoma eyo. Eyo, enihimya wira sohimya 
sothene siluluwanne ni sokoha, essíri. N’uwo muhana wakhula sokohiwa sothene, 
mwa sokoha ttharu sokhuveya: Emosá, eluluwanne ni makhalelo awinyu, yanenli 
ni makhalelo a ekumi anyu, ni yaneraru eluluwanne ni ohiphaveliwa ni 
othanyiwa. Sokoha iya sinrowa omaliha minutu miloko mili. Kinnovekelani 
mukhaliheryo, mwakhulaka sokoha sinttharelana: 
 
Por favor, assinalar a resposta dada pelo participante ou escrever 
a informação requirida: 
 
MUATHELO WA 
SOKOHA 
 Nihiku  
N´syna na mulipha okoha  
 
Mulipa okhaliheriwa ni Salama 1
Data de ingresso no programa de CD da 
Salama (Mês, ano):  
Mulipa ohikhaliheriwa ni Salama 2
 
1 Mutthwene 
Mulopwana 1 
Muthiyana 2 
 
2 Iyakha  
 
3 Osomawawe: 
Kyiavo 1 
Yo pajerya  ni yanexexe 2 
Ya nethanu  namosa 3 
Ya nethanu napili ni nethanu naxexe 4 
Ya namuloko ni yanamuloko ni pili 5 
Escola etokwene 6 
 
4 Onkhalanyu Malema 1 
Ribáuè 2 
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5 Mukhalelowanyo: 
Mutchiyé 1 
Othela 2 
Nomualamuala 3 
Omualaniwa 4 
Namukweli 5 
 
6 
Nyuwo 
munnetta 
okereja? 
Ina 1 
N´nari 2 
 
7 
Mwira “ayo”, 
ekereja xen? 
Mwira n’nari 
n’pwahereke 
oholo ni 
yokoha ya 
nethanu na 
ttharu (8) 
Católica 1 
Doze apóstolos 2 
Sione 3 
Assembleia de Deus 4 
Evangélica de Cristo 5 
Velhos apóstolos 6 
Testemunhos de Jeová 7 
Muçulmana 8 
Arco-Íris 9 
Anglicana 10 
Presbiteriana 11 
Ekina (Tivil?) 12 
 
8 
Imara kavi 
nyu 
munettanyu 
okereja iwó? 
Mahiko othene 1 
Mahiko vakanene va semanani 2 
Nihiko nimossa va semanani 3 
Mahiko vakani vamuerini 4 
Nihiko nimossa vamuerini 5 
N’kitonko 6 
 
9 Mokhalano anamuane? (0-18 anos) 
Ina 1 
N´nari 2 
 
10 Murino akavi? Ira hoye, muhilepe vo  etthu.  
 
11 Athu akavi ankala owan´nhinho?  
 
12 Musuwenle lini wi mokhalano HIV, ovinya mweri ni eyaka mwamwaleiwanyu? 
Mweri  
 
Eyakha 
  
 
13 
Nyuwo motoko waphaxar 
oxipiritali muaha wa 
muasithu a HIV? 
Ina 1 
N´nari 2 
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14 Montonko okhalano eretcha yowipunhera? 
Ina 1 
N´nari 2 
Nkisuwenle 3 
 
15 
Nyuwo mokhalana iretta 
sowisokonyera nanano va? 
(Namakoha: Muhimye 
iretta sikina sotutuxerya 
sihinmwale ni yokoha ya 
namuloko ni thanu na 
mosa) 
Sim 1 
Não 2 
Não sei 3 
 
16 
Mwira ayo, eretta xeni 
yowisokonyerya 
murinanyu nanano va? 
Ovukuwa olemela wanyu mwaha  wa 
n’mirimani wala nanxekuwa, okathi tu kathi 
wala okathi wovalana, vophiyerya mweri 
n’mosa 
1 
Meningite (Criptococose) 2 
Eyitica (Yannphumuni, wala n’nari) 3 
Sarcoma de Kaposi 4 
Ohimalela n’muruni ni wupuwela, 
muhinawerya ovara miteko sa mahikwene, 
vohikhala wi sitanyeriwe ni sokhumelela 
sovirikana ni HIV-SIDA (Ntoko ovulala, wala 
ovahuwa) 
5 
Orutthuwiya mwanó 6 
Ephumu 7 
Ovoreiya wa n´rupo noyara 8 
Nkisuwenle 9 
 
17 Nyuwo murina oretta olá  okhuma lini? (oretta yole ohinmwale nunmaro 16)?  Xontte muhimye mahiku maka  
 
18 Nyuwo n´pajenrye lini owurya ikinino mweri xeni ni eyaka xeni? (mweri ni eyakha) 
Mweri Eyakha 
  
 
19 Mwantoko ohiyerera owurya ikinino vapajenryanyu? 
Ayo 1 
N´nari 2 
 
20 
Nyuwo 
munwurya sai 
ekinino? 
Kinwura ntoko sihimmawe medico 1 
Kinawura apale kitharihelaka okathi mukina 
kin´nahiyerera muaha wolekelela owura ikinino 2 
Hoye, nkinwura sana wi emara yintchene kinnahiya 
owura wala kinapissera okati wa ikinino 3 
 
  
 178 
 
 
21 
Wahiya wa ale anvara muteko wa 
ekumi atchu akavi asuwenle wi  
mokhalano mwasitchu? 
Kavo kimulenlaka 1 
Mimosa na thanu atchuene 2 
Athanu namosa wala muloko 
nathano atchuene 3 
Muloko natchano namosa ni miloko 
miraru atchuene 4 
Opwaha-to miloko miraru atchuene 5 
 
22 
Atchu 
osuwenle wi 
mokhalano 
mwasithchue
ne yola tala: 
Xontte, muhimye  sowakhula sothene 
sihinmwale Ayo N´nari 
Aiyaka, mwasetaka 1 2 
Annáka 1 2 
Atíti, amáma 1 2 
Akina amussyaka 1 2 
Mpuanaka 1 2 
Namuathchamananaka 1 2 
Mutchu a ekereja 1 2 
Akina ko (thani) 
 
23 
Nyuwo munnichekuriwa ni 
mutchenkeso onaweyaweya 
iretcha? 
Ina 1 
N´nari 2 
 
24 
Wari ayo, imara 
kavi, 
munwakelanhu 
atchu a 
mutchenkeso 
enawehaweha 
aretcha 
animawani? 
Mahiko othene 1 
Mahiko vakanene va semanani 2 
Nihiko nimossa va semanani 3 
Mahiko vakani vamuerini 4 
Nihiko nimossa vamuerini 5 
Ekina (por favor especifique) 6 
 
25 - Nhu mokhalano yohima ekinaku wopaka yosoma ela? 
 
 
 
 
 
 
Koxukhuru, nophiya wokiseryani wa sokoha sopajerya. Vano ninrowa 
opajerya ya nenli. 
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WHOQOL-BREF 
Muayokoha ela enassa ossuwela, murrerelo wa mukaleloanhu, ekumi nitho ekina 
sammapurone makina samukaleloanhu xonthe muakule sokoha sothene. Muahikalano 
ekekayi mua yo koha wella, muthanle munonanhu wira thirene wekekahi. 
Ela podi okala yowakula yorerela ni imara sintchene muruni mwanhu. Xonthe mukaleno 
vavo mapatrawanho mukuweloamho, otheliwawanho, maxankihoanho, enovelekani wira 
mukaleno mupuelo wa okalawanho veri va isimana ixexe sokisera, n´tonhero mupuelo 
wo isimana sella exexe sokisera podiokalano yowakula wa yokoha ella. 
 Hoye Vakane Vakane vakane Vantchene Vantechenexa
Munakela m´wa atchu akina 
mukavihero mutthunanyu? 1  2  3  4  5  
 
Muhana ohela variari mwettelo m´pua mwa rota onhima sana mukalihero mwa 
kenlanho wa atchu akina isismana exexe sokissera. Siso mwa mukwenhenho mattelo wa 
nexexe mwa mukalihero munthene, wala mwattelo m´moha muaha okhaleno 
mukalihero n´nakala mmoha wa akina wa isimana ixexe sokissera. 
 
Sonthe musome wakula yokoha mone mota enovoreiayani wa intchitchimiho wa yella, ni 
muhele n´rota mwattelo wa mpimelo veri wa kula yokoha munlikahiheranhu wi enovaha 
yo wakula yarerela. 
 
 
Yonanara 
vantchene Yonanara
Nnakala 
yorera 
nnakala 
yonanara 
Yorera Yotepaxa orera 
1 
(G1)  
Mota heni 
munonelanhu 
mukaleloanhu?  
1  2  3  4  5  
 
 
Oyitteliwaxa Oyitteliwa
Nnakala 
otteliwa, 
nnakala 
oyitteliwa
Otteliwa Otteliwa vantchene 
2 
(G4)  
Npaka vavi 
mutheliwanhu 
nokumanho?  
1  2  3  4  5  
 
Mwa sokoha iya n´ninone n´paka vavi monnanho ittu kamosakamosa wa isimana exexe 
so kissera. 
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Hoye Vakane
N´nakala 
vatchene
, 
n´nakala 
vakhane 
Vantchene Vantchenexa
3 
(F1.4)  
N´paka vavi 
oretta wa 
eruthuanhu 
onokothiyerayan
e ovara 
muttekwanhu?  
1  2  3  4  5  
4 
(F11.3
)  
N´paka vavi 
muttunanhu wi 
n´nwehawehiye 
ekumi anyu?  
1  2  3  4  5  
 
 
Hoye Vakane
N´nakala 
vatchene, 
n´nakala 
vakhane 
Vantchene Vantchenexa 
5 
(F4.1)  
N´paka vavi 
onosivelayani 
okumi?  
1  2  3  4  5  
6 
(F24.2)  
Mota heni 
musuwenlanhu 
wi okumanhu 
wokhalano 
opwanela?  
1  2  3  4  5  
7 
(F5.3)  
N´paka lini 
muweranhu 
wikhalela?  
1  2  3  4  5  
8 
(F16.1)  
N´paka lini 
muweranhu 
okhala ni 
n´roromelo 
nihiku ti nihiku?  
1  2  3  4  5  
9 
(F22.1)  
N´paka vaví 
munonanyu wi 
okhala wanyu 
onnirera?  
1  2  3  4  5  
 
Sokoha ikinasene iri para wonihera n´paka vavi mwereranho wala mukanlanho kamosa 
wa isimana ixexe sokisera.  
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 Hoye Vakhane Vakhane Vakhane Vantchene Vantchenexa 
10 
(F2.1)  
Mokhalana 
ikhuru 
sinphiyera 
okhawanyu 
nihiku ti nihiku? 
1  2  3  4  5  
11 
(F7.1)  
Mokhala okupali 
okhala wa 
eruthu anyu? 
1  2  3  4  5  
12 
(F18.1
)  
Mokhalano 
mussuruku/ 
ompihera 
wokhaliherani 
mixankihosanho
? 
1  2  3  4  5  
13 
(F20.1
)  
N’pakha vavi, 
murinanyu 
okheiheriwa 
oleliwa ( sa 
ekumiannyu) 
1  2  3  4  5  
14 
(F21.1
)  
N´paka lini 
mukhanlanho 
okathi wa 
withuwa?  
1  2  3  4  5  
 
 
Ohonanara 
vantchene Yonanara
Nnakala 
yorera 
nnakala 
yonanara 
Yorera Yotepaxa orera 
15 
(F9.1)  
Muarowa 
ophima sai 
owerya wanyu, 
wira 
mwenyenye 
wala mwette 
n´mansinyu? 
1  2  3  4  5  
 
Sokoha sintharelana sipakheliwe wiwehaweha monele orera ni mwattheliwe mwaha va 
makalelo ekumanhu nwa mpuwa mwa isemana ixexe. 
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Oyitteliwaxa Oyitteliwa 
Nnakala 
otteliwa, 
nnakala 
oyitteliwa 
Otteliwa Otteliwa vantchene 
16 
(F3.3)  
Nikove sanho 
mutheliwa 
npakhavi?  
1  2  3  4  5  
17 
(F10.3)  
N´pakha vavi, 
munsiveliwanyu, 
ni eweryelo 
yovara miteko 
sanyu, nihiku ti 
nihiku? 
1  2  3  4  5  
18 
(F12.4)  
Muntteliwa 
n´paka vavi 
mwaweraka 
ovara 
mitekosanho?  
1  2  3  4  5  
19 
(F6.3)  
N´phaka vavi 
mutteliwanho 
nyuwo 
n´mansinyu?  
1  2  3  4  5  
20 
(F13.3)  
N´pakha vavi, 
munsiveliwanyu, 
nyuwo no atchu? 
1  2  3  4  5  
21 
(F15.3)  
N´pakha vavi, 
munsiveliwanyu 
ni makhalelo a 
ekhapa? 
1  2  3  4  5  
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 Oyitteliwaxa Oyitteliwa
Nnakala 
otteliwa, 
nnakala 
oyitteliwa 
Otteliwa Otteliwa vantchene
22 
(F14.4)  
Muntteliwa 
n´pakhavi 
nimukavihero 
munakelanho ni 
apatthanianyu? 
1  2  3  4  5  
23 
(F17.3)  
N´pakha vavi 
muntteliwanho 
ni makalelo a 
nipuro 
mukalanho?  
1  2  3  4  5  
24 
(F19.3)  
N´pakha vavi, 
munsiveliwanyu 
wa miteko 
sinpwanelanyu 
sa ekumi? 
1  2  3  4  5  
25 
(F23.3)  
N´pakha vavi, 
munsiveliwanyu 
ni mukukutta 
onokhaliheryani? 
1  2  3  4  5  
 
Sokoha sintharelana sihima opaka nille yovorenyeni mwerere ithu ikinasene mwa 
isemana ixexe sokisera.  
 
Nkintonko Imara vakani 
Imara 
eimosa 
emosa 
Imara 
sothene 
Kata 
emara
26 
(F8.1)  
Munkhala sai ni 
makhalelo onanara, 
n´toko oripiwa 
murima, ohiroromela, 
olipelela wala, 
opweleya? 
1  2  3  4  5  
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Ephimelo ya  withanya mwa atthu ankhala ni mwaxitthu 
 
N’yuwo muhana  ehela ekanyeryo nunmaro ninlikana orattene ele 
enowereyani. Mwakhala wira munnikupali vomalela enihimyaya, munrowa ohela 
ekanyeryo ni “X” nunmaro na nexexe Vano vakhala wira khamunkupali yohimya 
eyo,, munhela ekanyeryo nunmaro nopajerya (1). Nave, yakhala wira 
enupuwelanyu yovirikana ni miyupuelo ia mili, muhele ekanyeryo nunmaro na 
nenli walá na neraru n’tokó siryaya  
 
Kisavó sowakhuliwa orattene walá sovonyiwa.Yulupalexa  tile enonanyu 
wira ennilolwana nllé enovoreyani.Mwatthuná  mwikhalele,wira munjererye 
enonanyu opwanela wunjererya, walá okathi wowakhula sokoha. Xontte, 
mwilipiherye wira mwakhule sokoha khamosa khamosa, vanrerelaya, vohihiya 
n’nakhala emosá. . 
 
N’pantta wopajerya wa sokoha, onihimya sa osuwela wanyu, othamala 
wanyu, ni miruku sanyu mwa atthu Yale  anikhala ni HIV, makhalelo aya ni 
okhaliheriwa waya. 
 
  N´kinkupalesha N´kinkupali Kinnikupali Kinnicupalesha 
1 
Wa sovara saka mintchene 
sa okumi aka khavo 
onsuwela wi kokhalano 
mwasitchu 
□ □ □ □ 
2 Miyo kottheka mwaha wo khalano mwasitchu. □ □ □ □ 
3 
Makhalelo atchu wa mwaha 
wa mwasithcu annakiruhelo 
miyo otepacha mwanenaka. 
□ □ □ □ 
4 
Omulela mutchu wi miyo 
kokhalano mwasitchu 
diyawopiha. 
□ □ □ □ 
5 
Atchu arinono mwasitchu 
annihalela muteko wakhala 
wi ale ananvarelaya osuwela 
□ □ □ □ 
6 
Miyo kinnailipiha vantchene 
wi atchu ahisuwele wi miyo 
kokhalano mwasitchu. 
□ □ □ □ 
7 
Miyo inkinaisona okhala 
mutchu orera murima 
nntoko akina ntakhara miyo 
kokhalano mwasitchu 
□ □ □ □ 
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  N´kinkupalesha N´kinkupali Kinnikupali Kinnicupalesha 
8 Miyo khonakulihe muru vokhalano mwasitchu. □ □ □ □ 
9 
Atchu arinono mwasitchu 
annreheriwa nntoko atchu 
othanyiwa 
□ □ □ □ 
10 
Atchu anchene annikupali wi 
mukina akhalano mwasitchu 
onkhala namasivelasiwa. 
□ □ □ □ 
11 
Fatari ohi n’paka opathani 
tho wi kihalelihe wira 
kokhalano mwasitchu. 
□ □ □ □ 
12 
Okhalano mwasitchu 
onnakipakiha miyo 
wupuwela wi konanara 
□ □ □ □ 
13 
Ovinyera kasuwenlaka wi 
kakhalano mwasitchu, miyo 
kinnithaliwa okwipi welapo. 
□ □ □ □ 
14 
Atchu antchene annupuwela 
wi mutchu mmoha orinono 
mwasitchu tonanara. 
□ □ □ □ 
15 
Okhalano mwasitchu 
onnikiruhela wi miyo mutchu 
mmoha owopiha. 
□ □ □ □ 
16 
Atchu antchene arinono 
mwasitchu tothanheya 
yakhala wi atchu akina 
amonelela. 
□ □ □ □ 
17 
Miyo kinnikasopa vantchene 
wowivaherera wa olé 
kimmulelaka wi kokhalano 
mwasitchu. 
□ □ □ □ 
18 
Atchu akina asuwenle wi 
kokhalano mwasitchu 
arakamelana ni mi. 
□ □ □ □ 
19 
Owinyera kisuwenlaka wi 
miyo kokhalano mwasitchu 
miyo kiri awisasasa wi atchu 
anasa okithamyaka. 
□ □ □ □ 
20 
Atchu antchene annisona 
ohikhala sana vakhala ni 
mutchu orino mwasitchu. 
□ □ □ □ 
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N´kinkupalesha N´kinkupali Kinnikupali Kinnicupalesha 
21 
Miyo n´kinona wi kivithé, 
mwaha wokhalana 
mwasitchu. 
□ □ □ □ 
22 
Miyo kinnupuwela wi atchu 
akhala okiphuka yakhala wi 
asuwela wi kokhalano 
mwasitchu. 
□ □ □ □ 
23 
Okhalano mwasitchu 
mwerutchuni mwaka 
onnakithanyera othanyeya. 
□ □ □ □ 
 
Sohimya sintchene sa vathi, sin´natthumiha wi nyuwo muhalela atchu akina, wi 
nyuwo mokhalana mwasitchu, walá, atchu akina asuwela. Vakhala vohikhala 
vawinyu. Siso, yakhala wira sohimya sokhumelela, khasinireya mwa nyuwo, 
ninnivekela wira nyuwo muhana wupuwela siso, ni ovaha miruku, sinlolowana, 
mota warowanyu wana, walá mota sheni atchu sarowaya wonela itchu sosa 
salakeliwe. 
 
 Mupuwele, enamuna yohela ekanyeryo sokoha  enotthikela olikana ntoko ottulí. 
 
  N´kinkupalesha N´kinkupali Kinnikupali Kinnicupalesha 
24 
Miyo kinnona ovoreya, mota 
atchu sakikhalihaya, 
vansuwenlaya wira 
kokhalana mwasitchu.   
□ □ □ □ 
25 
Miyo kiri awasasa vekekhayi 
wi atchu asuwenle wi 
kokhalano mwasitchu akhala 
owalelaka atchu akina. 
□ □ □ □ 
26 
Miyo kinnittharua vowalela 
atchu akinaku wi kokhalano 
mwasitchu. 
□ □ □ □ 
27 
Wa makhalelo othene walela 
atchu akinaku wi kokhalano 
mwasitchu vari yovonyeya. 
□ □ □ □ 
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  N´kinkupalesha N´kinkupali Kinnikupali Kinnicupalesha 
28 
Atchu akina annikithanya, 
yasuwelaru wira kokhalano 
mwasitchu. 
□ □ □ □ 
29 
Atchu miyo kinaroromelaka 
ekekhayi ntakhara miyo 
ohiya okishikha vanonto 
asuwenlaya wi kokhalano 
mwasitchu. 
□ □ □ □ 
30 
Atchu akilenle wira myo 
kopuanela okhalana 
mwasitchu, mota kakhalaka 
ni ekumyaka. 
□ □ □ □ 
31 
Atchu akina akanttamenle, 
annova okottiwa yakhala 
wira osuwela wi myo 
kokhalano mwasitchu 
□ □ □ □ 
32 
Atchu akina khiattuna wira 
miyo kitakhanyerryane ni 
enaya vasuwenlaya wira 
miyo kokhalano mwasitchu. 
□ □ □ □ 
33 
Atchu khampavela 
okikwanya miyo, vasuenlaya 
wira miyo kokhalano 
mwasitchu. 
□ □ □ □ 
34 
Atchu akina anupuwela wi 
miyo kokhalana mulattu 
vanthowa wokhalano 
mwasitchu. 
□ □ □ □ 
35 
Miyo kohiya okumana ni 
atchu akina vanthowa na 
enamuna enkikhalihaya, 
vasuwenlaya wira miyo 
vokhalano mwasitchu. 
□ □ □ □ 
36 
Miyo akitchawa 
asinthamwenaka emara 
kalenlaka yawo wo khalano 
mwasitchu. 
□ □ □ □ 
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 N´kinkupalesha N´kinkupali Kinnikupali Kinnicupalesha 
37 
Miyo kahavekela atchu 
akuvenle ni miyo wi ahikhale 
analeliwe wi kokhalano 
mwasitchu. 
□ □ □ □ 
38 
Atchu asuwenle wi miyo 
kokhalano mwasithchu 
akhalano werera aohishikha 
ekhalelo aka, ni orera waka. 
□ □ □ □ 
39 
Atchu akhalano wova wa 
miyo asuwenlaya wi 
kokhalano mwasitchu. 
□ □ □ □ 
40 
Akhala mukina osuwente wi 
miyo kokhalana mwasitchu 
onniphavela sonana sa 
epantte yawaó. 
□ □ □ □ 
 
 
 
